<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions for ulceration and other skin changes caused by nerve damage in leprosy - Reinar, LM - 2019 | Cochrane Library</title> <meta content="Interventions for ulceration and other skin changes caused by nerve damage in leprosy - Reinar, LM - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012235.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interventions for ulceration and other skin changes caused by nerve damage in leprosy - Reinar, LM - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012235.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012235.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Interventions for ulceration and other skin changes caused by nerve damage in leprosy" name="citation_title"/> <meta content="Liv Merete Reinar" name="citation_author"/> <meta content="Norwegian Institute of Public Health" name="citation_author_institution"/> <meta content="livmerete.reinar@fhi.no" name="citation_author_email"/> <meta content="Louise Forsetlund" name="citation_author"/> <meta content="Norwegian Institute of Public Health" name="citation_author_institution"/> <meta content="Linda Faye Lehman" name="citation_author"/> <meta content="American Leprosy Missions" name="citation_author_institution"/> <meta content="Kjetil G Brurberg" name="citation_author"/> <meta content="Norwegian Institute of Public Health" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD012235.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/07/31" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012235.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012235.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012235.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012235.pub2&amp;doi=10.1002/14651858.CD012235.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="PrHmaMrX";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012235\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012235\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012235\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012235\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ms","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012235.pub2",title:"Interventions for ulceration and other skin changes caused by nerve damage in leprosy",firstPublishedDate:"Jul 31, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Skin Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=PrHmaMrX&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012235.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012235.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012235.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012235.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012235.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012235.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012235.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012235.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012235.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012235.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3057 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012235.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-sec-0113"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-sec-0071"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-sec-0107"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/appendices#CD012235-sec-0118"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/table_n/CD012235StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/table_n/CD012235StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interventions for ulceration and other skin changes caused by nerve damage in leprosy</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/information#CD012235-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Liv Merete Reinar</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/information#CD012235-cr-0003">Louise Forsetlund</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/information#CD012235-cr-0004">Linda Faye Lehman</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012235.pub2/information#CD012235-cr-0005">Kjetil G Brurberg</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/information/en#CD012235-sec-0128">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 31 July 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012235.pub2">https://doi.org/10.1002/14651858.CD012235.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012235-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012235-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012235-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012235-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012235-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012235-abs-0001" lang="en"> <section id="CD012235-sec-0001"> <h3 class="title" id="CD012235-sec-0001">Background</h3> <p>At the end of 2016, 145 countries reported to the World Health Organization (WHO) over 173,000 new cases of leprosy worldwide. In the past 20 years, over 16 million people have been treated for leprosy globally. The condition's main complications are injuries and ulceration caused by sensory loss from nerve damage. In this review we explored interventions to prevent or treat secondary damage to the skin in people affected by leprosy (Hansen's disease). This is an update of a Cochrane Review published in 2008. </p> </section> <section id="CD012235-sec-0002"> <h3 class="title" id="CD012235-sec-0002">Objectives</h3> <p>To assess the effects of education, information, self‐care programmes, dressings, skin care, footwear and other measures for preventing and healing secondary damage to the skin in persons affected by leprosy. </p> </section> <section id="CD012235-sec-0003"> <h3 class="title" id="CD012235-sec-0003">Search methods</h3> <p>We updated our searches of the following databases up to July 2018: the Cochrane Skin Group Specialised Register, CENTRAL, MEDLINE, Embase, AMED, LILACS, and CINAHL. We also searched five trial registers, three grey literature databases, and the reference lists of included studies for further references to relevant randomised controlled trials (RCTs). </p> </section> <section id="CD012235-sec-0004"> <h3 class="title" id="CD012235-sec-0004">Selection criteria</h3> <p>RCTs or quasi‐RCTs or randomised cross‐over trials involving anyone with leprosy and potential damage to peripheral nerves who was treated with any intervention designed to prevent damage, heal existing ulcers, and prevent development of new ulcers. Eligible comparisons were usual care, no interventions, or other interventions (e.g. other types of dressings or footwear). </p> </section> <section id="CD012235-sec-0005"> <h3 class="title" id="CD012235-sec-0005">Data collection and analysis</h3> <p>We adhered to standard methodological procedures expected by Cochrane. Primary outcomes were prevention of ulcer(s), healing of existing ulcer(s) and adverse events. We used GRADE to assess the certainty of evidence for each outcome. </p> </section> <section id="CD012235-sec-0006"> <h3 class="title" id="CD012235-sec-0006">Main results</h3> <p>We included 14 trials (854 participants). Eleven studies reported on gender (men: 472, women: 157). Participant age varied from 18 to 74 years. Most participants had a single, mainly non‐infected, wound on one foot, which had been there for less than a year. Only seven studies reported whole study duration (there was no follow‐up post‐treatment), which was on average six months (range: 1 to 12 months). The studies were conducted in Brazil, Ethiopia, Egypt, Indonesia, Mexico, South Korea, and India. Many 'Risk of bias' assessments were rated as unclear risk due to limited information. Six studies had high risk of bias in at least one domain, including selection and attrition bias. </p> <p>Thirteen studies evaluated different interventions for treating existing ulcers, one of them also evaluated prevention of new ulcers. One study aimed to prevent skin changes, such as cracking and fissures. Investigated interventions included: laser therapy, light‐emitting diode (LED), zinc tape, intralesional pentoxifylline, pulsed magnetic fields, wax therapy, ketanserin, human amniotic membrane gel, phenytoin, plaster shoes, and footwear. </p> <p>We are uncertain about the following key results, as the certainty of evidence is very low. All time points were measured from baseline. </p> <p>Three studies compared zinc tape versus other interventions and reported results in favour of zinc tape. One study compared zinc tape versus magnesium sulphate: at one month the number of healed ulcers and reduction in mean ulcer area was higher with zinc tape (risk ratio (RR) 2.00, 95% confidence interval (CI) 0.43 to 9.21, and mean difference (MD) ‐14.30 mm², 95% CI ‐26.51 to ‐2.09, respectively, 28 participants). Another study compared zinc tape and povidone iodine and found that even though there was a greater reduction in ulcer area after six weeks of treatment with zinc tape, there was no clear difference due to the wide 95% CI (MD 128.00 mm², 95% CI ‐110.01 to 366.01; 38 participants). The third study (90 participants) compared adhesive zinc tape with gauze soaked in Eusol, and found the healing time for deep ulcers was less compared to zinc tape: 17 days (95% CI 12 to 20) versus 30 days (95% CI 21 to 63). Adverse events were only collected in the study comparing zinc tape with gauze soaked in Eusol: there were no signs of skin sensitisation in either group at two months. </p> <p>Two studies compared topical phenytoin versus saline dressing and reported results in favour of phenytoin. One study reported a greater mean percentage reduction of ulcer area after four weeks with phenytoin 2% (MD 39.30%, 95% CI 25.82 to 52.78; 23 participants), and the other study reported a greater mean percentage reduction of ulcer volume (16.60%) after four weeks with phenytoin (95% CI 8.46 to 24.74; 100 participants). No adverse events were observed with either treatment during the four‐month treatment period (2 studies, 123 participants). Prevention of ulcers was not evaluated in these nor the zinc studies, as the interventions were not for preventative use. </p> <p>Two studies compared protective footwear (with or without self‐care) with either 1) polyvinyl chloride (PVC) boots, or 2) pulsed magnetic fields plus self‐care and protective footwear. In the study comparing canvas shoes versus PVC boots, none of the 72 participants with scars at the start of the study developed new ulcers over one‐year follow‐up. Healing of ulcers was assessed in 38 participants from this study, but we are unclear if there is a difference between groups. In the study comparing pulsed magnetic fields (in addition to self‐care and protective footwear) to only self‐care and footwear in 33 participants, we are uncertain if the mean volume of ulcers at four to five weeks' follow‐up was different between groups; this study did not evaluate the prevention of ulcers. Information for adverse events was only reported in the study comparing canvas shoes with PVC boots; the authors stated that the PVC boots could become hot in strong sunlight and possibly burn the feet. </p> </section> <section id="CD012235-sec-0007"> <h3 class="title" id="CD012235-sec-0007">Authors' conclusions</h3> <p>Based on the available evidence, we could not draw firm conclusions about the effects of the included interventions. The main evidence limitations were high or unclear risk of bias, including selection, performance, detection, and attrition bias; imprecision due to few participants in the studies; and indirectness from poor outcome measurement and inapplicable interventions. Future research should clearly report important outcomes, such as adverse events, and assess widely available interventions, which should include treatments aimed at prevention. These trials should ensure allocation concealment, blinding, and an adequate sample size. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012235-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012235-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012235-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012235-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012235-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012235-abs-0005">Bahasa Malaysia</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012235-abs-0004" lang="en"> <h3>Treatments for ulcers (wounds) and other skin changes in people with leprosy</h3> <p><b>Review question</b> </p> <p>We reviewed the evidence about the effects of treatments (e.g. education, self‐care, dressings, skin care, or footwear) designed to prevent or treat skin damage in people with leprosy and those with potential damage to peripheral nerves<i>.</i> Treatments could be compared against usual care, no treatment, or another treatment. Evidence is current to July 2018. </p> <p><b>Background</b> </p> <p>Leprosy (Hansen's disease) is a long‐lasting, infectious global disease, which may lead to complications like injuries and development of wounds (ulcers), particularly on the feet. Long‐term nerve and muscle damage impacts a person's quality of life, leading to mental and financial difficulties. Late diagnosis is the greatest cause of disability, so the key to effective management is early diagnosis and treatment, and early recognition and management of nerve damage, combined with effective health education to prevent limb damage. This review aimed to address uncertainties regarding the best way to prevent and treat skin damage. </p> <p><b>Study characteristics</b> </p> <p>We included 14 trials (854 participants with leprosy). Participants mostly had only one wound on one foot. Wounds were mainly simple (not infected) and varied in size and depth, and were less than one year old; some wounds were more complicated. Participants ranged from 18 to 74 years old. In the 11 studies which reported gender, more men were included. Studies were conducted in Brazil, Ethiopia, Egypt, Indonesia, Mexico, South Korea, and India, in mainly outpatient clinics. Most studies did not report funding sources. </p> <p>Treatments were mostly compared to dry dressings or dressings soaked in differing solutions. Other comparisons included special plaster, canvas shoes, and foot soak. </p> <p><b>Key results</b> </p> <p>Treatments evaluated included: laser therapy, light‐emitting diode (LED), zinc tape or paste, pentoxifylline injections, exposure to pulsed magnetic fields, wax therapy, ketanserin gel, amniotic membrane gel, phenytoin powder, plaster shoes, and footwear. Outcomes were measured from the beginning of treatment. The following key results are based on very low‐certainty evidence, so we are not sure of these results. </p> <p>Three studies compared zinc tape with other interventions: magnesium sulphate glycerin, povidone iodine, or gauze soaked in Eusol. After one month of treatment, the number of healed ulcers was higher and the ulcer area was lower in the zinc tape group compared with magnesium sulphate glycerin. There was no clear difference in the reduction of ulcer area at six weeks when comparing zinc tape to povidone iodine. The healing time for deep ulcers in the zinc tape group was 17 days compared to 30 days with gauze soaked in Eusol. This study also reported no signs of skin sensitisation in either group at two months; the other two studies provided no data on adverse events. </p> <p>Two studies compared topical phenytoin to salt water dressing. One study showed a greater reduction in ulcer area with phenytoin. The other study found a greater reduction in ulcer volume in favour of phenytoin. Both studies measured this outcome after four weeks of treatment. No adverse events were observed in either study. </p> <p>The five studies just described did not assess prevention of ulcers, as the therapies were for treatment rather than prevention. </p> <p>Two studies compared protective footwear (with or without self‐care) with either polyvinyl chloride (PVC ‐ a form of plastic) boots, or pulsed magnetic fields plus self‐care and protective footwear. In the study comparing canvas shoes versus PVC boots, none of the participants who had scars at the start developed new ulcers over one year. There was no clear difference between the groups in the number of people whose ulcers had healed. In the study assessing pulsed magnetic fields, prevention of new ulcers was not measured; however, there was no clear difference between groups in volume of ulcers four to five weeks after the start of treatment. Only one study reported information about adverse events: the PVC boots could become very hot in strong sunlight, with the possibility of burning. </p> <p><b>Certainty of the evidence</b> </p> <p>We judged the evidence as very low certainty, meaning the results are ambiguous. There were concerns regarding how participants were allocated to treatments, whether participants and study investigators knew which treatment had been received, and the number of participants who dropped out of the studies. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012235-sec-0113" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012235-sec-0113"></div> <h3 class="title" id="CD012235-sec-0114">Implications for practice</h3> <section id="CD012235-sec-0114"> <p>This review aimed to assess the effects of education, information, self‐care programmes, dressings, skin care, footwear, and other measures for preventing and healing secondary damage to the skin in persons affected by leprosy. Due to the ambiguity of the evidence (all of our key comparisons were based on very low‐certainty evidence), it is not possible to draw firm conclusions regarding the effects of each intervention assessed in this review on our prespecified outcomes. </p> <p>For some commonly recommended interventions (like self‐care, education), there is a lack of trials (but lack of evidence does not mean that interventions do not work). </p> <p>The evidence presented in this review was mainly based on very small studies, which makes it more difficult to provide reliable conclusions, and these studies assessed different interventions/comparisons, meaning there was too much clinical heterogeneity for meaningful meta‐analysis. </p> </section> <h3 class="title" id="CD012235-sec-0115">Implications for research</h3> <section id="CD012235-sec-0115"> <p>Further randomised trials are needed, and they should ensure the following.</p> <p> <ul id="CD012235-list-0015"> <li> <p>Allocation is concealed.</p> </li> <li> <p>Participants and outcome assessors are blinded.</p> </li> <li> <p>A sample size calculation is conducted to ensure enough participants are included to detect true effects of the intervention. </p> </li> <li> <p>Measures are made to ensure participants are followed up until the end of the study to reduce attrition bias. </p> </li> </ul> </p> <p>Future trials should consult the Cochrane Skin Outcomes Set Initiative to check for any core outcome measures (<a href="./references#CD012235-bbs2-0057" title="CochraneSkin . Core Outcome Set Initiative. cs‐cousin.org (accessed 8 July 2019). ">CS‐COUSIN</a>). </p> <p>Self‐care and simple dry dressings should be evaluated in new trials. Phenytoin and zinc tape might deserve further investigation (instead of expensive, novel, hospital‐based interventions). It would be helpful if some of the interventions that one or two of the trials indicated might be helpful, were tested in other well‐conducted trials. Comparisons could be usual care or other interventions (for example, other types of dressings, other types of footwear, other interventions designed to prevent or treat damage). There is a lack of trials evaluating interventions such as footwear and self‐care that aim to prevent ulcers and other skin changes; this should be addressed in future research. Wax therapy to prevent ulcers is another intervention that might be evaluated further; however, it is a therapy that so far is used in specialist care only. </p> <p>Based on what we have summarised, we suggest that future trialists ensure that they clearly report how they measure side effects, that participants are asked about acceptability of treatment, and that evaluated interventions are available in the community (not only hospital based). Outcomes, such as quality of life, acceptability of the intervention, and costs should be investigated more thoroughly in all new trials. Reporting of trials should follow Consort Guidelines (<a href="./references#CD012235-bbs2-0071" title="MoherD , SchulzKF , AltmanDG . The CONSORT statement: revised recommendations for improving the quality of reports of parallel‐group randomised trials. Lancet2001;357(9263):1191‐4. [MEDLINE: 11323066] ">Moher 2001</a>). </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012235-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012235-sec-0022"></div> <div class="table" id="CD012235-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Zinc tape compared to magnesium sulphate glycerin for ulceration caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Zinc tape compared to magnesium sulphate glycerin for ulceration caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic, India (<a href="./references#CD012235-bbs2-0014" title="WaltonR , FritschiE , UmapathyV . Treatment of plantar ulcers in leprosy patients in the community with adhesive zinc tape. Leprosy Review1986;57(1):53‐6. [CENTRAL: CN‐00181239] ">Walton 1986</a>)<br/> <b>Intervention:</b> zinc tape<br/> <b>Comparison:</b> magnesium sulphate/glycerin </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with magnesium sulphate/glycerin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Zinc tape</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcers</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Primary outcome: healing of ulcers (number of ulcers healed after 1 month)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.00<br/> (0.43 to 9.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>143 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>286 per 1000<br/> (61 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcers</p> <p>(mean ulcer area (mm<sup>3</sup>)<br/> Follow‐up: mean of one month </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean ulcer area was 56.7</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 14.3 lower<br/> (26.51 lower to 2.09 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Priimary outcome: adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: costs</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (such as 35% lost to follow‐up, consecutive cases were randomly allocated, no blinding of outcome assessor, and potential unit of analysis error). Also downgraded two levels for imprecision due to sparse data and wide confidence intervals. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012235-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Zinc tape compared to povidone iodine (10%) for ulceration and other skin changes caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Zinc tape compared to povidone iodine (10%) for ulceration and other skin changes caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration and other skin changes caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic, Indonesia (<a href="./references#CD012235-bbs2-0006" title="OverbeekST , ThamLM . Effect of zinc oxide tape on plantar ulcers in leprosy in Indonesia [Het effect van zinkoxide‐tape op plantaire ulcera bij leprapatiënten in Indonesië]. Nederlands Tidshrift foor Geneeskunde1991;135(30):1350‐3. [CENTRAL: CN‐00616028] ">Overbeek 1991</a>)<br/> <b>Intervention:</b> zinc tape<br/> <b>Comparison:</b> povidone iodine (10%) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with povidone iodine (10%)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with zinc tape</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcers</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcers</p> <p>(mean reduction of ulcer area at 6 weeks (mm<sup>2</sup>)) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction of ulcer area at six weeks was 260</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 128 higher<br/> (110.01 lower to 366.01 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: costs</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (quasi‐randomised trial, high loss to follow‐up, and no reporting of blinding of outcome assessor), and two levels due to imprecision (1 study, few participants, wide confidence interval). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012235-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Adhesive zinc tape compared to gauze soaked in eusol for ulceration caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Adhesive zinc tape compared to gauze soaked in eusol for ulceration caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration caused by nerve damage in leprosy<br/> <b>Setting:</b> hospital in India (<a href="./references#CD012235-bbs2-0013" title="SöderbergT , HallmansG , StenströmS , LoboD , PintoJ , MaroofS , et al. Treatment of leprosy wounds with adhesive zinc tape. Leprosy Review1982;53(4):271‐6. [CENTRAL: CN‐00181158] ">Söderberg 1982</a>)<br/> <b>Intervention:</b> adhesive zinc tape<br/> <b>Comparison:</b> gauze soaked in eusol </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign=""> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Risk with gauze soaked in eusol</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Risk with adhesive zinc tape</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Primary outcome: prevention of ulcers</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Total number of participants was 90 and they had a total of 128 plantar ulcers<sup>b</sup>. The average healing time was shorter for the group treated with zinc tape. The results varied between the two hospitals involved. In one hospital, it took about 20 days (CI 18 to 23) for superficial ulcers to heal in the zinc tape group versus about 30 (CI 27 to 33) in the gauze group. For deep ulcers the average healing time was two weeks more. In the other hospital, the average number of days to heal in the zinc tape group for superficial wounds was about 13 (CI 9 to 15) days and 23 (CI 16 to 28) days in the gauze group. For deep ulcers it took 17 days (CI 12 to 20) in the zinc tape group and 30 (CI 21 to 63) in the gauze group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events (skin sensitisation at 2 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The study authors reported: "No signs of skin sensitization were observed in either the tape‐treated or the gauze‐treated wounds". </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Secondary outcome: quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not clear how or if this was adequately measured. However, the study authors say: "The zinc tape has the following advantages: 1. shorter healing time, 2. low cost, 3. easy application, 4. more convenient for patients: (a) can be worn under shoes without causing pressure; (b) socially more acceptable, no bandages are needed". </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: costs</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (allocation random alternate basis, no blinding outcome assessor, and inadequate reporting of data), and two levels for imprecision (few participants)).<br/> <sup>b</sup> There was a lack information on how many participants and how many ulcers (deep or superficial ulcers) there were in intervention and control group. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012235-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Topical ketanserin (2%) compared to clioquinol cream (3%) or zinc paste for ulceration caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Topical ketanserin (2%) compared to clioquinol cream (3%) or zinc paste for ulceration caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic, Mexico (<a href="./references#CD012235-bbs2-0009" title="SalazarJ , SerranoG , Leon‐QuinteroG , Torres‐MendozaB . Use of topical ketanserin for the treatment of ulcers in leprosy patients. Indian Journal of Leprosy2001;73(2):103‐10. [CENTRAL: CN‐00374140] ">Salazar 2001</a>)<br/> <b>Intervention:</b> topical ketanserin (2%)<br/> <b>Comparison:</b> clioquinol cream (3%) or zinc paste </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with clioquinol cream (3%) or zinc paste</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with topical ketanserin (2%)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Primary outcome: prevention of ulcers</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Primary outcome: healing of ulcers (healing of ulcer at 3 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 6.00<br/> (1.45 to 24.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>66<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>61 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>364 per 1000<br/> (88 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events<br/> (assessed at 3 months as minimum, moderate or severe) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Treatment was not suspended in any of the patients because of side effects</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: cost of intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (randomisation procedure not reported, blinding not reported, and unclear if appropriate statistical analysis used) and two levels due to imprecision (1 study, very wide confidence interval).<br/> <sup>b</sup>Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (randomisation procedure not reported, blinding not reported), one level due to indirectness (not clear how side effects were measured and reported), and one level due to imprecision (1 study). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012235-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Topical phenytoin compared to saline dressing for ulceration and other skin changes caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Topical phenytoin compared to saline dressing for ulceration and other skin changes caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration and other skin changes caused by nerve damage in leprosy<br/> <b>Setting:</b> hospital, India<br/> <b>Intervention:</b> topical phenytoin: 2% (<a href="https://archie.cochrane.org/sections/documents/view?version=z1901301230375818131380639122700%26format=REVMAN#STD-Bhatia-2004" target="_blank">Bhatia 2004</a>), unknown (<a href="https://archie.cochrane.org/sections/documents/view?version=z1901301230375818131380639122700%26format=REVMAN#STD-Bansal-1993" target="_blank">Bansal 1993</a>)<br/> <b>Comparison:</b> saline dressing </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with saline dressing</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with topical phenytoin (2%)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcers</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcers (mean percentage of ulcer volume reduction at 4 weeks (<a href="./references#CD012235-bbs2-0001" title="BansalN , Mukul . Comparison of topical phenytoin with normal saline in the treatment of chronic trophic ulcers in leprosy. International Journal of Dermatology1993;32(3):210‐3. [CENTRAL: CN‐00091437] ">Bansal 1993</a>)) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean percentage reduction of ulcer volume was 55.5%</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 16.60% higher<br/> (8.46 higher to 24.74 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcers</p> <p>(mean percentage reduction of ulcer size area at 4 weeks (<a href="./references#CD012235-bbs2-0003" title="BhatiaA , NandaS , GuptaU , GuptaS , ReddyB . Topical phenytoin suspension and normal saline in the treatment of leprosy trophic ulcers: a randomised, double blind, comparative study. Journal of Dermatological Treatment2004;15(5):321‐7. [CENTRAL: CN‐00491464] ">Bhatia 2004</a>)) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean percentage reduction of ulcer size area was 49.1%</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 39.30% higher<br/> (25.82 higher to 52.78 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events</p> <p>(up to 4 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No adverse effects were observed in any of the patients treated with phenytoin or normal saline. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>123</p> <p>(2 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: cost of intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (non‐adequate random sequence generation, unit of analysis error) and two levels due to imprecision (sparse data and consequently wide confidence interval).<br/> <sup>b</sup>Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (unclear whether allocation was concealed and high risk of attrition bias) and two levels due to imprecision (sparse data). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012235-tbl-0006"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Footwear ‐ canvas shoes compared to PVC boots for ulceration and other skin changes caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Footwear ‐ canvas shoes compared to PVC boots for ulceration and other skin changes caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration and other skin changes caused by nerve damage in leprosy<br/> <b>Setting:</b> community practice, Ethiopia (<a href="./references#CD012235-bbs2-0011" title="SebokaG , SaundersonP , CurrieH . Footwear for farmers affected by leprosy. Leprosy Review1998;69(2):182‐3. [CENTRAL: CN‐00339604] ">Seboka 1998</a>)<br/> <b>Intervention:</b> footwear ‐ canvas shoes<br/> <b>Comparison:</b> footwear ‐ PVC boots </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with PVC boots</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with canvas shoes</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Primary outcome: prevention of ulcer (number of persons developing new ulcers at 1 year) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>None of the 45 participants with scars developed new ulcers</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>None of the 27 participants with scars developed new ulcers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 (1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Seventy‐two participants had scars (not ulcers) at the start of the study (27 in canvas group, 45 in PVC group) and none of these developed new ulcers during the year. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Primary outcome: healing of ulcer (number of persons being ulcer‐free at 1 year)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.16<br/> (0.77 to 1.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>38<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>692 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>803 per 1000<br/> (533 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Primary outcome: healing of ulcer (number of persons having ulcers not healed at 1 year) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.52<br/> (0.15 to 1.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>38<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>308 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>160 per 1000<br/> (46 to 538) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>One adverse comment was that PVC boots could become very hot in strong sunlight, with possibility of burning the feet </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The canvas shoes were socially acceptable, but 85% of farmers rated them as good for their work, rather than "excellent" (8%) at first follow‐up at three months. More than 80% rated the PVC boots as excellent for social acceptability and work suitability. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>110<sup>d</sup> </p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: costs</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>110<sup>d</sup> </p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Costs not reported. Study authors only reported that canvas shoes and PVC boots cost the same. PVC boots are more durable than canvas shoes. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (unclear randomisation, unclear blinding) and two levels due to imprecision (1 study, small number of participants, wide confidence interval).<br/> <sup>b</sup>Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (unclear randomisation, unclear blinding), one level due to indirectness (unclear how this outcome was measured), and one level for imprecision.<br/> <sup>c</sup>Downgraded by one level to moderate‐certainty evidence. One level due to study limitations (unclear randomisation, unclear blinding).<br/> <sup>d</sup>For these outcomes, the results are reported for all 110 participants in the study (i.e. those with existing ulcers and those with no existing ulcers). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012235-tbl-0007"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Padded moulded double‐rocker plaster shoe compared to padded below‐knee plaster for ulceration and other skin changes caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Padded moulded double‐rocker plaster shoe compared to padded below‐knee plaster for ulceration and other skin changes caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration and other skin changes caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic, India (<a href="./references#CD012235-bbs2-0008" title="PringDJ , CasiebancaN . Simple plantar ulcers treated by below‐knee plaster and moulded double‐rocker plaster shoe ‐ a comparative study. Leprosy Review1982;53(4):261‐4. [CENTRAL: CN‐00249869] ">Pring 1982</a>)<br/> <b>Intervention:</b> padded moulded double‐rocker plaster shoe<br/> <b>Comparison:</b> padded below‐knee plaster </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with padded below‐knee plaster</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with padded moulded double‐rocker plaster shoe</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Primary outcome: healing of ulcer (ulcers fully or nearly healed at 6 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.96<br/> (0.77 to 1.19) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>55<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>875 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>840 per 1000<br/> (674 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study authors stated: "The MD shoe is more acceptable to the patient"</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: costs of intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study authors stated: "The MD shoe is ......cheaper to apply and, more important.."</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : moulded double‐rocker; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (no information on baseline characteristics; unit of analysis is ulcers, not patients; unclear randomisation procedure; unclear if blinding of outcome assessor), one level due to indirectness (padded moulded double‐rocker plaster shoe and padded below‐knee plasters might not be acceptable interventions today for people with leprosy), and one level due to imprecision (1 study, small number of participants). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012235-tbl-0008"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Exposure to pulsed magnetic fields (in addition to self‐care and protective footwear) compared to self‐care and footwear for ulceration and other skin changes caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Exposure to pulsed magnetic fields (in addition to self‐care and protective footwear) compared to self‐care and footwear for ulceration and other skin changes caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration and other skin changes caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic, India (<a href="./references#CD012235-bbs2-0010" title="SarmaGR , SubrahmanyamS , DeenabandhuA , BabuCR , MadhivathananS , KesavarajN . Exposure to pulsed magnetic fields in the treatment of plantar ulcers in leprosy patients ‐ a pilot , randomized, double blind, controlled clinical trial. Indian Journal of Leprosy1997;69(3):241‐50. [CENTRAL: CN‐00145841] ">Sarma 1997</a>)<br/> <b>Intervention:</b> exposure to pulsed magnetic fields (in addition to self‐care and protective footwear)<br/> <b>Comparison:</b> self‐care and footwear </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign=""> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Risk with self‐care and footwear</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Risk with exposure to pulsed magnetic fields (in addition to self‐care and protective footwear)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (at 4 to 5 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>In the control group, the geometric mean volumes of the ulcers were 2843 cu mm and 1478 cu mm on the day of admission and at the end of treatment (P = 0.03); the corresponding values in the PMF group were 2428 cu mm and 337 cu mm, respectively (P &lt; 0.001). A decrease in the volume of 40% or more was observed in 53% of control patients and 89% of PMF participants (P = 0.02): a decrease of 80% or more was observed in none of the controls and in 33% of PMF participants. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome 2 (healing of ulcer):</p> <p>Mean volume of ulcers at four to five weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean volume (cm<sup>2</sup>) after four to five weeks was 1.48 </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD was 1.14 lower (5.37 lower to 3.09 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome 3 (adverse events)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome 1 (quality of life)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome 2 (acceptability of treatment)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome 3 (cost of intervention)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The authors state: "The cost of construction of an enclosure is around Rs. 5000/‐ (about 150 USD) and the function generator together with the centre‐zero milliammeter costs another Rs. 6000/‐ (about 180 USD). Where uninterrupted power supply is a problem, an inverter and a 12‐volt battery together costing about RS. 5000/‐ (about 150 USD) would be required." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>PMF</b> : pulsed magnetic field; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup> Downgraded by three levels. One level due to study limitations (unclear randomisation procedure, 7 of 20 patients lost to follow‐up) and two levels due to imprecision (1 study with few participants). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012235-tbl-0009"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Low‐level laser therapy compared to simple dressing for ulceration and other skin changes caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Low‐level laser therapy compared to simple dressing for ulceration and other skin changes caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration and other skin changes caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic in Brasil (<a href="./references#CD012235-bbs2-0002" title="BarretoJG , SalgadoCG . Clinic‐epidemiological evaluation of ulcers in patients with leprosy sequelae and the effect of low level laser therapy on wound healing: a randomized clinical trial. BMC Infectious Diseases2010;10:237. [CENTRAL: CN‐00760396; PUBMED: 20698989] ">Barreto 2010</a>)<br/> <b>Intervention:</b> low‐level laser therapy<br/> <b>Comparison:</b> simple dressing </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with simple dressing</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with low‐level laser therapy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (size of ulcer (area) at 12 weeks (cm<sup>2</sup>)) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean size of ulcer (area) after 12 weeks was 4.4</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.60 lower<br/> (6.47 lower to 5.27 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (size of ulcer (depth) at 12 weeks (mm))</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean size of ulcer (depth) after 12 weeks was 5.4</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1.30 mm lower<br/> (5.26 lower to 2.66 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse effects</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: costs</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Costs not analysed between groups, but trial authors state: "Patients have an average of 3.4 simple dressings per week at the dressing service of UREMC, resulting in an estimated expenditure of USD 100,000 per year on disposable dressing material alone." </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by four levels. One level due to study limitations (unclear allocation concealment, no blinding of outcome assessor), one level due to indirectness (we are unsure if the intervention ‐ laser therapy ‐ is available to people with ulcers caused by nerve damage in leprosy) and two levels due to imprecision (1 study, small sample size, wide confidence interval).<br/> <sup>b</sup>Downgraded by four levels. One level due to study limitations (unclear allocation concealment, no blinding of outcome assessor), one level due to indirectness (we are unsure if the intervention ‐ laser therapy ‐ is available to people with ulcers caused by nerve damage in leprosy) and two levels due to imprecision (1 study, small sample size). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012235-tbl-0010"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 10.</span> <span class="table-title">Intralesional pentoxifylline compared to daily simple dressing for ulceration and other skin changes caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Intralesional pentoxifylline compared to daily simple dressing for ulceration and other skin changes caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration and other skin changes caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic, Egypt (<a href="./references#CD012235-bbs2-0005" title="MikhaelNM , El‐EsawyFM . Intralesional pentoxifylline in the treatment of lepromatous ulcers. Journal of the Egyptian Women's Dermatologic Society2015;12(2):102‐7. [CENTRAL: CN‐01299200] ">Mikhael 2015</a>)<br/> <b>Intervention:</b> intralesional pentoxifylline<br/> <b>Comparison:</b> daily simple dressing </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with daily simple dressing</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with intralesional pentoxifylline</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Primary outcome: healing of ulcer (complete healing of ulcer at 4 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 9.00<br/> (1.64 to 49.45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>500 per 1000<br/> (154 to 846) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (ulcer depth (cm) at 4 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean ulcer depth was 0.45</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.22 cm lower<br/> (0.40 lower to 0.04 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events (at 4 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The patients were asked about any possible side effects such as pain, skin rash, discolouration, or discomfort. There were no side effects, except tolerable pain during the injection in intervention group. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝<br/> Very low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: cost of intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>OR</b> : odds ratio; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by three levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment and unclear if there was blinding of outcome assessor) and two levels due to imprecision (1 small study, very wide confidence intervals).<br/> <sup>b</sup>Downgraded by three levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment and unclear if there was blinding of outcome assessor), one level due to imprecision (1 small study) and one level due to indirectness (unclear how information of side effects were documented and if both intervention and control group were asked). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012235-tbl-0011"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 11.</span> <span class="table-title">Light‐emitting diode (LED) irradiation compared to conventional dressing therapy for ulceration and other skin changes caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Light‐emitting diode (LED) irradiation compared to conventional dressing therapy for ulceration and other skin changes caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration and other skin changes caused by nerve damage in leprosy<br/> <b>Setting:</b> hospital/outpatient clinic, Korea (<a href="./references#CD012235-bbs2-0004" title="LeeRH , LeeJM , KimJP . Research on effect of light emitting diode (LED) on treating skin ulcer of Hansen's disease. Korean Leprosy Bulletin2012;45(1):41‐52. [CENTRAL: CN‐01045879] ">Lee 2012</a>)<br/> <b>Intervention:</b> light‐emitting diode (LED) irradiation<br/> <b>Comparison:</b> conventional dressing therapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with conventional dressing therapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with LED irradiation</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (mean change of wound size (mm<sup>3</sup>) after 8 months treatment) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change of wound size was 26.55</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 311.47 higher<br/> (106.47 higher to 516.47 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: cost of intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by three levels to very low‐certainty evidence. One level due to study limitations (concealment or sequence generation not reported, no blinding) and two levels due to imprecision (only 1 study, few participants, wide confidence interval). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012235-tbl-0012"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 12.</span> <span class="table-title">Wax therapy compared to foot soaks for skin changes caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Wax therapy compared to foot soaks for skin changes caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> skin changes caused by nerve damage in leprosy<br/> <b>Setting:</b> hospital, India (<a href="./references#CD012235-bbs2-0012" title="SharmaR , BargotraR , GuptaR , DarHA . Comparative study of the effects of wax therapy and foot soaks on dry plantar skin and ulcers in leprosy patients. JK Science2005;7(2):81‐3. [CENTRAL: CN‐01911700; EMBASE: 40846955] ">Sharma 2005</a>)<br/> <b>Intervention:</b> wax therapy<br/> <b>Comparison:</b> foot soaks </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with foot soaks</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with wax therapy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not applicable</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Tertiary outcome: prevention and treatment of other skin changes (number of feet being fissure‐ and callous‐free at 6 weeks) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.22<br/> (1.07 to 4.60) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>44<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>300 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>666 per 1000<br/> (321 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse effects</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment (at 6 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>"Patients given wax therapy felt subjectively much better than those who had foot soaks" </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outome: cost of intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT</b> : randomised controlled trial; <b>RR</b>: risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by four levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment, unclear if outcome assessor was blinded, and study authors are not clear in numbers of persons or feet reported), two levels due to imprecision (1 study with 44 participants, wide confidence interval) and one level due to indirectness (wax therapy probably not available to most people with leprosy; treatment is given in hospital).<br/> <sup>b</sup>Downgraded by four levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment, unclear if outcome assessor was blinded, and study authors are not clear in numbers of persons or feet reported), two levels due to imprecision (1 study with 44 participants) and one level due to indirectness (wax therapy probably not available to most people with leprosy; treament is given in hospital). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012235-tbl-0013"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 13.</span> <span class="table-title">hAMMSC‐CM + vitamin C compared to hAMMSC‐CM for ulceration caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>hAMMSC‐CM + vitamin C compared to hAMMSC‐CM for ulceration caused by nerve damage in leprosy </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic in Indonesia (<a href="./references#CD012235-bbs2-0007" title="PrakoeswaCR , NatallyaFR , HarnindyaD , ThohirohA , OktaviyantiRN , PratiwiKD , et al. The efficacy of topical human amniotic membrane‐mesenchymal stem cell‐conditions medium (hAMMSC‐CM) and a mixture of topical hAMMSC‐CM + vitamin C and hAMMSC‐CM + vitamin E on chronic plantar ulcers in leprosy: a randomised control trial. Journal of Dermatological Treatment2018;29(8):835‐40. [CENTRAL: CN‐01607409; DOI: 10.1080/09546634.2018.1467541] ">Prakoeswa 2018</a>)<br/> <b>Intervention:</b> hAMMSC‐CM + vitamin C<br/> <b>Comparison:</b> hAMMSC‐CM </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with</b> </p> <p><b>hAMMSC‐CM</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with</b> </p> <p><b>hAMMSC‐CM + vitamin C</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not applicable</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (size, cm², at 8 weeks)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction was 1.70</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.31 cm<sup>2</sup> higher </p> <p>(0.35 lower to 0.97 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (depth, cm², at 8 weeks)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction was 0.35</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.10 cm<sup>2</sup> lower </p> <p>(0.17 lower to 0.03 lower)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>"No adverse events were encountered in any group"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outome: cost of intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by three levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment, unclear if outcome assessor was blinded), two levels due to imprecision (1 study with a total of 66 patients with three arms).<br/> <sup>b</sup>Downgraded by three levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment, unclear if outcome assessor was blinded, one level due to sparce data (1 study with a total of 66 patients with three arms) and one level due to other considerations (unclear how adverse events were measured). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012235-tbl-0014"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 14.</span> <span class="table-title">hAMMSC‐CM + vitamin E compared to hAMMSC‐CM for ulceration caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>hAMMSC‐CM + vitamin E compared to hAMMSC‐CM for ulceration caused by nerve damage in leprosy </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic in Indonesia (<a href="./references#CD012235-bbs2-0007" title="PrakoeswaCR , NatallyaFR , HarnindyaD , ThohirohA , OktaviyantiRN , PratiwiKD , et al. The efficacy of topical human amniotic membrane‐mesenchymal stem cell‐conditions medium (hAMMSC‐CM) and a mixture of topical hAMMSC‐CM + vitamin C and hAMMSC‐CM + vitamin E on chronic plantar ulcers in leprosy: a randomised control trial. Journal of Dermatological Treatment2018;29(8):835‐40. [CENTRAL: CN‐01607409; DOI: 10.1080/09546634.2018.1467541] ">Prakoeswa 2018</a>)<br/> <b>Intervention:</b> hAMMSC‐CM + vitamin E<br/> <b>Comparison:</b> hAMMSC‐CM </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with</b> </p> <p><b>hAMMSC‐CM</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with</b> </p> <p><b>hAMMSC‐CM + vitamin E</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not applicable</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (size, cm<sup>2</sup> at 8 weeks) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction was 1.70</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1<b>.</b>14 cm<sup>2</sup> higher </p> <p>(0.35 higher to 0.97 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (depth, cm<sup>2</sup> at 8 weeks) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction was 0.35</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.08 cm<sup>2</sup> lower </p> <p>(0.17 lower to 0.01 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study authors reported: "No adverse events were encountered in any group"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outome: cost of intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by three levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment, unclear if outcome assessor was blinded), two levels due to imprecision (1 study with a total of 66 patients with 3 arms).<br/> <sup>b</sup>Downgraded by three levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment, unclear if outcome assessor was blinded), one level due to sparce data (1 study with a total of 66 patients with 3 arms) and one level due to other considerations (unclear how adverse events were measured). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012235-tbl-0015"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 15.</span> <span class="table-title">hAMMSC‐CM + vitamin E compared to hAMMSC‐CM + vitamin C for ulceration caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>hAMMSC‐ CM +vitamin E compared to hAMMSC‐CM + vitamin C for ulceration caused by nerve damage in leprosy </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic in Indonesia (<a href="./references#CD012235-bbs2-0007" title="PrakoeswaCR , NatallyaFR , HarnindyaD , ThohirohA , OktaviyantiRN , PratiwiKD , et al. The efficacy of topical human amniotic membrane‐mesenchymal stem cell‐conditions medium (hAMMSC‐CM) and a mixture of topical hAMMSC‐CM + vitamin C and hAMMSC‐CM + vitamin E on chronic plantar ulcers in leprosy: a randomised control trial. Journal of Dermatological Treatment2018;29(8):835‐40. [CENTRAL: CN‐01607409; DOI: 10.1080/09546634.2018.1467541] ">Prakoeswa 2018</a>)<br/> <b>Intervention:</b> hAMMSC‐CM + vitamin E<br/> <b>Comparison:</b> hAMMSC‐CM + vitamin C </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with</b> </p> <p><b>hAMMSC‐CM + vitamin C</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with</b> </p> <p><b>hAMMSC‐CM + vitamin E</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not applicable</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (size, cm<sup>2</sup>, at 8 weeks) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction was 2.01</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.83 cm<sup>2</sup> higher </p> <p>(0.03 lower to 1.69 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (depth, cm<sup>2</sup>, at 8 weeks) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction was 0.25</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.02 cm<sup>2</sup> higher </p> <p>(0.06 lower to 0.10 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study authors reported: "No adverse events were encountered in any group"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p>Very low<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outome: cost of intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by three levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment, unclear if outcome assessor was blinded), two levels due to imprecision (1 study with a total of 66 patients with three arms).<br/> <sup>b</sup>Downgraded by three levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment, unclear if outcome assessor was blinded, one level due to sparce data (1 study with a total of 66 patients with 3 arms) and one level due to other considerations (unclear how adverse events were measured). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012235-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012235-sec-0023"></div> <p>We have included a glossary with an explanation of some of the terms used, see <a href="#CD012235-tbl-0016">Table 1</a>. </p> <div class="table" id="CD012235-tbl-0016"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Glossary of terms</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Definition</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Afferent nerves</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensory nerves that carry information from the outside world, such as sensations of heat, cold, and pain, to the brain and spinal cord. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Autonomic fibres</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nerve fibres that collectively make up the sympathetic (involuntary) and parasympathetic ('relaxation response') parts of the autonomic peripheral nervous system. Common symptoms of autonomic nerve damage include an inability to sweat normally and change in vasodilatation. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bacilli</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Plural of bacillus, bacteria.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Capillary haemodynamics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood flow in the capillaries, where oxygen transfer occurs in the body.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Efferent nerves</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Motor nerves that transmit impulses from the brain and spinal cord to the muscles.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Facial nerve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>It is composed of motor, sensory fibres and autonomic fibres. The important motor part innervates the facial muscles responsible for eye closure and mouth and facial movements. In leprosy, the eye is at risk of corneal ulceration for exposure and decreased lachrymal gland function. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fibroblast</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A large flat cell that secretes the proteins that form collagen and elastic fibres and the substance between the cells of connective tissue. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medial nerve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>It is composed of motor, sensory, and autonomic fibres. The autonomic fibres are responsible for sweating and oil gland secretion. Sensation is affected on the lateral side of the forearm and the palmar side of the hand, thumb, index, middle, and half of the ring finger. It innervates the muscles of the hand and in leprosy affects predominately the intrinsic muscles of the thumb, making opposition and prehension difficult. Weakness and paralysis causes the thumb to be flat within the hand. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor fibres</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor nerves (or efferent nerves)<i>,</i> transmit impulses from the brain and spinal cord to the muscles. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multibacillary</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Having numerous bacilli. "Multibacillary leprosy" classification by World Health Organization for the purpose of treatment is a person with more than five lesions. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Paucibacillary</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Having just a few bacilli. "Paucibacillary leprosy" classification by World Health Organization for the purpose of treatment is a person with five or fewer lesions. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Peripheral nerve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A vast transmission network of afferent and efferent nerves from the central nervous system (brain and spinal cord) distally to every other part of the body. The motor, sensory, and autonomic fibres have specific functions within the area innervated by the specific peripheral nerve. Nerves can be composed primarily of motor or sensory fibres or be mixed, having both motor and sensory fibres. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Peroneal nerve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The common peroneal divides into the superficial and deep peroneal branches. The deep branch innervates the muscles of the anterior compartment of the leg (anterior tibial muscle, the long extensor muscle of the big toe and the long extensor muscles of the toes). When weak or paralysed, it makes it difficult to lift the foot and toes as well as evert the foot when walking. In leprosy, it is frequently referred to as "foot drop". Its sensory fibres innervate the lateral dorsal surface of the lower leg and foot. The sensory fibres of the superficial branch provides sensation to the web space of the big toe and the medial surface of the second toe. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tibial nerve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One of the two major divisions of the sciatic nerve, it courses down the back of the leg to terminate as the medial and lateral plantar nerves in the foot; it supplies the hamstring muscles, the muscles of the back of the lower leg, and the intrinsic muscles of the foot. It causes clawing of the toes if muscles are paralysed. It provides sensation to the back of the leg and sole of the foot. The sensory loss to the sole of the foot puts the foot at high risk for injury and ulceration. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sensory fibres</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sensory nerves (or afferent nerves), carry information from the outside world, such as sensations of temperature (hot, cold), touch, texture and pain, to the brain and spinal cord. They alert the body to pleasant feelings as well as to danger. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sural nerve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A sensory nerve in the calf region (sura) of the leg. It is made up of collateral branches of the tibial nerve and common fibular nerve. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Trigeminal nerve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The three‐branch trigeminal (fifth cranial) nerve innervating the face, eyes, nose, mouth, and jaws. The corneal sensory loss in leprosy can cause the eye to be at risk for increased dryness and corneal abrasions. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ulceration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Formation or development of an ulcer. On the skin, it is a loss of epidermis, often part of the dermis and even subcutaneous fat layers of the skin. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ulnar nerve in the upper extremity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is composed of motor, sensory, and autonomic fibres. The autonomic fibres are responsible for sweating and oil gland secretion. Sensation is affected on the ulnar (medial) side of the forearm, hand, the palmar side of the 5th and half of the 4th fingers. It innervates the muscles of the hand and in leprosy affects predominately the distal intrinsic muscles used for fine motor tasks. Weakness and paralysis causes finger clawing. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vasodilation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A widening of the blood vessels caused by a relaxation of the smooth muscle cells in the vessel wall. The sympathetic nervous system has nerves that play an important role in vasodilatation and vasoconstriction. </p> </td> </tr> </tbody> </table> </div> <section id="CD012235-sec-0024"> <h3 class="title" id="CD012235-sec-0024">Description of the condition</h3> <p>Leprosy (Hansen's disease) is a chronic infectious disease caused by the bacterium <i>Mycobacterium leprae (M leprae)</i> (<a href="./references#CD012235-bbs2-0066" title="LockwoodD , ColstonMJ , FinePE , LucasS , RoseSP , McDougallAC , et al. Prevention of disabilities and rehabilitation. Leprosy Review2002; Vol. 73:S35‐43. ">Lockwood 2002a</a>). Official figures show that just over 173,000 people were detected with leprosy in 2016, mainly in Asia, the Americas and Africa. The World Health Organization (WHO) stated that less than 14 countries reported more than 1000 new cases in 2015, suggesting that leprosy is gradually becoming limited to a small number of countries (<a href="./references#CD012235-bbs2-0084" title="World Health Organization. Weekly epidemiological record. Global leprosy update, 2015: time for action, accountability and inclusion. www.who.int/wer2016; Vol. 91, issue 35:405‐20. ">WHO 2016</a>). The WHO fact sheet on leprosy states that 216,108 people from 145 countries were taking medication for leprosy at the end of 2016 (<a href="./references#CD012235-bbs2-0085" title="World Health Organization. WHO. Leprosy fact sheet. October 2017. www.who.int/mediacentre/factsheets/fs101/en/ (accessed prior to 8 February 2018). ">WHO 2017</a>). </p> <p>Although the detection rate is declining slowly worldwide, it is rising in a few places (<a href="./references#CD012235-bbs2-0069" title="MandavilliA . In India, a renewed fight against leprosy. www.nytimes.com/2019/04/17/health/leprosy‐india‐disease.html 17 April 2019. ">Mandavilli 2019</a>). The proportion of children under 15 years of age among new cases of leprosy ranges widely between countries: from 0.8% to 38.1% in 2015 (mean 8.9%) (<a href="./references#CD012235-bbs2-0084" title="World Health Organization. Weekly epidemiological record. Global leprosy update, 2015: time for action, accountability and inclusion. www.who.int/wer2016; Vol. 91, issue 35:405‐20. ">WHO 2016</a>). The significant number of childhood cases shows that person‐to‐person transmission continues to be a problem and many people suffer from the consequences of leprosy (<a href="./references#CD012235-bbs2-0070" title="McDougallAC , LockwoodD , ColstonMJ , FinePEM , LucasS , RoseSP , et al. Report of the International Leprosy Association Technical Forum. Leprosy Review2002;73(Suppl):S1‐62. ">McDougall 2002</a>). Numbers are based on the number of persons with visible impairments of the eyes, hands, and/or feet at the time of diagnosis (WHO disability grade 2). Over 14,000 new cases of leprosy in 2015 were diagnosed with grade 2 disability, which is 2.1 per million population (<a href="./references#CD012235-bbs2-0084" title="World Health Organization. Weekly epidemiological record. Global leprosy update, 2015: time for action, accountability and inclusion. www.who.int/wer2016; Vol. 91, issue 35:405‐20. ">WHO 2016</a>). In this report, the proportion of new cases with grade 2 disabilities ranged from 4.4% to 25.4%. The numbers of new leprosy cases with disability grade 2 increased from 12,392 in 2006 to 14,059 in 2015 (<a href="./references#CD012235-bbs2-0084" title="World Health Organization. Weekly epidemiological record. Global leprosy update, 2015: time for action, accountability and inclusion. www.who.int/wer2016; Vol. 91, issue 35:405‐20. ">WHO 2016</a>). The variation can be explained by the methods of detection and reporting in those countries. The low levels of grade 2 disabilities indicates improved disease awareness and early disease detection in communities and health systems. A total of 3039 relapses were reported from 103 countries in 2015 (<a href="./references#CD012235-bbs2-0084" title="World Health Organization. Weekly epidemiological record. Global leprosy update, 2015: time for action, accountability and inclusion. www.who.int/wer2016; Vol. 91, issue 35:405‐20. ">WHO 2016</a>). </p> <p>South‐East Asia has the highest prevalence of leprosy (persons on leprosy treatment), followed by the Americas, Africa, the Western Pacific, Eastern Mediterranean and Europe. Of all those identified as having the disease, 60% live in India, 13% live in Brazil, and 8% live in Indonesia (<a href="./references#CD012235-bbs2-0084" title="World Health Organization. Weekly epidemiological record. Global leprosy update, 2015: time for action, accountability and inclusion. www.who.int/wer2016; Vol. 91, issue 35:405‐20. ">WHO 2016</a>). </p> <p>Leprosy is treated with a combination of immunosuppressive and antibiotic drugs (multidrug therapy) <a href="./references#CD012235-bbs2-0066" title="LockwoodD , ColstonMJ , FinePE , LucasS , RoseSP , McDougallAC , et al. Prevention of disabilities and rehabilitation. Leprosy Review2002; Vol. 73:S35‐43. ">Lockwood 2002a</a>). The drugs are rifampicin, dapsone, and clofazimine, which are effective in killing the bacilli, but do not prevent or treat the nerve inflammation and damage. The inflammation and damage is caused by the immune system responses, requiring other interventions, such as corticosteroids, surgery, or both (<a href="./references#CD012235-bbs2-0066" title="LockwoodD , ColstonMJ , FinePE , LucasS , RoseSP , McDougallAC , et al. Prevention of disabilities and rehabilitation. Leprosy Review2002; Vol. 73:S35‐43. ">Lockwood 2002a</a>). The effectiveness of corticosteroids has been evaluated in a systematic review (<a href="./references#CD012235-bbs2-0077" title="VanVeenNH , NichollsPG , SmithWC , RichardusJH . Corticosteroids for treating nerve damage in leprosy. Cochrane Database of Systematic Reviews2007, Issue 2. [DOI: 10.1002/14651858.CD005491.pub2] ">Van Veen 2007</a>), whilst surgery for treating nerve damage in leprosy was reviewed in another systematic review (<a href="./references#CD012235-bbs2-0079" title="VanVeenNH , SchreudersTA , TheuvenerWJ , AgrawalA , RichardusJH . Decompressive surgery for treating nerve damage in leprosy. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.CD006983.pub3] ">Van Veen 2012</a>). Virtually all people detected with leprosy should be registered with their local health services and treated with multidrug therapy (<a href="./references#CD012235-bbs2-0083" title="World Health Organization Geneva. Global leprosy: UN update on the 2012 situation. Weekly Epidemiological Record2013;88(35):365‐80. [www.who.int/wer/2013/wer8835.pdf] ">WHO 2013</a>). People affected by leprosy who are or have been treated with multidrug therapy are not infectious (<a href="./references#CD012235-bbs2-0081" title="World Health Organization. Working to overcome the global impact of neglected tropical diseases. First WHO report on neglected tropical diseases 2010. apps.who.int/iris/bitstream/10665/44440/1/9789241564090_eng.pdf (accessed 13 August 2015):64‐9. [9789241564090] ">WHO 2010</a>). </p> <p>See <a href="#CD012235-fig-0001">Figure 1</a> for pictures of ulcers. </p> <div class="figure" id="CD012235-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Examples of ulcers in patients with leprosy: (A) Blister formed after walking long distances that later became an ulcer. (B) Fissure on the base of the second toe of the right foot. (C) Right medial malleolus ulcer from a patient with leprosy and HBP. (D) Plantar ulcer on the region of second metatarsal head. (E) Myiasis in a chronic leg ulcer. (F) Chronic ulcer on a lower limb stump.Pictures first appeared in Barreto 2010, with kind permission from Josafá Gonçalves Barreto." data-id="CD012235-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Examples of ulcers in patients with leprosy: (A) Blister formed after walking long distances that later became an ulcer. (B) Fissure on the base of the second toe of the right foot. (C) Right medial malleolus ulcer from a patient with leprosy and HBP. (D) Plantar ulcer on the region of second metatarsal head. (E) Myiasis in a chronic leg ulcer. (F) Chronic ulcer on a lower limb stump. </p> <p>Pictures first appeared in <a href="./references#CD012235-bbs2-0002" title="BarretoJG , SalgadoCG . Clinic‐epidemiological evaluation of ulcers in patients with leprosy sequelae and the effect of low level laser therapy on wound healing: a randomized clinical trial. BMC Infectious Diseases2010;10:237. [CENTRAL: CN‐00760396; PUBMED: 20698989] ">Barreto 2010</a>, with kind permission from Josafá Gonçalves Barreto. </p> </div> </div> </div> <section id="CD012235-sec-0025"> <h4 class="title">Clinical manifestations and complications</h4> <p>Generally, leprosy starts with a patch or lesion on the skin and enlargement of nerves which may also damage peripheral nerves (<a href="./references#CD012235-bbs2-0052" title="WyattGB . Leprosy. In: BellDR editor(s). Tropical Medicine. 4th Edition. Oxford: Blackwell Science Ltd, 1995:293‐309. ">Bell 1995</a>; <a href="./references#CD012235-bbs2-0066" title="LockwoodD , ColstonMJ , FinePE , LucasS , RoseSP , McDougallAC , et al. Prevention of disabilities and rehabilitation. Leprosy Review2002; Vol. 73:S35‐43. ">Lockwood 2002a</a>). Often the first signs are a lighter colour patch of skin with loss of hair, sweating and a loss of sensation to temperature and touch and enlarged peripheral nerves when palpated. The principal manifestations are skin patches or lesions with loss of sensation (flat or raised red patches on the skin) and specific enlarged peripheral nerves. The number of lesions may range from one to many depending on a person's immunity. In those with a large number of bacteria, the skin may become diffusely thickened and dry and peripheral nerves enlarged. Inflammation of peripheral nerves can damage nerve function (autonomic, sensory, and motor) and may cause later complications (<a href="./references#CD012235-bbs2-0052" title="WyattGB . Leprosy. In: BellDR editor(s). Tropical Medicine. 4th Edition. Oxford: Blackwell Science Ltd, 1995:293‐309. ">Bell 1995</a>; <a href="./references#CD012235-bbs2-0066" title="LockwoodD , ColstonMJ , FinePE , LucasS , RoseSP , McDougallAC , et al. Prevention of disabilities and rehabilitation. Leprosy Review2002; Vol. 73:S35‐43. ">Lockwood 2002a</a>). Most complications are the result of nerve damage through direct invasion by the <i>M leprae</i> bacteria or inflammation caused by reactions of the person's immune system. If treated early, much of the nerve damage leading to problems in the face, hands, and feet can be prevented (<a href="./references#CD012235-bbs2-0078" title="VanVeenNH , LockwoodDN , vanBrakelWH , Ramirez JrJ , RichardusJH . Interventions for erythema nodosum leprosum. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD006949.pub2] ">Van Veen 2009</a>). </p> <p>Initially, the small sensory and autonomic nerve fibres in the skin are damaged, causing local loss of hair, inability to sweat and difficulty detecting temperature and touch sensations. Damage to peripheral nerves can lead to more widespread skin dryness, loss of sensation, and weakness or paralysis of muscles in areas of the body supplied by the affected nerve. The eyes, hands, and feet, with loss of sensation, paralysis and dryness, are at a higher risk of injury and require daily self‐care. The dry skin can lead to cracks. If cracks, injuries, and ulcerations are not cared for and rested, they can become infected and lead to further injury and destruction, resulting in visible damage and destruction of the eyes, hands, and feet. These are easily seen impairments; this destruction and paralysis are visible and commonly known as grade 2 disability in leprosy (<a href="./references#CD012235-bbs2-0066" title="LockwoodD , ColstonMJ , FinePE , LucasS , RoseSP , McDougallAC , et al. Prevention of disabilities and rehabilitation. Leprosy Review2002; Vol. 73:S35‐43. ">Lockwood 2002a</a>). If a new leprosy case is seen with a visible grade 2 disability (<a href="./references#CD012235-bbs2-0083" title="World Health Organization Geneva. Global leprosy: UN update on the 2012 situation. Weekly Epidemiological Record2013;88(35):365‐80. [www.who.int/wer/2013/wer8835.pdf] ">WHO 2013</a>), then the diagnosis has been late. Community health education programmes, health systems, or both, need to explore strategies to improve early disease detection as well as early detection of nerve function loss and treatment. </p> <p>The peripheral nerves may be enlarged and/or painful with or without loss of function (sensory loss or muscle weakness). Common enlarged nerves are the auricular nerve, facial nerve, radial cutaneous and ulnar cutaneous and ulnar nerve at the elbow, peroneal nerve, posterior tibial and sural nerves. Nerve palpation for enlargement and pain plus testing for sensory loss and muscle weakness are important parts of the routine clinical exam. </p> <p>Peripheral nerve function is tested in the face by checking corneal sensation (trigeminal nerve) and eye closure weakness (facial nerve). Peripheral nerve function in the upper extremities evaluates sensory areas and muscle strength of areas innervated by the ulnar and median nerves. Peripheral nerve function in the lower limb evaluates sole sensory loss (posterior tibial nerve) and strength in raising the foot upwards towards the shin or dorsiflexion (peroneal nerve). </p> <p>Major areas affected by nerve damage in leprosy are the hands (especially the palms), feet (especially the soles), and eyes (<a href="./references#CD012235-bbs2-0066" title="LockwoodD , ColstonMJ , FinePE , LucasS , RoseSP , McDougallAC , et al. Prevention of disabilities and rehabilitation. Leprosy Review2002; Vol. 73:S35‐43. ">Lockwood 2002a</a>). The main complication of sensory nerve damage and the loss of intrinsic muscle function is ulceration, particularly of the feet (<a href="./references#CD012235-bbs2-0058" title="deWinMM , TheuvenetWJ , RochePW , deBieRA , vanMamerenH . The paper grip test for screening on intrinsic muscle paralysis in the foot of leprosy patients. International Journal of Leprosy and Other Mycobacterial Diseases2002;70(1):16‐24. [PUBMED: 12120036] ">de Win 2002</a>; <a href="./references#CD012235-bbs2-0066" title="LockwoodD , ColstonMJ , FinePE , LucasS , RoseSP , McDougallAC , et al. Prevention of disabilities and rehabilitation. Leprosy Review2002; Vol. 73:S35‐43. ">Lockwood 2002a</a>). The multidrug therapy offered to people infected with <i>M leprae</i> is efficacious in killing the bacilli if given for a sufficient length of time of six to 12 months (<a href="./references#CD012235-bbs2-0080" title="World Health Organization Regional Office for South‐East Asia. Global strategy for further reducing the leprosy burden and sustaining leprosy control activities (2006‐2010). Operational guidelines 2006. www.who.int/lep/resources/SEAGLP20062.pdf. New Dehli: World Health Organization, Regional office for South‐East Asia, (accessed 13 August 2015). [SEA / GLP/ 2006.2] ">WHO 2006</a>). Even with treatment, some people with leprosy can have immune reactions during and after treatment that require immediate action to reduce the inflammation to prevent or minimise permanent secondary damage to skin and peripheral nerves. If the reaction is not identified and treated adequately, damage cannot be reversed (<a href="./references#CD012235-bbs2-0066" title="LockwoodD , ColstonMJ , FinePE , LucasS , RoseSP , McDougallAC , et al. Prevention of disabilities and rehabilitation. Leprosy Review2002; Vol. 73:S35‐43. ">Lockwood 2002a</a>; <a href="./references#CD012235-bbs2-0078" title="VanVeenNH , LockwoodDN , vanBrakelWH , Ramirez JrJ , RichardusJH . Interventions for erythema nodosum leprosum. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD006949.pub2] ">Van Veen 2009</a>). </p> <p>Late diagnosis is the greatest cause of disability, followed by reactions that happen before, during, and after treatment. Frequently, they are either not identified, not treated adequately, or both. It is assumed that for those with permanent nerve damage, further damage and complications may be reduced by good self‐care practices, the use of protective footwear, surgery, etc (<a href="./references#CD012235-bbs2-0066" title="LockwoodD , ColstonMJ , FinePE , LucasS , RoseSP , McDougallAC , et al. Prevention of disabilities and rehabilitation. Leprosy Review2002; Vol. 73:S35‐43. ">Lockwood 2002a</a>). Existing <a href="./references#CD012235-bbs2-0082" title="World Health Organization Regional Office for South‐East Asia. Guidelines for strengthening participation of persons affected by leprosy in leprosy services 2011. www.searo.who.int/entity/global_leprosy_programme/publications/guide_strengthening_participation_persons_affected_2011.pdf (accessed 13 August 2015). [SEA‐GLP‐2011.2] ">WHO 2011</a> guidelines emphasise the importance of preventing disabilities and mention "identify", "train", "support" and "integrate" as being important principles. Some strategies are suggested as follows (<a href="./references#CD012235-bbs2-0082" title="World Health Organization Regional Office for South‐East Asia. Guidelines for strengthening participation of persons affected by leprosy in leprosy services 2011. www.searo.who.int/entity/global_leprosy_programme/publications/guide_strengthening_participation_persons_affected_2011.pdf (accessed 13 August 2015). [SEA‐GLP‐2011.2] ">WHO 2011</a>, page 11). </p> <p> <ul id="CD012235-list-0001"> <li> <p>"Involve persons affected by leprosy to encourage individuals to go for early evaluation."</p> </li> <li> <p>"Formally engage persons affected by leprosy in the promotion of self‐care and the identification of people in need of practising self‐care." </p> </li> <li> <p>"Involve persons affected by leprosy in identifying individuals in need of aids and appliances such as protective footwear." </p> </li> </ul> </p> <p>Successful rehabilitation is an important issue that can be achieved through a combination of efforts made by the community and the individuals with their families (<a href="./references#CD012235-bbs2-0082" title="World Health Organization Regional Office for South‐East Asia. Guidelines for strengthening participation of persons affected by leprosy in leprosy services 2011. www.searo.who.int/entity/global_leprosy_programme/publications/guide_strengthening_participation_persons_affected_2011.pdf (accessed 13 August 2015). [SEA‐GLP‐2011.2] ">WHO 2011</a>). In September 2018, India's Supreme Court ruled that "the government must end discriminatory laws, conduct regular surveillance to detect new cases, provide treatment to everyone who needs it, and promote awareness of leprosy as a curable disease" (<a href="./references#CD012235-bbs2-0069" title="MandavilliA . In India, a renewed fight against leprosy. www.nytimes.com/2019/04/17/health/leprosy‐india‐disease.html 17 April 2019. ">Mandavilli 2019</a>). </p> </section> <section id="CD012235-sec-0026"> <h4 class="title">Diagnosis</h4> <p>Leprosy is diagnosed clinically by the following principal signs (<a href="./references#CD012235-bbs2-0066" title="LockwoodD , ColstonMJ , FinePE , LucasS , RoseSP , McDougallAC , et al. Prevention of disabilities and rehabilitation. Leprosy Review2002; Vol. 73:S35‐43. ">Lockwood 2002a</a>): </p> <p> <ul id="CD012235-list-0002"> <li> <p>skin lesions with a decrease in sensation, i.e. parts of the skin may feel numb and not able to detect temperature, touch, or painful stimuli such as a pin prick; </p> </li> <li> <p>thickened (enlarged) peripheral nerves that can easily be felt through the skin; and/or</p> </li> <li> <p>positive smear, i.e. evidence of the causative bacterium, <i>M leprae</i>, using microscopic examination of a sample of tissue (skin smear). </p> </li> </ul> </p> <p>Skin biopsy is also used for the diagnosis (<a href="./references#CD012235-bbs2-0075" title="SinghA , WengX , NathI . Skin biopsy in leprosy. In: KhopkarU editor(s). Skin Biopsy ‐ Perspectives. London, UK: IntechOpen Limited, 2011:73‐86. [DOI: 10.5772/833; ISBN: 978‐953‐307‐290‐6] ">Singh 2011</a>). </p> </section> <section id="CD012235-sec-0027"> <h4 class="title">Classification</h4> <p>There are two main forms of classification (<a href="./references#CD012235-bbs2-0067" title="LockwoodDN . Leprosy elimination‐a virtual phenomenon or reality?. BMJ2002;324(7352):1516‐8. [PUBMED: 12077045] ">Lockwood 2002b</a>): 1) the Ridley‐Jopling scheme; and 2) the WHO operational classification of paucibacillary/multibacillary classification. </p> <section id="CD012235-sec-0028"> <h5 class="title">Ridley‐Jopling scheme</h5> <p>This scheme classifies leprosy on a scale from 'tuberculoid' to 'lepromatous', based on the clinical appearance and bacterial index of lesions (<a href="./references#CD012235-bbs2-0067" title="LockwoodDN . Leprosy elimination‐a virtual phenomenon or reality?. BMJ2002;324(7352):1516‐8. [PUBMED: 12077045] ">Lockwood 2002b</a>). 'Tuberculoid' indicates that the body's immunity is good and there are few skin lesions. 'Lepromatous' means that the body has a poor immune response to the mycobacteria, and there is uncontrolled bacterial multiplication, many skin lesions, and also lesions in the mucosa of the nose and mouth. Peripheral nerve damage can occur at any point on the scale. Between the extremes of 'tuberculoid' and 'lepromatous' are the 'unstable borderline tuberculoid' and 'borderline lepromatous' forms (<a href="./references#CD012235-bbs2-0067" title="LockwoodDN . Leprosy elimination‐a virtual phenomenon or reality?. BMJ2002;324(7352):1516‐8. [PUBMED: 12077045] ">Lockwood 2002b</a>). </p> </section> <section id="CD012235-sec-0029"> <h5 class="title">WHO operational classification</h5> <p>This classification is based on the number of skin lesions (<a href="./references#CD012235-bbs2-0053" title="BrittonWJ , LockwoodDN . Leprosy. Lancet2004;363(9416):1209‐19. [PUBMED: 15081655] ">Britton 2004</a>): </p> <p> <ul id="CD012235-list-0003"> <li> <p>paucibacillary ‐ up to five lesions</p> </li> <li> <p>multibacillary ‐ more than five lesions (or a positive smear at any site).</p> </li> </ul> </p> <p>This is a simple classification scheme that makes treatment simpler for field workers, but it is less specific than the Ridley‐Jopling scheme. The WHO operational classification system is the most widely used. </p> </section> </section> <section id="CD012235-sec-0030"> <h4 class="title">Impact</h4> <p>Nerve damage can happen before, during, and after chemotherapy treatment. It affects approximately 30% of people diagnosed with leprosy (2.6% with paucibacillary, 37% with multibacillary, 2 years after diagnosis and multidrug therapy treatment; <a href="./references#CD012235-bbs2-0065" title="LockwoodD . Leprosy. Bacterial Tropical Infections, Medicine. The Medicine Publishing Company Ltd, 2001:17‐20. ">Lockwood 2001</a>). Data from 2002 showed that approximately 6% to 9% of people with newly‐diagnosed leprosy presented with grade 2 disabilities (visible deformity or damage present), and as many as 20% to 56% of people have established nerve damage at diagnosis (<a href="./references#CD012235-bbs2-0068" title="LockwoodD . Leprosy. Clinical Evidence. Vol. 4, BMJ Publishing Group, 2002:709‐16. ">Lockwood 2002c</a>). These figures vary from country to country and between disease types. <a href="./references#CD012235-bbs2-0072" title="PennaG , Bührer‐SékulaS , KerrLR , StefaniMM , RodriguesLC , deAraújoMG , et al. Uniform multidrug therapy for leprosy patients in Brazil (U‐MDT/CT‐BR): results of an open label, randomized and controlled clinical trial, among multibacillary patients. PLOS Neglected Tropical Diseases2017;11(7):1‐19. [PUBMED: 28704363] ">Penna 2017</a> demonstrated the progression of impairments/disability in around 30% of participants after multidrug therapy completion. </p> </section> </section> <section id="CD012235-sec-0031"> <h3 class="title" id="CD012235-sec-0031">Description of the intervention</h3> <p>Leprosy is treated with multidrug therapy. Other interventions, which we will not cover in this review, are aimed at treating immune reactions with corticosteroids, surgery, or both (<a href="./references#CD012235-bbs2-0066" title="LockwoodD , ColstonMJ , FinePE , LucasS , RoseSP , McDougallAC , et al. Prevention of disabilities and rehabilitation. Leprosy Review2002; Vol. 73:S35‐43. ">Lockwood 2002a</a>). </p> <p>The interventions of relevance to this review are those used in leprosy care which are aimed at the prevention and/or treatment of secondary damage to skin, nerves, and limbs. Preventive interventions include information, education, footwear and self‐care. Foot soaks, Vaseline and wax therapy are also meant to prevent ulcers and skin changes. Interventions aimed at treating ulcers include footwear, dressings (i.e. zinc tape, saline, iodine, gauze soaked in different ointments, dry dressings), self‐care, information and education (<a href="./references#CD012235-bbs2-0066" title="LockwoodD , ColstonMJ , FinePE , LucasS , RoseSP , McDougallAC , et al. Prevention of disabilities and rehabilitation. Leprosy Review2002; Vol. 73:S35‐43. ">Lockwood 2002a</a>). Therapies like different ointments and gels for topical use; other dressings; and laser, light‐emitting diode (LED), or pulsed magnetic fields have been used in trials to aid healing of existing ulcers. </p> <p>Usual care that aims to prevent ulcers might be information, education, footwear and self‐care. Usual care for people that have developed ulcer(s) could also be footwear, self‐care, dry dressings, or dressings with saline. Surgical interventions are not covered in our review. </p> </section> <section id="CD012235-sec-0032"> <h3 class="title" id="CD012235-sec-0032">How the intervention might work</h3> <p>The rationale behind the use of, for example, appropriate footwear is to protect feet from secondary damage that can lead to superficial sores on the soles of the feet, and later ulcers and secondary infections (<a href="./references#CD012235-bbs2-0070" title="McDougallAC , LockwoodD , ColstonMJ , FinePEM , LucasS , RoseSP , et al. Report of the International Leprosy Association Technical Forum. Leprosy Review2002;73(Suppl):S1‐62. ">McDougall 2002</a>). Many other interventions have been tried in healing such ulcers (<a href="./references#CD012235-bbs2-0076" title="SrinivasanH . Do we need trials of agents alleged to improve healing of plantar ulcers?. Leprosy Review1989;60(4):278‐82. [PUBMED: 2691790] ">Srinivasan 1989</a>). </p> <p>Self‐care includes daily management to reduce the effects of nerve function impairment (<a href="./references#CD012235-bbs2-0066" title="LockwoodD , ColstonMJ , FinePE , LucasS , RoseSP , McDougallAC , et al. Prevention of disabilities and rehabilitation. Leprosy Review2002; Vol. 73:S35‐43. ">Lockwood 2002a</a>). Education, information, and empowerment of those affected by leprosy (and their carers) is part of some leprosy programmes (<a href="./references#CD012235-bbs2-0055" title="CrossH , ChoudharyR . STEP: An intervention to address the issue of stigma related to leprosy in Southern Nepal. Leprosy Review2005;76(4):316‐24. [PUBMED: 16411511] ">Cross 2005a</a>; <a href="./references#CD012235-bbs2-0056" title="CrossH , ChoudharyR . Self‐care: A catalyst for community development. Asian Pacific Rehabilitation2005;16(2):100‐14. ">Cross 2005b</a>; <a href="./references#CD012235-bbs2-0070" title="McDougallAC , LockwoodD , ColstonMJ , FinePEM , LucasS , RoseSP , et al. Report of the International Leprosy Association Technical Forum. Leprosy Review2002;73(Suppl):S1‐62. ">McDougall 2002</a>). </p> <p>As for dressings, phenytoin is a topical dressing thought to enhance cutaneous healing (<a href="./references#CD012235-bbs2-0062" title="HokkamE , El‐LabbanG , ShamsM , RifaatS , El‐MezaienM . The use of topical phenytoin for healing of chronic venous ulcerations. International Journal of Surgery2011;9(4):335‐8. ">Hokkam 2011</a>). Zinc tape is also thought to enhance healing, as zinc might play a part in the healing of wounds. Over many years ordinary adhesive zinc tape has been used (<a href="./references#CD012235-bbs2-0063" title="KumarA , ShmananL . Adhesive zinc tape treatment of uncomplicated ulcers amongst leprosy outpatients. Leprosy Review1986;57(1):45‐51. [PUBMED: 3702580] ">Kumar 1986</a>). Dry dressings and saline dressings are used to protect ulcers from contamination and thus enhance healing. </p> <p>Adverse reactions to any dressings could be allergic or local irritation or pain associated with application or injection. Other adverse effects might be disadvantages related to time and resources for the person involved (hospitalisation, frequent visits to outpatient clinics, etc.). </p> </section> <section id="CD012235-sec-0033"> <h3 class="title" id="CD012235-sec-0033">Why it is important to do this review</h3> <p>The key to effective management of leprosy is early diagnosis and treatment, and early recognition and management of nerve damage, combined with effective health education to prevent limb damage (<a href="./references#CD012235-bbs2-0066" title="LockwoodD , ColstonMJ , FinePE , LucasS , RoseSP , McDougallAC , et al. Prevention of disabilities and rehabilitation. Leprosy Review2002; Vol. 73:S35‐43. ">Lockwood 2002a</a>; <a href="./references#CD012235-bbs2-0067" title="LockwoodDN . Leprosy elimination‐a virtual phenomenon or reality?. BMJ2002;324(7352):1516‐8. [PUBMED: 12077045] ">Lockwood 2002b</a>). Successful treatment of nerve damage itself can be effective for preventing ulcer development. Corticosteroids have been used for this purpose (<a href="./references#CD012235-bbs2-0066" title="LockwoodD , ColstonMJ , FinePE , LucasS , RoseSP , McDougallAC , et al. Prevention of disabilities and rehabilitation. Leprosy Review2002; Vol. 73:S35‐43. ">Lockwood 2002a</a>). However, a systematic review of three RCTs comparing prednisolone with placebo or comparing different doses of corticosteroids did not show a statistically significant long‐term effect (<a href="./references#CD012235-bbs2-0077" title="VanVeenNH , NichollsPG , SmithWC , RichardusJH . Corticosteroids for treating nerve damage in leprosy. Cochrane Database of Systematic Reviews2007, Issue 2. [DOI: 10.1002/14651858.CD005491.pub2] ">Van Veen 2007</a>). Also, corticosteroids are not well tolerated by everyone and may cause harmful effects (<a href="./references#CD012235-bbs2-0066" title="LockwoodD , ColstonMJ , FinePE , LucasS , RoseSP , McDougallAC , et al. Prevention of disabilities and rehabilitation. Leprosy Review2002; Vol. 73:S35‐43. ">Lockwood 2002a</a>). It is therefore still of importance to find the best way to prevent or treat skin damage. </p> <p>People with leprosy are, after a few days on chemotherapy, no longer infectious and can lead a normal social life. This has contributed to the management of leprosy programmes worldwide moving away from clinics dedicated to the treatment of leprosy, to primary healthcare services in general (<a href="./references#CD012235-bbs2-0066" title="LockwoodD , ColstonMJ , FinePE , LucasS , RoseSP , McDougallAC , et al. Prevention of disabilities and rehabilitation. Leprosy Review2002; Vol. 73:S35‐43. ">Lockwood 2002a</a>; <a href="./references#CD012235-bbs2-0081" title="World Health Organization. Working to overcome the global impact of neglected tropical diseases. First WHO report on neglected tropical diseases 2010. apps.who.int/iris/bitstream/10665/44440/1/9789241564090_eng.pdf (accessed 13 August 2015):64‐9. [9789241564090] ">WHO 2010</a>). Despite the opportunity to live a normal social life, long‐term nerve and muscle damage can lead to great psychosocial and financial difficulties, social stigmatisation, and decreased quality of life for people with leprosy. Care and awareness of limb use will in all circumstances be necessary, and education of those with leprosy is considered a central element to achieve a satisfactory level of self‐care (<a href="./references#CD012235-bbs2-0066" title="LockwoodD , ColstonMJ , FinePE , LucasS , RoseSP , McDougallAC , et al. Prevention of disabilities and rehabilitation. Leprosy Review2002; Vol. 73:S35‐43. ">Lockwood 2002a</a>). </p> <section id="CD012235-sec-0034"> <h4 class="title">Why we presented a new protocol</h4> <p>When we made the decision to update our review from 2008 (<a href="./references#CD012235-bbs2-0087" title="ReinarLM , ForsetlundL , BjørndalA , LockwoodD . Interventions for skin changes caused by nerve damage in leprosy. Cochrane Database of Systematic Reviews2008, Issue 3. [DOI: 10.1002/14651858.CD004833.pub3] ">Reinar 2008</a>), we wanted to do this by way of a new protocol. In the new protocol the numbers of prespecified outcomes were reduced to those that are most clinically relevant, and it includes both RCTs and quasi‐RCTs. </p> <p>We included RCTs and quasi‐RCTs where the method of allocation was such as alternation, date of birth, or case record number (<a href="./references#CD012235-bbs2-0061" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a><i>).</i> This deviates from the previous protocol (<a href="./references#CD012235-bbs2-0086" title="ReinarLM , ForsetlundL , BjørndalA , PaiVV , SuneethaS , MuzaffarullahS , et al. Interventions for skin changes caused by nerve damage in leprosy. Cochrane Database of Systematic Reviews2003, Issue 4. [DOI: 10.1002/14651858.CD004833] ">Reinar 2003</a>). In our published review (<a href="./references#CD012235-bbs2-0087" title="ReinarLM , ForsetlundL , BjørndalA , LockwoodD . Interventions for skin changes caused by nerve damage in leprosy. Cochrane Database of Systematic Reviews2008, Issue 3. [DOI: 10.1002/14651858.CD004833.pub3] ">Reinar 2008</a>), we identified and included three studies with an alternating allocation procedure, four studies reported as RCTs, and one study for which we could not determine whether the allocation procedure had been random or quasi‐random. </p> <p>The reason for including quasi‐randomised trials was that the risk of bias is not necessarily very different. According to Altman and Bland, quasi‐random methods are "in principle unbiased ‐ being unrelated to patients' characteristics ‐ problems arise from the openness of the allocation system" (<a href="./references#CD012235-bbs2-0051" title="AltmanDG , BlandJM . Statistics notes. Treatment allocation in controlled trials: why randomise?. BMJ1999;318(7192):1209. [DOI: : 10.1136/bmj.318.7192.1209; PUBMED: 10221955] ">Altman 1999</a>). This point was elaborated in <a href="./references#CD012235-bbs2-0054" title="ChalmersI . Why transition from alternation to randomisation in clinical trials was made. BMJ1999;319(7221):1372. [DOI: : 10.1136/bmj.319.7221.1372; PUBMED: 10567161] ">Chalmers 1999</a>. As for RCTs, the results from a study by <a href="./references#CD012235-bbs2-0073" title="PildalJ , ChanAW , HróbjartssonA , ForfangE , AltmanDG , GøtschePC . Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study. BMJ2005;330(7499):1049. [PUBMED: 15817527] ">Pildal 2005</a>, revealed that of 96 studies not reporting on the concealment of the allocation procedure, only 15 (16%) actually had reported in the respective study protocols that concealment would be done. In the randomised studies that we included, none reported on concealment. On this basis, we assumed that most likely the randomised studies had not concealed allocation and so did not deviate from quasi‐randomised trials in that respect. Consequently, they would all be prone to selection bias. Therefore, we chose to display the whole of the evidence base that had used these two designs, a decision we affirmed in the protocol. </p> </section> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012235-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012235-sec-0035"></div> <p>To assess the effects of education, information, self‐care programmes, dressings, skin care, footwear and other measures for preventing and healing secondary damage to the skin in persons affected by leprosy. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012235-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012235-sec-0036"></div> <section id="CD012235-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012235-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs), quasi‐RCTs, and randomised cross‐over trials. We did not include observational studies. Quasi‐RCTs were defined as trials with an allocation procedure such as alternation, date of birth or case record number. </p> </section> <section id="CD012235-sec-0039"> <h4 class="title">Types of participants</h4> <p>People with leprosy and potential damage to peripheral nerves who were on multidrug treatment or were post‐treatment. We considered studies that included participants living in the community or those that were hospitalised. Case definitions were typically based on the Ridley‐Jopling scheme or the World Health Organization (WHO) operational classification of paucibacillary/multibacillary classification. However, we also included studies that did not specify the diagnostic criteria. We included studies with participants of all ages, genders, all countries, and all kinds of ulcers caused by leprosy. Studies with a subset of leprosy participants would have been included if they constituted more than 90%. </p> </section> <section id="CD012235-sec-0040"> <h4 class="title">Types of interventions</h4> <p>Education, information, self‐care programmes, dressings (i.e. zinc tape, saline, iodine, gauze soaked in different ointments, dry dressings), skin care, footwear, or other measures designed to prevent or treat damage. </p> <p>Comparisons might be usual care, no interventions, or other interventions (for example, other types of dressings, other types of footwear, other measures designed to prevent or treat damage). Interventions could be given in primary care, outpatient units, or in hospitals. </p> </section> <section id="CD012235-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD012235-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD012235-list-0004"> <li> <p>Prevention of ulcer(s), as measured in the studies at typically six weeks or less, up to three months, six months, or one year or more. </p> </li> <li> <p>Healing of existing ulcer(s), as measured in the studies at six weeks or less, up to three months, six months, or one year or more (e.g. number of ulcers healed, size of ulcers, number of new ulcers). </p> </li> <li> <p>Adverse events, either those sufficiently serious to stop the intervention, or minor ones reported by participants. </p> </li> </ul> </p> </section> <section id="CD012235-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD012235-list-0005"> <li> <p>Quality of life measures or other psychological or functional measures.</p> </li> <li> <p>Acceptability of treatment by person affected by leprosy, as measured in the studies.</p> </li> <li> <p>Cost of intervention, as direct costs, if reported by study authors.</p> </li> </ul> </p> <section id="CD012235-sec-0044"> <h6 class="title">Tertiary outcome</h6> <p> <ul id="CD012235-list-0006"> <li> <p>Prevention or treatment of other skin changes, such as cracking, thickening or pigmentary changes. </p> </li> </ul> </p> </section> </section> </section> </section> <section id="CD012235-sec-0045"> <h3 class="title">Search methods for identification of studies</h3> <p>We aimed to identify all relevant RCTs regardless of language or publication status (published, unpublished, in press, or in progress). </p> <section id="CD012235-sec-0046"> <h4 class="title">Electronic searches</h4> <p>For this update, we revised all our search strategies in line with current Cochrane Skin practices. Details of the previous search strategies are available in <a href="./references#CD012235-bbs2-0087" title="ReinarLM , ForsetlundL , BjørndalA , LockwoodD . Interventions for skin changes caused by nerve damage in leprosy. Cochrane Database of Systematic Reviews2008, Issue 3. [DOI: 10.1002/14651858.CD004833.pub3] ">Reinar 2008</a>. </p> <p>The Cochrane Skin Information Specialist searched the following databases up to 25 July 2018. </p> <p> <ul id="CD012235-list-0007"> <li> <p>Cochrane Skin Group Specialised Register using the search strategy in <a href="./appendices#CD012235-sec-0119">Appendix 1</a>. </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2018, Issue 6), in the Cochrane Library using the strategy in <a href="./appendices#CD012235-sec-0120">Appendix 2</a>. </p> </li> <li> <p>MEDLINE via Ovid (from 1946) using the strategy in <a href="./appendices#CD012235-sec-0121">Appendix 3</a>. </p> </li> <li> <p>Embase via Ovid (from 1974) using the strategy in <a href="./appendices#CD012235-sec-0122">Appendix 4</a>. </p> </li> <li> <p>CINAHL (Cumulative Index to Nursing and Allied Health Literature) (EBSCO) using the strategy in <a href="./appendices#CD012235-sec-0123">Appendix 5</a>. </p> </li> <li> <p>AMED (Allied and Complementary Medicine Database) using the strategy in <a href="./appendices#CD012235-sec-0124">Appendix 6</a>. </p> </li> <li> <p>LILACS (Latin American and Caribbean Health Science Information Database) using the strategy in <a href="./appendices#CD012235-sec-0125">Appendix 7</a>. </p> </li> </ul> </p> <section id="CD012235-sec-0047"> <h5 class="title">Trial registers</h5> <p>We (LF, LMR) searched the following trial registers for ongoing trials using the term 'lepro*' up to 24 February 2019. </p> <p> <ul id="CD012235-list-0008"> <li> <p>ISRCTN registry (<a href="http://www.controlled-trials.com" target="_blank">www.controlled‐trials.com</a>). </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>). </p> </li> <li> <p>Australian New Zealand Clinical Trials Registry (<a href="http://www.anzctr.org.au" target="_blank">www.anzctr.org.au</a>). </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (ICTRP) (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>). </p> </li> <li> <p>EU Clinical Trials Register (<a href="https://www.clinicaltrialsregister.eu/" target="_blank">www.clinicaltrialsregister.eu/</a>). </p> </li> </ul> </p> </section> </section> <section id="CD012235-sec-0048"> <h4 class="title">Searching other resources</h4> <section id="CD012235-sec-0049"> <h5 class="title">Grey literature</h5> <p>We (LF, LMR) searched for grey literature to identify studies not indexed in the databases listed above, using the following databases up to 24 February 2019. </p> <p> <ul id="CD012235-list-0009"> <li> <p>OpenSIGLE (<a href="http://www.opengrey.eu" target="_blank">www.opengrey.eu</a>) (search phrase: leprosy and ulcer*). </p> </li> <li> <p>OAIster (<a href="http://www.oclc.org/oaister" target="_blank">www.oclc.org/oaister</a>) (search phrase: kw:leprosy ti:leprosy ulcer*). </p> </li> <li> <p>Grey Literature Report (<a href="http://www.greylit.org" target="_blank">www.greylit.org</a>) (search phrase: leprosy). </p> </li> </ul> </p> </section> <section id="CD012235-sec-0050"> <h5 class="title">References from published papers</h5> <p>We checked the bibliographies of included studies and identified reviews for further references to relevant trials. </p> <p>We did not search for unpublished and ongoing trials by corresponding with authors, field experts, or experts on tropical medicine or leprosy or both (deviation from protocol). </p> </section> <section id="CD012235-sec-0051"> <h5 class="title">Adverse effects</h5> <p>We did not perform a separate search for adverse effects of the target interventions. We considered adverse effects described in the trials we read in full text only. We considered all adverse effects reported in the included trials. </p> </section> </section> </section> <section id="CD012235-sec-0052"> <h3 class="title" id="CD012235-sec-0052">Data collection and analysis</h3> <p>Some parts of the methods section of this review use text that was originally published in other Cochrane Reviews co‐authored by KGB (predominantly <a href="./references#CD012235-bbs2-0064" title="LarunL , BrurbergKG , Odgaard‐JensenJ , PriceJR . Exercise therapy for chronic fatigue syndrome. Cochrane Database of Systematic Reviews2015, Issue 2. [DOI: 10.1002/14651858.CD003200.pub3] ">Larun 2015</a>). </p> <section id="CD012235-sec-0053"> <h4 class="title">Selection of studies</h4> <p>Two review authors (LMR, LF) independently screened all titles and abstracts identified in the literature searches for RCTs and quasi‐RCTs. We excluded studies that clearly did not have a trial design with random or quasi‐random allocation of participants. Before inclusion or exclusion, the same two review authors independently read the full text of studies that we assessed as eligible. At this point, we discussed any disagreement with a third review author (KGB), and decisions were made by consensus. We made judgements based on the inclusion criteria stated above (<a href="#CD012235-sec-0037">Criteria for considering studies for this review</a>). </p> </section> <section id="CD012235-sec-0054"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (LMR, LF) independently performed the data extraction and entered data onto a data extraction form. One author (LMR) entered data into Review Manager (<a href="./references#CD012235-bbs2-0074" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>), and one review author (LF) checked the Review Manager file. We were not blinded to the names of trial authors or journals. We used the same piloted data extraction form that we used for our previous review (<a href="./references#CD012235-bbs2-0087" title="ReinarLM , ForsetlundL , BjørndalA , LockwoodD . Interventions for skin changes caused by nerve damage in leprosy. Cochrane Database of Systematic Reviews2008, Issue 3. [DOI: 10.1002/14651858.CD004833.pub3] ">Reinar 2008</a>). The data items we extracted were title, country where study took place, type of study, type of participants, type of interventions, control group interventions, setting, number of eligible participants, number entered into each study group, demographical data of participants, primary and secondary outcomes, results, unit of allocation, unit of analysis and length of follow‐up. </p> </section> <section id="CD012235-sec-0055"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We (LMR, LF) used Cochrane's 'Risk of bias' tool to make judgements of low, high, and unclear risk of bias for all included studies for all outcomes (<a href="./references#CD012235-bbs2-0061" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We discussed any disagreement with a third review author (KGB), and decisions were made by consensus. We also presented the review authors' judgement about each 'Risk of bias' item presented as a percentage across all included studies as a 'Risk of bias' graph (<a href="#CD012235-fig-0002">Figure 2</a>). </p> <div class="figure" id="CD012235-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012235-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <p>We assessed selection bias by judging and reporting methods used for sequence generation and allocation concealment. Quasi‐randomised trials were judged as 'high risk of bias' regarding sequence generation and unclear for concealment of allocation. Randomised trials not reporting on allocation concealment were judged as 'unclear'. We assessed performance bias by judging and reporting any blinding of participants, personnel, and outcome assessors. We also looked for and reported any other threats to validity concerning systematic differences between groups in the care provided. We assessed detection bias by judging and reporting any blinding of participants, personnel, and outcome assessors. We assessed attrition bias by looking for systematic differences in loss to follow‐up between groups. We also looked for and reported other potential threats to validity concerning systematic differences between groups in how outcomes were determined. We assessed reporting bias (selective outcome reporting) by examining the protocol or methods section of the included study for mention of outcomes that were not reported later in the study or for outcomes that would have been expected to have been measured. If our search had identified study protocols we would have used these in the assessment of potential publication bias. We assessed other risks of bias by judging and reporting, for example, avoidance of cointerventions, differences in baseline characteristics, recruiting bias, or inappropriate influence of funder. We did not exclude studies at high risk of bias. </p> <p>We summarised 'Risk of bias' assessments for each key outcome for each study in a 'Risk of bias' summary table (<a href="#CD012235-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD012235-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012235-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> </section> <section id="CD012235-sec-0056"> <h4 class="title">Measures of treatment effect</h4> <section id="CD012235-sec-0057"> <h5 class="title">Dichotomous data</h5> <p>Effect estimates based on dichotomous data were reported as risk ratios (RRs) with 95% confidence intervals (CIs). </p> </section> <section id="CD012235-sec-0058"> <h5 class="title">Continuous data</h5> <p>We calculated continuous outcomes as mean differences (MD) with 95% CIs.</p> <p>If different scales had been used for the same outcome, we would have calculated standardised mean differences (SMDs) to allow pooling. Studies which reported change data would have been pooled with studies using post‐test data in the same meta‐analysis, with change data and endpoint data as subgroups. </p> </section> </section> <section id="CD012235-sec-0059"> <h4 class="title">Unit of analysis issues</h4> <section id="CD012235-sec-0060"> <h5 class="title">Cluster‐randomised trials</h5> <p>Unit of analysis errors may occur if analyses are conducted on a different level to the allocation. Authors of cluster‐randomised trials may fail to account for the intraclass correlation coefficient (ICC), leading to a 'unit of analysis' error; whereby CIs are unduly narrow and statistical significance overestimated (<a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012235/references#CD012235-bbs2-0006" target="_blank">Divine 1992</a>). If we had included a cluster‐randomised trial and clustering had not been accounted for in primary studies, we would have contacted the corresponding author to obtain the ICC, if we thought it would make a difference to the results. In that case, we could have adjusted for this by using methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012235/references#CD012235-bbs2-0007" target="_blank">Higgins 2011</a>) (chapter 16.3). If cluster studies are appropriately analysed taking into account the ICC, and relevant data are reported, synthesis with other studies will be possible using the generic inverse variance technique. In that case, we would have presented data adjusted for the clustering effect as if from a parallel‐group randomised study, but we would have performed sensitivity analysis in which such studies would have been excluded. </p> <p>For this update, we did not identify any cluster‐randomised trials. However, since some trials randomised participants of which some had several ulcers, there is for these studies, an element of clustering. In principle, this should have been accounted for in the analysis. In the studies that explicitly included people with several ulcers without reporting how this was handled in the analysis, we made a note of this in the <a href="./references#CD012235-sec-0134" title="">Characteristics of included studies</a> table. However, we judged that the clustering was not comprehensive enough to make any difference to the reported results. </p> </section> <section id="CD012235-sec-0061"> <h5 class="title">Multiple levels of intensity</h5> <p>One study may address the effects of the same intervention with multiple levels of intensity (e.g. frequency of follow‐up). In that case, for dichotomous outcomes we would have summed up the sample sizes and the number of people with events across all relevant intervention groups. For continuous outcomes, we would have combined means and standard deviations using methods described in chapter 7 (section 7.7.3.8) of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012235/references#CD012235-bbs2-0007" target="_blank">Higgins 2011</a>). </p> </section> <section id="CD012235-sec-0062"> <h5 class="title">Multiple interventions</h5> <p>Studies may also combine several interventions with one comparison group. We did not identify any studies with multiple interventions. In that case, we would have analysed the effects of each intervention group versus the comparison separately, but divided the total number of participants in the comparison group. In the case of continuous outcomes the total number of participants in the comparison group would also have been divided, but the means and standard deviations would have been left unchanged (see chapter 16, section 16.5.4 in <a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012235/references#CD012235-bbs2-0007" target="_blank">Higgins 2011</a>). </p> </section> <section id="CD012235-sec-0063"> <h5 class="title">Randomised cross‐over trials</h5> <p>If we had found and included randomised cross‐over trials we would have analysed data from the first period only. </p> </section> </section> <section id="CD012235-sec-0064"> <h4 class="title">Dealing with missing data</h4> <p>We planned to carry out analyses of all outcomes of interest according to the participants' allocated treatment, irrespective of whether they received that treatment or not. However, some studies had loss to follow‐up of participants. In these cases, we did not attempt to impute missing data. </p> <p>For studies published in the previous 10 years, we contacted two trial authors to ask for data and more information, but neither of them responded. </p> </section> <section id="CD012235-sec-0065"> <h4 class="title">Assessment of heterogeneity</h4> <p>When we judged that the included trials were too clinically heterogeneous to warrant a formal meta‐analysis, we did not perform a meta‐analysis, but presented the results of the included trials in a narrative format. </p> <p>In the case of a meta‐analysis, we would have assessed statistical heterogeneity on the basis of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> recommendations: I² values of 0% to 40% might not be important; 30% to 60% may represent moderate heterogeneity; 50% to 90% may represent substantial heterogeneity; 75% to 100% may represent considerable heterogeneity (<a href="./references#CD012235-bbs2-0061" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> <p>In addition to the I² value (<a href="./references#CD012235-bbs2-0061" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>), we would have presented the Chi² statistic and its P value and considered the direction and magnitude of the treatment effects. The Chi² test is underpowered to detect heterogeneity in meta‐analyses with few studies (<a href="./references#CD012235-bbs2-0061" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>), and hence a P value of 0.10 would have been used as a threshold of statistical significance. </p> </section> <section id="CD012235-sec-0066"> <h4 class="title">Assessment of reporting biases</h4> <p>We attempted to obtain unpublished results to minimise the risk of reporting bias. There were too few studies in each comparison to perform funnel plots to identify publication bias. </p> </section> <section id="CD012235-sec-0067"> <h4 class="title">Data synthesis</h4> <p>We presented the results of trials we assessed to be too heterogeneous to combine in a narrative format. The results of single studies are illustrated in forest plots for visualisation. In a meta‐analysis we would have estimated the effect across studies by using a random‐effects model because we would have expected some clinical heterogeneity (slightly different interventions, populations and comparators) among studies. Where results are estimated for individual studies with low numbers of outcomes (&lt; 10 in total) or where the total sample size is less than 30 participants and a risk ratio is used, we also reported the proportion of outcomes in each treatment group together with a P value from a Fisher's exact test (<a href="./references#CD012235-bbs2-0061" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We created the forest plots using Review Manager 5 (<a href="./references#CD012235-bbs2-0074" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). </p> </section> <section id="CD012235-sec-0068"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We did not have sufficient data to undertake subgroup analyses according to the study's classification of disease severity. </p> </section> <section id="CD012235-sec-0069"> <h4 class="title">Sensitivity analysis</h4> <p>No study results were pooled in this review. Accordingly, we could not perform sensitivity analysis for pooled results separately by addressing the effects on the results of excluding: </p> <p> <ul id="CD012235-list-0010"> <li> <p>studies assessed as being at high risk of bias;</p> </li> <li> <p>quasi‐randomised trials; and</p> </li> <li> <p>cluster‐randomised trials.</p> </li> </ul> </p> <section id="CD012235-sec-0070"> <h5 class="title">'Summary of findings' table</h5> <p>We (LMR, LF) used the GRADE approach to assess the certainty of the body of evidence (<a href="./references#CD012235-bbs2-0059" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s) . Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html. GRADE Working Group, (accessed prior to 25 March 2019). ">GRADE Handbook 2013</a>). We produced 'Summary of findings' tables presenting the overall certainty of evidence for primary and secondary outcomes for each comparison. The outcomes reported in our 'Summary of findings' tables are as follows. </p> <p> <ul id="CD012235-list-0011"> <li> <p>Prevention of ulcers</p> </li> <li> <p>Healing of ulcers</p> </li> <li> <p>Adverse events</p> </li> <li> <p>Quality of life</p> </li> <li> <p>Acceptability of treatment</p> </li> <li> <p>Costs</p> </li> </ul> </p> <p>We used GRADEpro to prepare the 'Summary of findings' tables (<a href="./references#CD012235-bbs2-0060" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version (accessed prior to 25 March 2019). Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT 2018</a>). We judged the following domains in all included studies: study design, risk of bias, inconsistency, indirectness, imprecision and other considerations. We made an overall assessment of the certainty of the evidence as high, moderate, low, and very low (<a href="./references#CD012235-bbs2-0061" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>, chapter 11). Any disagreements were discussed with a third review author (KGB) and were resolved by reaching consensus. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012235-sec-0071" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012235-sec-0071"></div> <section id="CD012235-sec-0072"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD012235-sec-0134" title="">Characteristics of included studies</a>. </p> <section id="CD012235-sec-0073"> <h4 class="title">Results of the search</h4> <p>The searches for this update identified 2093 citations to potentially relevant new trials. We excluded 2051 references based on titles and abstracts. We identified two relevant ongoing studies (<a href="./references#CD012235-bbs2-0049" title="CTRI/2012/12/003178 . Efficacy of autologous platelet‐rich fibrin (PRF) over moist sterile saline dressing in chronic trophic ulcers in Hansen’s disease patients – a randomised control trial [Efficacy of autologous platelet‐rich fibrin (PRF) over moist sterile saline dressing in chronic trophic]. www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=5041 (first received 4 December 2012). ">CTRI/2012/12/003178</a>; <a href="./references#CD012235-bbs2-0050" title="NCT03072004 . Low level laser therapy effects in peripheral nerves patient with leprosy [Evaluation of low level laser therapy effects in peripheral nerves patient affected with leprosy: randomized controlled trial]. www.clinicaltrials.gov/ct2/show/study/NCT03072004 (first received 7 March 2017). ">NCT03072004</a>; see <a href="./references#CD012235-sec-0136" title="">Characteristics of ongoing studies</a>). We assessed the remaining 40 records in full text, and excluded 34 (<a href="./references#CD012235-sec-0135" title="">Characteristics of excluded studies</a>). We included six new studies, along with eight studies from the previous review, which brought the total number of included studies to 14 (<a href="./references#CD012235-sec-0134" title="">Characteristics of included studies</a>). See the study flow diagram for a summary of the screening process (<a href="#CD012235-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD012235-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012235-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012235-sec-0074"> <h4 class="title">Included studies</h4> <section id="CD012235-sec-0075"> <h5 class="title">Design</h5> <p>We included 14 trials (randomised and quasi‐randomised) with a total of 854 participants. The studies were published between 1982 and 2018. Two studies had three arms, and one study reported on two separately conducted trials (multicentre study). The initial assessment and baseline reporting of leprosy and damage to peripheral nerves was recorded in varying details, as was the reporting of outcome measurements and results. </p> </section> <section id="CD012235-sec-0076"> <h5 class="title">Sample sizes</h5> <p>All included trials were small, with between 25 and 110 adult participants affected by leprosy. </p> </section> <section id="CD012235-sec-0077"> <h5 class="title">Participants</h5> <p>In 12 of the studies, all participants had ulcers at trial entry. In one study (<a href="./references#CD012235-bbs2-0011" title="SebokaG , SaundersonP , CurrieH . Footwear for farmers affected by leprosy. Leprosy Review1998;69(2):182‐3. [CENTRAL: CN‐00339604] ">Seboka 1998</a>), some of the participants had scars, not ulcers. One study only included participants with anaesthetic feet with fissures or callosities, or both (<a href="./references#CD012235-bbs2-0012" title="SharmaR , BargotraR , GuptaR , DarHA . Comparative study of the effects of wax therapy and foot soaks on dry plantar skin and ulcers in leprosy patients. JK Science2005;7(2):81‐3. [CENTRAL: CN‐01911700; EMBASE: 40846955] ">Sharma 2005</a>). The participants were aged between 18 and 74 years, but age was not reported in four studies (<a href="./references#CD012235-bbs2-0008" title="PringDJ , CasiebancaN . Simple plantar ulcers treated by below‐knee plaster and moulded double‐rocker plaster shoe ‐ a comparative study. Leprosy Review1982;53(4):261‐4. [CENTRAL: CN‐00249869] ">Pring 1982</a>; <a href="./references#CD012235-bbs2-0012" title="SharmaR , BargotraR , GuptaR , DarHA . Comparative study of the effects of wax therapy and foot soaks on dry plantar skin and ulcers in leprosy patients. JK Science2005;7(2):81‐3. [CENTRAL: CN‐01911700; EMBASE: 40846955] ">Sharma 2005</a>; <a href="./references#CD012235-bbs2-0013" title="SöderbergT , HallmansG , StenströmS , LoboD , PintoJ , MaroofS , et al. Treatment of leprosy wounds with adhesive zinc tape. Leprosy Review1982;53(4):271‐6. [CENTRAL: CN‐00181158] ">Söderberg 1982</a>; <a href="./references#CD012235-bbs2-0014" title="WaltonR , FritschiE , UmapathyV . Treatment of plantar ulcers in leprosy patients in the community with adhesive zinc tape. Leprosy Review1986;57(1):53‐6. [CENTRAL: CN‐00181239] ">Walton 1986</a>). Gender was not reported in three studies (<a href="./references#CD012235-bbs2-0008" title="PringDJ , CasiebancaN . Simple plantar ulcers treated by below‐knee plaster and moulded double‐rocker plaster shoe ‐ a comparative study. Leprosy Review1982;53(4):261‐4. [CENTRAL: CN‐00249869] ">Pring 1982</a>; <a href="./references#CD012235-bbs2-0012" title="SharmaR , BargotraR , GuptaR , DarHA . Comparative study of the effects of wax therapy and foot soaks on dry plantar skin and ulcers in leprosy patients. JK Science2005;7(2):81‐3. [CENTRAL: CN‐01911700; EMBASE: 40846955] ">Sharma 2005</a>; <a href="./references#CD012235-bbs2-0014" title="WaltonR , FritschiE , UmapathyV . Treatment of plantar ulcers in leprosy patients in the community with adhesive zinc tape. Leprosy Review1986;57(1):53‐6. [CENTRAL: CN‐00181239] ">Walton 1986</a>), but information from the remaining studies suggests there were more men amongst the participants (472 men and 157 women). </p> <p>All studies except <a href="./references#CD012235-bbs2-0012" title="SharmaR , BargotraR , GuptaR , DarHA . Comparative study of the effects of wax therapy and foot soaks on dry plantar skin and ulcers in leprosy patients. JK Science2005;7(2):81‐3. [CENTRAL: CN‐01911700; EMBASE: 40846955] ">Sharma 2005</a> included participants affected by leprosy with plantar ulcers, and three studies also included participants with ulcers elsewhere, mostly the hands (<a href="./references#CD012235-bbs2-0001" title="BansalN , Mukul . Comparison of topical phenytoin with normal saline in the treatment of chronic trophic ulcers in leprosy. International Journal of Dermatology1993;32(3):210‐3. [CENTRAL: CN‐00091437] ">Bansal 1993</a>; <a href="./references#CD012235-bbs2-0004" title="LeeRH , LeeJM , KimJP . Research on effect of light emitting diode (LED) on treating skin ulcer of Hansen's disease. Korean Leprosy Bulletin2012;45(1):41‐52. [CENTRAL: CN‐01045879] ">Lee 2012</a>; <a href="./references#CD012235-bbs2-0009" title="SalazarJ , SerranoG , Leon‐QuinteroG , Torres‐MendozaB . Use of topical ketanserin for the treatment of ulcers in leprosy patients. Indian Journal of Leprosy2001;73(2):103‐10. [CENTRAL: CN‐00374140] ">Salazar 2001</a>). The majority of participants had only one wound (ulcer) on one foot. The wounds were mainly simple (not infected) and they varied in size and depth; some wounds were more complicated. The majority of participants had their wounds for less than a year. </p> </section> <section id="CD012235-sec-0078"> <h5 class="title">Setting</h5> <p>The trials took place in Brazil, Ethiopia, Egypt, Indonesia, Mexico, South Korea, and most in India. Four studies were hospital based (<a href="./references#CD012235-bbs2-0001" title="BansalN , Mukul . Comparison of topical phenytoin with normal saline in the treatment of chronic trophic ulcers in leprosy. International Journal of Dermatology1993;32(3):210‐3. [CENTRAL: CN‐00091437] ">Bansal 1993</a>; <a href="./references#CD012235-bbs2-0003" title="BhatiaA , NandaS , GuptaU , GuptaS , ReddyB . Topical phenytoin suspension and normal saline in the treatment of leprosy trophic ulcers: a randomised, double blind, comparative study. Journal of Dermatological Treatment2004;15(5):321‐7. [CENTRAL: CN‐00491464] ">Bhatia 2004</a>; <a href="./references#CD012235-bbs2-0012" title="SharmaR , BargotraR , GuptaR , DarHA . Comparative study of the effects of wax therapy and foot soaks on dry plantar skin and ulcers in leprosy patients. JK Science2005;7(2):81‐3. [CENTRAL: CN‐01911700; EMBASE: 40846955] ">Sharma 2005</a>; <a href="./references#CD012235-bbs2-0013" title="SöderbergT , HallmansG , StenströmS , LoboD , PintoJ , MaroofS , et al. Treatment of leprosy wounds with adhesive zinc tape. Leprosy Review1982;53(4):271‐6. [CENTRAL: CN‐00181158] ">Söderberg 1982</a>), while nine were based at outpatient clinics (<a href="./references#CD012235-bbs2-0002" title="BarretoJG , SalgadoCG . Clinic‐epidemiological evaluation of ulcers in patients with leprosy sequelae and the effect of low level laser therapy on wound healing: a randomized clinical trial. BMC Infectious Diseases2010;10:237. [CENTRAL: CN‐00760396; PUBMED: 20698989] ">Barreto 2010</a>; <a href="./references#CD012235-bbs2-0006" title="OverbeekST , ThamLM . Effect of zinc oxide tape on plantar ulcers in leprosy in Indonesia [Het effect van zinkoxide‐tape op plantaire ulcera bij leprapatiënten in Indonesië]. Nederlands Tidshrift foor Geneeskunde1991;135(30):1350‐3. [CENTRAL: CN‐00616028] ">Overbeek 1991</a>; <a href="./references#CD012235-bbs2-0007" title="PrakoeswaCR , NatallyaFR , HarnindyaD , ThohirohA , OktaviyantiRN , PratiwiKD , et al. The efficacy of topical human amniotic membrane‐mesenchymal stem cell‐conditions medium (hAMMSC‐CM) and a mixture of topical hAMMSC‐CM + vitamin C and hAMMSC‐CM + vitamin E on chronic plantar ulcers in leprosy: a randomised control trial. Journal of Dermatological Treatment2018;29(8):835‐40. [CENTRAL: CN‐01607409; DOI: 10.1080/09546634.2018.1467541] ">Prakoeswa 2018</a>; <a href="./references#CD012235-bbs2-0008" title="PringDJ , CasiebancaN . Simple plantar ulcers treated by below‐knee plaster and moulded double‐rocker plaster shoe ‐ a comparative study. Leprosy Review1982;53(4):261‐4. [CENTRAL: CN‐00249869] ">Pring 1982</a>; <a href="./references#CD012235-bbs2-0009" title="SalazarJ , SerranoG , Leon‐QuinteroG , Torres‐MendozaB . Use of topical ketanserin for the treatment of ulcers in leprosy patients. Indian Journal of Leprosy2001;73(2):103‐10. [CENTRAL: CN‐00374140] ">Salazar 2001</a>; <a href="./references#CD012235-bbs2-0011" title="SebokaG , SaundersonP , CurrieH . Footwear for farmers affected by leprosy. Leprosy Review1998;69(2):182‐3. [CENTRAL: CN‐00339604] ">Seboka 1998</a>; <a href="./references#CD012235-bbs2-0010" title="SarmaGR , SubrahmanyamS , DeenabandhuA , BabuCR , MadhivathananS , KesavarajN . Exposure to pulsed magnetic fields in the treatment of plantar ulcers in leprosy patients ‐ a pilot , randomized, double blind, controlled clinical trial. Indian Journal of Leprosy1997;69(3):241‐50. [CENTRAL: CN‐00145841] ">Sarma 1997</a>; <a href="./references#CD012235-bbs2-0005" title="MikhaelNM , El‐EsawyFM . Intralesional pentoxifylline in the treatment of lepromatous ulcers. Journal of the Egyptian Women's Dermatologic Society2015;12(2):102‐7. [CENTRAL: CN‐01299200] ">Mikhael 2015</a>; <a href="./references#CD012235-bbs2-0014" title="WaltonR , FritschiE , UmapathyV . Treatment of plantar ulcers in leprosy patients in the community with adhesive zinc tape. Leprosy Review1986;57(1):53‐6. [CENTRAL: CN‐00181239] ">Walton 1986</a>). One study included both in‐ and outpatients (<a href="./references#CD012235-bbs2-0004" title="LeeRH , LeeJM , KimJP . Research on effect of light emitting diode (LED) on treating skin ulcer of Hansen's disease. Korean Leprosy Bulletin2012;45(1):41‐52. [CENTRAL: CN‐01045879] ">Lee 2012</a>). </p> </section> <section id="CD012235-sec-0079"> <h5 class="title">Interventions</h5> <p>The studies evaluated various treatment interventions: low laser therapy (3 times per week) (<a href="./references#CD012235-bbs2-0002" title="BarretoJG , SalgadoCG . Clinic‐epidemiological evaluation of ulcers in patients with leprosy sequelae and the effect of low level laser therapy on wound healing: a randomized clinical trial. BMC Infectious Diseases2010;10:237. [CENTRAL: CN‐00760396; PUBMED: 20698989] ">Barreto 2010</a>), light‐emitting diode (LED; 20 minutes) (<a href="./references#CD012235-bbs2-0004" title="LeeRH , LeeJM , KimJP . Research on effect of light emitting diode (LED) on treating skin ulcer of Hansen's disease. Korean Leprosy Bulletin2012;45(1):41‐52. [CENTRAL: CN‐01045879] ">Lee 2012</a>), weekly injected intralesional pentoxifylline (<a href="./references#CD012235-bbs2-0005" title="MikhaelNM , El‐EsawyFM . Intralesional pentoxifylline in the treatment of lepromatous ulcers. Journal of the Egyptian Women's Dermatologic Society2015;12(2):102‐7. [CENTRAL: CN‐01299200] ">Mikhael 2015</a>), daily to weekly zinc tape (<a href="./references#CD012235-bbs2-0006" title="OverbeekST , ThamLM . Effect of zinc oxide tape on plantar ulcers in leprosy in Indonesia [Het effect van zinkoxide‐tape op plantaire ulcera bij leprapatiënten in Indonesië]. Nederlands Tidshrift foor Geneeskunde1991;135(30):1350‐3. [CENTRAL: CN‐00616028] ">Overbeek 1991</a>; <a href="./references#CD012235-bbs2-0013" title="SöderbergT , HallmansG , StenströmS , LoboD , PintoJ , MaroofS , et al. Treatment of leprosy wounds with adhesive zinc tape. Leprosy Review1982;53(4):271‐6. [CENTRAL: CN‐00181158] ">Söderberg 1982</a>), zinc tape in addition to self‐care and sandals (<a href="./references#CD012235-bbs2-0014" title="WaltonR , FritschiE , UmapathyV . Treatment of plantar ulcers in leprosy patients in the community with adhesive zinc tape. Leprosy Review1986;57(1):53‐6. [CENTRAL: CN‐00181239] ">Walton 1986</a>), padded moulded double‐rocker plaster shoe (in addition to education) (<a href="./references#CD012235-bbs2-0008" title="PringDJ , CasiebancaN . Simple plantar ulcers treated by below‐knee plaster and moulded double‐rocker plaster shoe ‐ a comparative study. Leprosy Review1982;53(4):261‐4. [CENTRAL: CN‐00249869] ">Pring 1982</a>), topical ketanserin (every 12 hours) (<a href="./references#CD012235-bbs2-0009" title="SalazarJ , SerranoG , Leon‐QuinteroG , Torres‐MendozaB . Use of topical ketanserin for the treatment of ulcers in leprosy patients. Indian Journal of Leprosy2001;73(2):103‐10. [CENTRAL: CN‐00374140] ">Salazar 2001</a>), topical human amniotic membrane‐mesenchymal stem cell‐conditioned medium (every 3 days) (<a href="./references#CD012235-bbs2-0007" title="PrakoeswaCR , NatallyaFR , HarnindyaD , ThohirohA , OktaviyantiRN , PratiwiKD , et al. The efficacy of topical human amniotic membrane‐mesenchymal stem cell‐conditions medium (hAMMSC‐CM) and a mixture of topical hAMMSC‐CM + vitamin C and hAMMSC‐CM + vitamin E on chronic plantar ulcers in leprosy: a randomised control trial. Journal of Dermatological Treatment2018;29(8):835‐40. [CENTRAL: CN‐01607409; DOI: 10.1080/09546634.2018.1467541] ">Prakoeswa 2018</a>), daily pulsed magnetic fields (in addition to self‐care and protective footwear) (<a href="./references#CD012235-bbs2-0010" title="SarmaGR , SubrahmanyamS , DeenabandhuA , BabuCR , MadhivathananS , KesavarajN . Exposure to pulsed magnetic fields in the treatment of plantar ulcers in leprosy patients ‐ a pilot , randomized, double blind, controlled clinical trial. Indian Journal of Leprosy1997;69(3):241‐50. [CENTRAL: CN‐00145841] ">Sarma 1997</a>), PVC boots (daily) (<a href="./references#CD012235-bbs2-0011" title="SebokaG , SaundersonP , CurrieH . Footwear for farmers affected by leprosy. Leprosy Review1998;69(2):182‐3. [CENTRAL: CN‐00339604] ">Seboka 1998</a>), daily wax therapy (<a href="./references#CD012235-bbs2-0012" title="SharmaR , BargotraR , GuptaR , DarHA . Comparative study of the effects of wax therapy and foot soaks on dry plantar skin and ulcers in leprosy patients. JK Science2005;7(2):81‐3. [CENTRAL: CN‐01911700; EMBASE: 40846955] ">Sharma 2005</a>), and daily topical phenytoin dressings (<a href="./references#CD012235-bbs2-0001" title="BansalN , Mukul . Comparison of topical phenytoin with normal saline in the treatment of chronic trophic ulcers in leprosy. International Journal of Dermatology1993;32(3):210‐3. [CENTRAL: CN‐00091437] ">Bansal 1993</a>; <a href="./references#CD012235-bbs2-0003" title="BhatiaA , NandaS , GuptaU , GuptaS , ReddyB . Topical phenytoin suspension and normal saline in the treatment of leprosy trophic ulcers: a randomised, double blind, comparative study. Journal of Dermatological Treatment2004;15(5):321‐7. [CENTRAL: CN‐00491464] ">Bhatia 2004</a>). </p> </section> <section id="CD012235-sec-0080"> <h5 class="title">Comparisons</h5> <p>Nine of the interventions were compared to dry dressings or dressings soaked in differing solutions. Padded, moulded double‐rocker plaster shoes were compared to padded below‐knee plasters, which were the traditional method; PVC boots were compared to canvas shoes; and hot wax therapy was compared to 20 minutes foot soak in water plus Vaseline. </p> </section> <section id="CD012235-sec-0081"> <h5 class="title">Duration</h5> <p>Four interventions were given for four weeks (<a href="./references#CD012235-bbs2-0001" title="BansalN , Mukul . Comparison of topical phenytoin with normal saline in the treatment of chronic trophic ulcers in leprosy. International Journal of Dermatology1993;32(3):210‐3. [CENTRAL: CN‐00091437] ">Bansal 1993</a>; <a href="./references#CD012235-bbs2-0003" title="BhatiaA , NandaS , GuptaU , GuptaS , ReddyB . Topical phenytoin suspension and normal saline in the treatment of leprosy trophic ulcers: a randomised, double blind, comparative study. Journal of Dermatological Treatment2004;15(5):321‐7. [CENTRAL: CN‐00491464] ">Bhatia 2004</a>; <a href="./references#CD012235-bbs2-0010" title="SarmaGR , SubrahmanyamS , DeenabandhuA , BabuCR , MadhivathananS , KesavarajN . Exposure to pulsed magnetic fields in the treatment of plantar ulcers in leprosy patients ‐ a pilot , randomized, double blind, controlled clinical trial. Indian Journal of Leprosy1997;69(3):241‐50. [CENTRAL: CN‐00145841] ">Sarma 1997</a>; <a href="./references#CD012235-bbs2-0014" title="WaltonR , FritschiE , UmapathyV . Treatment of plantar ulcers in leprosy patients in the community with adhesive zinc tape. Leprosy Review1986;57(1):53‐6. [CENTRAL: CN‐00181239] ">Walton 1986</a>), three were given for six weeks (<a href="./references#CD012235-bbs2-0008" title="PringDJ , CasiebancaN . Simple plantar ulcers treated by below‐knee plaster and moulded double‐rocker plaster shoe ‐ a comparative study. Leprosy Review1982;53(4):261‐4. [CENTRAL: CN‐00249869] ">Pring 1982</a>; <a href="./references#CD012235-bbs2-0006" title="OverbeekST , ThamLM . Effect of zinc oxide tape on plantar ulcers in leprosy in Indonesia [Het effect van zinkoxide‐tape op plantaire ulcera bij leprapatiënten in Indonesië]. Nederlands Tidshrift foor Geneeskunde1991;135(30):1350‐3. [CENTRAL: CN‐00616028] ">Overbeek 1991</a>; <a href="./references#CD012235-bbs2-0012" title="SharmaR , BargotraR , GuptaR , DarHA . Comparative study of the effects of wax therapy and foot soaks on dry plantar skin and ulcers in leprosy patients. JK Science2005;7(2):81‐3. [CENTRAL: CN‐01911700; EMBASE: 40846955] ">Sharma 2005</a>), three were given for eight weeks (<a href="./references#CD012235-bbs2-0005" title="MikhaelNM , El‐EsawyFM . Intralesional pentoxifylline in the treatment of lepromatous ulcers. Journal of the Egyptian Women's Dermatologic Society2015;12(2):102‐7. [CENTRAL: CN‐01299200] ">Mikhael 2015</a>; <a href="./references#CD012235-bbs2-0007" title="PrakoeswaCR , NatallyaFR , HarnindyaD , ThohirohA , OktaviyantiRN , PratiwiKD , et al. The efficacy of topical human amniotic membrane‐mesenchymal stem cell‐conditions medium (hAMMSC‐CM) and a mixture of topical hAMMSC‐CM + vitamin C and hAMMSC‐CM + vitamin E on chronic plantar ulcers in leprosy: a randomised control trial. Journal of Dermatological Treatment2018;29(8):835‐40. [CENTRAL: CN‐01607409; DOI: 10.1080/09546634.2018.1467541] ">Prakoeswa 2018</a>; <a href="./references#CD012235-bbs2-0013" title="SöderbergT , HallmansG , StenströmS , LoboD , PintoJ , MaroofS , et al. Treatment of leprosy wounds with adhesive zinc tape. Leprosy Review1982;53(4):271‐6. [CENTRAL: CN‐00181158] ">Söderberg 1982</a>), two were given for 12 weeks (<a href="./references#CD012235-bbs2-0002" title="BarretoJG , SalgadoCG . Clinic‐epidemiological evaluation of ulcers in patients with leprosy sequelae and the effect of low level laser therapy on wound healing: a randomized clinical trial. BMC Infectious Diseases2010;10:237. [CENTRAL: CN‐00760396; PUBMED: 20698989] ">Barreto 2010</a>; <a href="./references#CD012235-bbs2-0009" title="SalazarJ , SerranoG , Leon‐QuinteroG , Torres‐MendozaB . Use of topical ketanserin for the treatment of ulcers in leprosy patients. Indian Journal of Leprosy2001;73(2):103‐10. [CENTRAL: CN‐00374140] ">Salazar 2001</a>), and one intervention was given for 12 months (<a href="./references#CD012235-bbs2-0011" title="SebokaG , SaundersonP , CurrieH . Footwear for farmers affected by leprosy. Leprosy Review1998;69(2):182‐3. [CENTRAL: CN‐00339604] ">Seboka 1998</a>). <a href="./references#CD012235-bbs2-0004" title="LeeRH , LeeJM , KimJP . Research on effect of light emitting diode (LED) on treating skin ulcer of Hansen's disease. Korean Leprosy Bulletin2012;45(1):41‐52. [CENTRAL: CN‐01045879] ">Lee 2012</a> did not report duration of treatment period, but the whole study lasted eight months. </p> </section> <section id="CD012235-sec-0082"> <h5 class="title">Outcomes</h5> <p>All trials but one reported as the primary outcome 'Healing of existing ulcers', measured either as proportion healed or number of ulcers healed. Adverse events were covered in a few trials, but there was limited information on how this outcome was measured. Costs were not systematically assessed, and neither were acceptability of treatment nor any quality of life measures. The follow‐up period from baseline varied from one month to one year. The follow‐up period did not, in any trials, go beyond the study duration, and outcomes were measured either during the trials or at the end of study duration, or both. </p> <p>Typical outcome measures were number of ulcers healed, size of ulcers or reduction of ulcer size, number of new ulcers, ulcer‐free at one year, ulcers not healed, ulcers fully healed, and use of adapted footwear. </p> <p>None of the 14 included studies measured quality of life. Prevention of ulcers was only reported in <a href="./references#CD012235-bbs2-0011" title="SebokaG , SaundersonP , CurrieH . Footwear for farmers affected by leprosy. Leprosy Review1998;69(2):182‐3. [CENTRAL: CN‐00339604] ">Seboka 1998</a>. Only one study measured our tertiary outcome: prevention or treatment of other skin changes, such as cracking, thickening or pigmentary changes (<a href="./references#CD012235-bbs2-0012" title="SharmaR , BargotraR , GuptaR , DarHA . Comparative study of the effects of wax therapy and foot soaks on dry plantar skin and ulcers in leprosy patients. JK Science2005;7(2):81‐3. [CENTRAL: CN‐01911700; EMBASE: 40846955] ">Sharma 2005</a>). </p> </section> <section id="CD012235-sec-0083"> <h5 class="title">Funding sources</h5> <p>The included studies were funded by trusts, universities, research councils, leprosy trusts, and government grants. However, the majority of studies did not report funding source (<a href="./references#CD012235-sec-0134" title="">Characteristics of included studies</a>). </p> </section> </section> <section id="CD012235-sec-0084"> <h4 class="title">Excluded studies</h4> <p>We excluded 34 of the studies we read in full text (<a href="./references#CD012235-sec-0135" title="">Characteristics of excluded studies</a>). The main reason for exclusion was that they were not randomised trials (21 studies), they did not have a relevant intervention (7 studies), or publication type (being reviews or an editorial; 6 studies). One controlled trial evaluated wax therapy for dry feet (<a href="./references#CD012235-bbs2-0031" title="MahajanPM , KulkarniVN , JadhavVH , MehtaJM . Wax therapy for dry feet in leprosy. Indian Journal of Leprosy1995;67(4):383‐8. [PUBMED: 8849915] ">Mahajan 1995</a>), but was not included because the allocation procedure seemed to be neither random nor quasi‐random. </p> </section> </section> <section id="CD012235-sec-0085"> <h3 class="title">Risk of bias in included studies</h3> <p>We assessed all studies for risk of bias (<a href="./references#CD012235-sec-0134" title="">Characteristics of included studies</a>). Due to generally poor reporting it was often difficult to make the assessments; hence, we rated many assessments at unclear risk of bias. We rated seven studies at high risk of bias in at least one domain including selection bias (random sequence generation) (<a href="./references#CD012235-bbs2-0001" title="BansalN , Mukul . Comparison of topical phenytoin with normal saline in the treatment of chronic trophic ulcers in leprosy. International Journal of Dermatology1993;32(3):210‐3. [CENTRAL: CN‐00091437] ">Bansal 1993</a>; <a href="./references#CD012235-bbs2-0006" title="OverbeekST , ThamLM . Effect of zinc oxide tape on plantar ulcers in leprosy in Indonesia [Het effect van zinkoxide‐tape op plantaire ulcera bij leprapatiënten in Indonesië]. Nederlands Tidshrift foor Geneeskunde1991;135(30):1350‐3. [CENTRAL: CN‐00616028] ">Overbeek 1991</a>; <a href="./references#CD012235-bbs2-0013" title="SöderbergT , HallmansG , StenströmS , LoboD , PintoJ , MaroofS , et al. Treatment of leprosy wounds with adhesive zinc tape. Leprosy Review1982;53(4):271‐6. [CENTRAL: CN‐00181158] ">Söderberg 1982</a>), attrition bias (<a href="./references#CD012235-bbs2-0003" title="BhatiaA , NandaS , GuptaU , GuptaS , ReddyB . Topical phenytoin suspension and normal saline in the treatment of leprosy trophic ulcers: a randomised, double blind, comparative study. Journal of Dermatological Treatment2004;15(5):321‐7. [CENTRAL: CN‐00491464] ">Bhatia 2004</a>; <a href="./references#CD012235-bbs2-0006" title="OverbeekST , ThamLM . Effect of zinc oxide tape on plantar ulcers in leprosy in Indonesia [Het effect van zinkoxide‐tape op plantaire ulcera bij leprapatiënten in Indonesië]. Nederlands Tidshrift foor Geneeskunde1991;135(30):1350‐3. [CENTRAL: CN‐00616028] ">Overbeek 1991</a>; <a href="./references#CD012235-bbs2-0010" title="SarmaGR , SubrahmanyamS , DeenabandhuA , BabuCR , MadhivathananS , KesavarajN . Exposure to pulsed magnetic fields in the treatment of plantar ulcers in leprosy patients ‐ a pilot , randomized, double blind, controlled clinical trial. Indian Journal of Leprosy1997;69(3):241‐50. [CENTRAL: CN‐00145841] ">Sarma 1997</a>; <a href="./references#CD012235-bbs2-0014" title="WaltonR , FritschiE , UmapathyV . Treatment of plantar ulcers in leprosy patients in the community with adhesive zinc tape. Leprosy Review1986;57(1):53‐6. [CENTRAL: CN‐00181239] ">Walton 1986</a>). We did not consider any studies to be at low risk of bias for all domains. Please see <a href="#CD012235-fig-0002">Figure 2</a> for the 'Risk of bias' summary: review authors' judgements about each domain for each included study, and see <a href="#CD012235-fig-0003">Figure 3</a> for the 'Risk of bias' graph: review authors' judgements about each domain presented as percentages across all included studies. </p> <section id="CD012235-sec-0086"> <h4 class="title">Allocation</h4> <p>We judged three trials to be clearly quasi‐randomised and we rated these at high risk of selection bias from random sequence generation (<a href="./references#CD012235-bbs2-0001" title="BansalN , Mukul . Comparison of topical phenytoin with normal saline in the treatment of chronic trophic ulcers in leprosy. International Journal of Dermatology1993;32(3):210‐3. [CENTRAL: CN‐00091437] ">Bansal 1993</a>; <a href="./references#CD012235-bbs2-0006" title="OverbeekST , ThamLM . Effect of zinc oxide tape on plantar ulcers in leprosy in Indonesia [Het effect van zinkoxide‐tape op plantaire ulcera bij leprapatiënten in Indonesië]. Nederlands Tidshrift foor Geneeskunde1991;135(30):1350‐3. [CENTRAL: CN‐00616028] ">Overbeek 1991</a>; <a href="./references#CD012235-bbs2-0013" title="SöderbergT , HallmansG , StenströmS , LoboD , PintoJ , MaroofS , et al. Treatment of leprosy wounds with adhesive zinc tape. Leprosy Review1982;53(4):271‐6. [CENTRAL: CN‐00181158] ">Söderberg 1982</a>). Two trials were potentially quasi‐randomised (<a href="./references#CD012235-bbs2-0009" title="SalazarJ , SerranoG , Leon‐QuinteroG , Torres‐MendozaB . Use of topical ketanserin for the treatment of ulcers in leprosy patients. Indian Journal of Leprosy2001;73(2):103‐10. [CENTRAL: CN‐00374140] ">Salazar 2001</a>; <a href="./references#CD012235-bbs2-0014" title="WaltonR , FritschiE , UmapathyV . Treatment of plantar ulcers in leprosy patients in the community with adhesive zinc tape. Leprosy Review1986;57(1):53‐6. [CENTRAL: CN‐00181239] ">Walton 1986</a>), but as we were not sure, we assessed them as having unclear randomisation procedures along with four other studies (<a href="./references#CD012235-bbs2-0004" title="LeeRH , LeeJM , KimJP . Research on effect of light emitting diode (LED) on treating skin ulcer of Hansen's disease. Korean Leprosy Bulletin2012;45(1):41‐52. [CENTRAL: CN‐01045879] ">Lee 2012</a>; <a href="./references#CD012235-bbs2-0008" title="PringDJ , CasiebancaN . Simple plantar ulcers treated by below‐knee plaster and moulded double‐rocker plaster shoe ‐ a comparative study. Leprosy Review1982;53(4):261‐4. [CENTRAL: CN‐00249869] ">Pring 1982</a>; <a href="./references#CD012235-bbs2-0010" title="SarmaGR , SubrahmanyamS , DeenabandhuA , BabuCR , MadhivathananS , KesavarajN . Exposure to pulsed magnetic fields in the treatment of plantar ulcers in leprosy patients ‐ a pilot , randomized, double blind, controlled clinical trial. Indian Journal of Leprosy1997;69(3):241‐50. [CENTRAL: CN‐00145841] ">Sarma 1997</a>; <a href="./references#CD012235-bbs2-0011" title="SebokaG , SaundersonP , CurrieH . Footwear for farmers affected by leprosy. Leprosy Review1998;69(2):182‐3. [CENTRAL: CN‐00339604] ">Seboka 1998</a>). We assessed five studies as having adequate randomisation sequence generation (<a href="./references#CD012235-bbs2-0002" title="BarretoJG , SalgadoCG . Clinic‐epidemiological evaluation of ulcers in patients with leprosy sequelae and the effect of low level laser therapy on wound healing: a randomized clinical trial. BMC Infectious Diseases2010;10:237. [CENTRAL: CN‐00760396; PUBMED: 20698989] ">Barreto 2010</a>; <a href="./references#CD012235-bbs2-0003" title="BhatiaA , NandaS , GuptaU , GuptaS , ReddyB . Topical phenytoin suspension and normal saline in the treatment of leprosy trophic ulcers: a randomised, double blind, comparative study. Journal of Dermatological Treatment2004;15(5):321‐7. [CENTRAL: CN‐00491464] ">Bhatia 2004</a>; <a href="./references#CD012235-bbs2-0005" title="MikhaelNM , El‐EsawyFM . Intralesional pentoxifylline in the treatment of lepromatous ulcers. Journal of the Egyptian Women's Dermatologic Society2015;12(2):102‐7. [CENTRAL: CN‐01299200] ">Mikhael 2015</a>; <a href="./references#CD012235-bbs2-0007" title="PrakoeswaCR , NatallyaFR , HarnindyaD , ThohirohA , OktaviyantiRN , PratiwiKD , et al. The efficacy of topical human amniotic membrane‐mesenchymal stem cell‐conditions medium (hAMMSC‐CM) and a mixture of topical hAMMSC‐CM + vitamin C and hAMMSC‐CM + vitamin E on chronic plantar ulcers in leprosy: a randomised control trial. Journal of Dermatological Treatment2018;29(8):835‐40. [CENTRAL: CN‐01607409; DOI: 10.1080/09546634.2018.1467541] ">Prakoeswa 2018</a>; <a href="./references#CD012235-bbs2-0012" title="SharmaR , BargotraR , GuptaR , DarHA . Comparative study of the effects of wax therapy and foot soaks on dry plantar skin and ulcers in leprosy patients. JK Science2005;7(2):81‐3. [CENTRAL: CN‐01911700; EMBASE: 40846955] ">Sharma 2005</a>). We considered all studies at unclear risk of selection bias regarding allocation concealment due to limited information reported in the publications. </p> </section> <section id="CD012235-sec-0087"> <h4 class="title">Blinding</h4> <p>Although participants in many cases could have been blinded to their intervention, this was usually not described or reported in the included trials. Two studies reported that the patient and health care providers as well as the outcome assessor were blinded and we accordingly considered these as having low risk of performance and detection bias (<a href="./references#CD012235-bbs2-0003" title="BhatiaA , NandaS , GuptaU , GuptaS , ReddyB . Topical phenytoin suspension and normal saline in the treatment of leprosy trophic ulcers: a randomised, double blind, comparative study. Journal of Dermatological Treatment2004;15(5):321‐7. [CENTRAL: CN‐00491464] ">Bhatia 2004</a>; <a href="./references#CD012235-bbs2-0010" title="SarmaGR , SubrahmanyamS , DeenabandhuA , BabuCR , MadhivathananS , KesavarajN . Exposure to pulsed magnetic fields in the treatment of plantar ulcers in leprosy patients ‐ a pilot , randomized, double blind, controlled clinical trial. Indian Journal of Leprosy1997;69(3):241‐50. [CENTRAL: CN‐00145841] ">Sarma 1997</a>), while <a href="./references#CD012235-bbs2-0001" title="BansalN , Mukul . Comparison of topical phenytoin with normal saline in the treatment of chronic trophic ulcers in leprosy. International Journal of Dermatology1993;32(3):210‐3. [CENTRAL: CN‐00091437] ">Bansal 1993</a> reported only blinding of outcome assessor (low risk of detection bias). We considered the remaining studies as having unclear risk of performance and detection bias. </p> </section> <section id="CD012235-sec-0088"> <h4 class="title">Incomplete outcome data</h4> <p>We had some concerns about attrition bias in four studies mainly due to loss of follow‐up (<a href="./references#CD012235-bbs2-0003" title="BhatiaA , NandaS , GuptaU , GuptaS , ReddyB . Topical phenytoin suspension and normal saline in the treatment of leprosy trophic ulcers: a randomised, double blind, comparative study. Journal of Dermatological Treatment2004;15(5):321‐7. [CENTRAL: CN‐00491464] ">Bhatia 2004</a>; <a href="./references#CD012235-bbs2-0006" title="OverbeekST , ThamLM . Effect of zinc oxide tape on plantar ulcers in leprosy in Indonesia [Het effect van zinkoxide‐tape op plantaire ulcera bij leprapatiënten in Indonesië]. Nederlands Tidshrift foor Geneeskunde1991;135(30):1350‐3. [CENTRAL: CN‐00616028] ">Overbeek 1991</a>; <a href="./references#CD012235-bbs2-0010" title="SarmaGR , SubrahmanyamS , DeenabandhuA , BabuCR , MadhivathananS , KesavarajN . Exposure to pulsed magnetic fields in the treatment of plantar ulcers in leprosy patients ‐ a pilot , randomized, double blind, controlled clinical trial. Indian Journal of Leprosy1997;69(3):241‐50. [CENTRAL: CN‐00145841] ">Sarma 1997</a>; <a href="./references#CD012235-bbs2-0014" title="WaltonR , FritschiE , UmapathyV . Treatment of plantar ulcers in leprosy patients in the community with adhesive zinc tape. Leprosy Review1986;57(1):53‐6. [CENTRAL: CN‐00181239] ">Walton 1986</a>); therefore, we considered these studies at high risk of attrition bias. We rated one study as unclear on attrition bias (<a href="./references#CD012235-bbs2-0013" title="SöderbergT , HallmansG , StenströmS , LoboD , PintoJ , MaroofS , et al. Treatment of leprosy wounds with adhesive zinc tape. Leprosy Review1982;53(4):271‐6. [CENTRAL: CN‐00181158] ">Söderberg 1982</a>) and we considered the remaining studies at low risk of attrition bias. </p> </section> <section id="CD012235-sec-0089"> <h4 class="title">Selective reporting</h4> <p>We have no reason to suspect any selective reporting in the studies. However, for all but one study we did not have access to the study protocols (<a href="./references#CD012235-bbs2-0002" title="BarretoJG , SalgadoCG . Clinic‐epidemiological evaluation of ulcers in patients with leprosy sequelae and the effect of low level laser therapy on wound healing: a randomized clinical trial. BMC Infectious Diseases2010;10:237. [CENTRAL: CN‐00760396; PUBMED: 20698989] ">Barreto 2010</a>), but we did inspect the methods section in each study. We assessed all studies as having low risk of selective reporting. </p> </section> <section id="CD012235-sec-0090"> <h4 class="title">Other potential sources of bias</h4> <p>We considered seven studies to be at unclear risk of other biases. Five studies randomised some participants with more than two ulcers (<a href="./references#CD012235-bbs2-0001" title="BansalN , Mukul . Comparison of topical phenytoin with normal saline in the treatment of chronic trophic ulcers in leprosy. International Journal of Dermatology1993;32(3):210‐3. [CENTRAL: CN‐00091437] ">Bansal 1993</a>; <a href="./references#CD012235-bbs2-0002" title="BarretoJG , SalgadoCG . Clinic‐epidemiological evaluation of ulcers in patients with leprosy sequelae and the effect of low level laser therapy on wound healing: a randomized clinical trial. BMC Infectious Diseases2010;10:237. [CENTRAL: CN‐00760396; PUBMED: 20698989] ">Barreto 2010</a>; <a href="./references#CD012235-bbs2-0008" title="PringDJ , CasiebancaN . Simple plantar ulcers treated by below‐knee plaster and moulded double‐rocker plaster shoe ‐ a comparative study. Leprosy Review1982;53(4):261‐4. [CENTRAL: CN‐00249869] ">Pring 1982</a>; <a href="./references#CD012235-bbs2-0009" title="SalazarJ , SerranoG , Leon‐QuinteroG , Torres‐MendozaB . Use of topical ketanserin for the treatment of ulcers in leprosy patients. Indian Journal of Leprosy2001;73(2):103‐10. [CENTRAL: CN‐00374140] ">Salazar 2001</a>; <a href="./references#CD012235-bbs2-0014" title="WaltonR , FritschiE , UmapathyV . Treatment of plantar ulcers in leprosy patients in the community with adhesive zinc tape. Leprosy Review1986;57(1):53‐6. [CENTRAL: CN‐00181239] ">Walton 1986</a>), but the average cluster size was so small (less than 1.5) that the potential impact of a unit of analysis error was negligible. Hence, we considered these at unclear risk of other biases. Another study did not report clearly the number of feet included in the analyses, so we also considered this study at unclear risk of other biases (<a href="./references#CD012235-bbs2-0012" title="SharmaR , BargotraR , GuptaR , DarHA . Comparative study of the effects of wax therapy and foot soaks on dry plantar skin and ulcers in leprosy patients. JK Science2005;7(2):81‐3. [CENTRAL: CN‐01911700; EMBASE: 40846955] ">Sharma 2005</a>). There was a unit of analysis error (90 participants with 128 ulcers) in <a href="./references#CD012235-bbs2-0013" title="SöderbergT , HallmansG , StenströmS , LoboD , PintoJ , MaroofS , et al. Treatment of leprosy wounds with adhesive zinc tape. Leprosy Review1982;53(4):271‐6. [CENTRAL: CN‐00181158] ">Söderberg 1982</a>. There was also a difference between hospitals in the proportion of participants who wore shoes in this study which might influence the results. </p> <p>We considered the remaining seven studies to be at low risk of other biases.</p> </section> </section> <section id="CD012235-sec-0091"> <h3 class="title" id="CD012235-sec-0091">Effects of interventions</h3> <p>See: <a href="./full#CD012235-tbl-0001"><b>Summary of findings for the main comparison</b> Zinc tape compared to magnesium sulphate glycerin for ulceration caused by nerve damage in leprosy</a>; <a href="./full#CD012235-tbl-0002"><b>Summary of findings 2</b> Zinc tape compared to povidone iodine (10%) for ulceration and other skin changes caused by nerve damage in leprosy</a>; <a href="./full#CD012235-tbl-0003"><b>Summary of findings 3</b> Adhesive zinc tape compared to gauze soaked in eusol for ulceration caused by nerve damage in leprosy</a>; <a href="./full#CD012235-tbl-0004"><b>Summary of findings 4</b> Topical ketanserin (2%) compared to clioquinol cream (3%) or zinc paste for ulceration caused by nerve damage in leprosy</a>; <a href="./full#CD012235-tbl-0005"><b>Summary of findings 5</b> Topical phenytoin compared to saline dressing for ulceration and other skin changes caused by nerve damage in leprosy</a>; <a href="./full#CD012235-tbl-0006"><b>Summary of findings 6</b> Footwear ‐ canvas shoes compared to PVC boots for ulceration and other skin changes caused by nerve damage in leprosy</a>; <a href="./full#CD012235-tbl-0007"><b>Summary of findings 7</b> Padded moulded double‐rocker plaster shoe compared to padded below‐knee plaster for ulceration and other skin changes caused by nerve damage in leprosy</a>; <a href="./full#CD012235-tbl-0008"><b>Summary of findings 8</b> Exposure to pulsed magnetic fields (in addition to self‐care and protective footwear) compared to self‐care and footwear for ulceration and other skin changes caused by nerve damage in leprosy</a>; <a href="./full#CD012235-tbl-0009"><b>Summary of findings 9</b> Low‐level laser therapy compared to simple dressing for ulceration and other skin changes caused by nerve damage in leprosy</a>; <a href="./full#CD012235-tbl-0010"><b>Summary of findings 10</b> Intralesional pentoxifylline compared to daily simple dressing for ulceration and other skin changes caused by nerve damage in leprosy</a>; <a href="./full#CD012235-tbl-0011"><b>Summary of findings 11</b> Light‐emitting diode (LED) irradiation compared to conventional dressing therapy for ulceration and other skin changes caused by nerve damage in leprosy</a>; <a href="./full#CD012235-tbl-0012"><b>Summary of findings 12</b> Wax therapy compared to foot soaks for skin changes caused by nerve damage in leprosy</a>; <a href="./full#CD012235-tbl-0013"><b>Summary of findings 13</b> hAMMSC‐CM + vitamin C compared to hAMMSC‐CM for ulceration caused by nerve damage in leprosy</a>; <a href="./full#CD012235-tbl-0014"><b>Summary of findings 14</b> hAMMSC‐CM + vitamin E compared to hAMMSC‐CM for ulceration caused by nerve damage in leprosy</a>; <a href="./full#CD012235-tbl-0015"><b>Summary of findings 15</b> hAMMSC‐CM + vitamin E compared to hAMMSC‐CM + vitamin C for ulceration caused by nerve damage in leprosy</a> </p> <p>None of the 14 included studies measured quality of life (secondary outcome). Prevention of ulcers (primary outcome) was only reported in <a href="./references#CD012235-bbs2-0011" title="SebokaG , SaundersonP , CurrieH . Footwear for farmers affected by leprosy. Leprosy Review1998;69(2):182‐3. [CENTRAL: CN‐00339604] ">Seboka 1998</a>. Only one study measured our tertiary outcome (prevention or treatment of other skin changes such as cracking, thickening or pigmentary changes) (<a href="./references#CD012235-bbs2-0012" title="SharmaR , BargotraR , GuptaR , DarHA . Comparative study of the effects of wax therapy and foot soaks on dry plantar skin and ulcers in leprosy patients. JK Science2005;7(2):81‐3. [CENTRAL: CN‐01911700; EMBASE: 40846955] ">Sharma 2005</a>). </p> <section id="CD012235-sec-0092"> <h4 class="title">Interventions for people with leprosy and existing ulcer(s)</h4> <section id="CD012235-sec-0093"> <h5 class="title">Zinc tape compared to magnesium sulphate/glycerin</h5> <p>One study with 28 participants evaluated the effect of zinc tape versus sulphate/glycerin (<a href="./references#CD012235-bbs2-0014" title="WaltonR , FritschiE , UmapathyV . Treatment of plantar ulcers in leprosy patients in the community with adhesive zinc tape. Leprosy Review1986;57(1):53‐6. [CENTRAL: CN‐00181239] ">Walton 1986</a>), but the number of healed ulcers (primary outcome) was higher with zinc tape after one month; however, the 95% confidence interval (CI) included 1, showing some uncertainty (risk ratio (RR) 2.00, 95% CI 0.43 to 9.21; <a href="./references#CD012235-fig-0005" title="">Analysis 1.1</a>; Fisher's exact test P = 0.65; 4/14 versus 2/14 participants). In addition, the mean ulcer area was smaller in the zinc tape group (mean difference (MD) ‐14.30 mm², 95% CI ‐26.51 to ‐2.09; <a href="./references#CD012235-fig-0006" title="">Analysis 1.2</a>). We judged the evidence to be of very low certainty and accordingly have very little confidence in the effect estimate. We downgraded due to study limitations (such as 35% loss to follow‐up, consecutive cases were randomly allocated, no blinding of outcome assessor, and potential unit of analysis error. We also downgraded for imprecision due to sparse data and wide CIs. The study authors did not report adverse events, acceptability of treatment or costs. See <a href="./full#CD012235-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD012235-sec-0094"> <h5 class="title">Zinc tape compared to povidone iodine</h5> <p>One study (<a href="./references#CD012235-bbs2-0006" title="OverbeekST , ThamLM . Effect of zinc oxide tape on plantar ulcers in leprosy in Indonesia [Het effect van zinkoxide‐tape op plantaire ulcera bij leprapatiënten in Indonesië]. Nederlands Tidshrift foor Geneeskunde1991;135(30):1350‐3. [CENTRAL: CN‐00616028] ">Overbeek 1991</a>), with 38 participants evaluated the effect of zinc tape versus povidone iodine (10%) on healing of ulcers (primary outcome). The authors did not detect a clear difference in the mean reduction of ulcer area at six weeks between the two groups because the result was highly imprecise (MD 128.00 mm², 95% CI ‐110.01 to 366.01; <a href="./references#CD012235-fig-0007" title="">Analysis 2.1</a>). We judged the evidence to be of very low certainty, and consequently we have very little confidence in the effect estimate. We also downgraded due to study limitations (quasi‐randomised trial, high loss to follow‐up, and no reporting of blinding of outcome assessor), and due to imprecision (1 study, few participants, wide CI). The study authors did not report prevention of ulcers, adverse events, acceptability of treatment or costs. See <a href="./full#CD012235-tbl-0002">summary of findings Table 2</a>. </p> </section> <section id="CD012235-sec-0095"> <h5 class="title">Zinc tape compared to gauze soaked in Eusol</h5> <p>One study with 90 participants evaluated the effect of applications of zinc or gauze soaked in Eusol on healing of ulcer(s) (primary outcome) after one month (<a href="./references#CD012235-bbs2-0013" title="SöderbergT , HallmansG , StenströmS , LoboD , PintoJ , MaroofS , et al. Treatment of leprosy wounds with adhesive zinc tape. Leprosy Review1982;53(4):271‐6. [CENTRAL: CN‐00181158] ">Söderberg 1982</a>); the results were extracted from a figure in the publication. The participants had a total of 128 plantar ulcers. The average healing time was shorter for the group treated with zinc tape. The results varied between the two hospitals involved. In one hospital it took about 20 days (95% CI 18 to 23) for superficial ulcers to heal in the zinc tape group versus about 30 (95% CI 27 to 33) in the gauze group. For deep ulcers the average healing time was two weeks more. In the other hospital the average number of days to heal in the zinc tape group for superficial wounds were about 13 (95% CI 9 to 15) days and 23 (95% CI 16 to 28) days in the gauze group. For deep ulcers it took 17 days (95% CI 12 to 20) in the zinc tape group and 30 (95% CI 21 to 63) in the gauze group. There was a lack of information on how many participants and how many ulcers (deep or superficial ulcers) there were in the intervention and control group. We judged the evidence to be of very low certainty and have very little confidence in the reported results. For adverse events, the study authors reported that there were no signs of skin sensitisation in either group. We downgraded due to study limitations (allocation random alternate basis, no blinding of outcome assessor, and inadequate reporting of data), and due to imprecision (few participants). No signs of adverse events (skin sensitisation ‐ primary outcome) were observed. In terms of acceptability of treatment and costs, the authors reported that the zinc tape had a shorter healing time, lower cost, easier application and was more convenient for participants, and that it could be worn under shoes without causing pressure and was socially more acceptable with no bandages needed. However, it was not clear how the study measured these findings and no further data were reported. See <a href="./full#CD012235-tbl-0003">summary of findings Table 3</a>. </p> </section> <section id="CD012235-sec-0096"> <h5 class="title">Topical ketanserin (2%) compared to clioquinol cream (3%) or zinc oxide paste</h5> <p>One study with 66 participants evaluated the effect of topical ketanserin (2%) versus clioquinol cream (3%) or zinc oxide paste (<a href="./references#CD012235-bbs2-0009" title="SalazarJ , SerranoG , Leon‐QuinteroG , Torres‐MendozaB . Use of topical ketanserin for the treatment of ulcers in leprosy patients. Indian Journal of Leprosy2001;73(2):103‐10. [CENTRAL: CN‐00374140] ">Salazar 2001</a>), and showed a benefit of topical ketanserin on the 'risk' of ulcer healing (primary outcome) (RR 6.00, 95% CI 1.45 to 24.75; <a href="./references#CD012235-fig-0008" title="">Analysis 3.1</a>) after three months. We judged the evidence to be of very low certainty and have very little confidence in the effect estimate. We downgraded due to study limitations (randomisation procedure not reported, blinding not reported, and unclear if appropriate statistical analysis used) and due to imprecision (1 study, very wide CI). The authors reported that treatment was not suspended in any of the participants due to adverse events (primary outcome) (very low‐certainty evidence), study limitations (randomisation procedure not reported, blinding not reported), indirectness (not clear how side effects were measured and reported), or due to imprecision (1 study). The study authors did not report acceptability of treatment or costs. See <a href="./full#CD012235-tbl-0004">summary of findings Table 4</a>. </p> </section> <section id="CD012235-sec-0097"> <h5 class="title">Topical phenytoin (2% or 4%) compared to saline dressing, and topical 4% phenytoin versus 2% phenytoin </h5> <p>Two studies with a total of 123 participants at inclusion evaluated the effect of topical phenytoin versus saline dressing on healing of ulcer(s) (primary outcome) at four weeks (<a href="./references#CD012235-bbs2-0001" title="BansalN , Mukul . Comparison of topical phenytoin with normal saline in the treatment of chronic trophic ulcers in leprosy. International Journal of Dermatology1993;32(3):210‐3. [CENTRAL: CN‐00091437] ">Bansal 1993</a>; <a href="./references#CD012235-bbs2-0003" title="BhatiaA , NandaS , GuptaU , GuptaS , ReddyB . Topical phenytoin suspension and normal saline in the treatment of leprosy trophic ulcers: a randomised, double blind, comparative study. Journal of Dermatological Treatment2004;15(5):321‐7. [CENTRAL: CN‐00491464] ">Bhatia 2004</a>). <a href="./references#CD012235-bbs2-0001" title="BansalN , Mukul . Comparison of topical phenytoin with normal saline in the treatment of chronic trophic ulcers in leprosy. International Journal of Dermatology1993;32(3):210‐3. [CENTRAL: CN‐00091437] ">Bansal 1993</a> alternately assigned 50 participants to a phenytoin group and 50 to a saline group. The dose of phenytoin was not reported. Ten participants had two ulcers each and for these, one ulcer was treated with phenytoin and one with saline. The authors reported that MD in percentage ulcer volume reduction at four weeks were 16.60% (95% CI 8.46 to 24.74) (<a href="./references#CD012235-fig-0009" title="">Analysis 4.1</a>). The other study made three comparisons: both 2% and 4% phenytoin were compared to saline dressings and 4% phenytoin was compared to 2% phenytoin (<a href="./references#CD012235-bbs2-0003" title="BhatiaA , NandaS , GuptaU , GuptaS , ReddyB . Topical phenytoin suspension and normal saline in the treatment of leprosy trophic ulcers: a randomised, double blind, comparative study. Journal of Dermatological Treatment2004;15(5):321‐7. [CENTRAL: CN‐00491464] ">Bhatia 2004</a>). The outcome was mean percentage reduction of ulcer size area. In the comparison of 2% phenytoin with saline dressings, the ulcers of 23 participants out of the 30 included, were measured. MD in percentage reduction at four weeks was 39.30% (95% CI 25.82 to 52.78) in favour of the 2% phenytoin group (<a href="./references#CD012235-fig-0010" title="">Analysis 5.1</a>). <a href="./references#CD012235-bbs2-0003" title="BhatiaA , NandaS , GuptaU , GuptaS , ReddyB . Topical phenytoin suspension and normal saline in the treatment of leprosy trophic ulcers: a randomised, double blind, comparative study. Journal of Dermatological Treatment2004;15(5):321‐7. [CENTRAL: CN‐00491464] ">Bhatia 2004</a> also compared 4% phenytoin to saline dressings. The intervention group had 15 participants included and of these the ulcers of five participants were measured (<a href="./references#CD012235-bbs2-0003" title="BhatiaA , NandaS , GuptaU , GuptaS , ReddyB . Topical phenytoin suspension and normal saline in the treatment of leprosy trophic ulcers: a randomised, double blind, comparative study. Journal of Dermatological Treatment2004;15(5):321‐7. [CENTRAL: CN‐00491464] ">Bhatia 2004</a>). MD in percentage reduction of ulcer size area between groups was 40.90 (95% CI 27.69 to 54.11) (<a href="./references#CD012235-fig-0011" title="">Analysis 6.1</a>). However, the number of participants in the table are not consistent with those given in the text. In the text it stated that the ulcers of 11 participants in both phenytoin groups, i.e. 2% and 4%, had healed, which means that the ulcers of 11 participants must have been measured. Regarding the third comparison in <a href="./references#CD012235-bbs2-0003" title="BhatiaA , NandaS , GuptaU , GuptaS , ReddyB . Topical phenytoin suspension and normal saline in the treatment of leprosy trophic ulcers: a randomised, double blind, comparative study. Journal of Dermatological Treatment2004;15(5):321‐7. [CENTRAL: CN‐00491464] ">Bhatia 2004</a>, 4% compared to 2% phenytoin, the MD between groups in percentage reduction of ulcer size area was 1.60% (95% CI ‐12.05 to 15.25) (<a href="./references#CD012235-fig-0012" title="">Analysis 7.1</a>). No adverse effects (primary outcome) were observed in any of the participants treated with phenytoin or normal saline. </p> <p>As we do not know which solution of phenytoin <a href="./references#CD012235-bbs2-0001" title="BansalN , Mukul . Comparison of topical phenytoin with normal saline in the treatment of chronic trophic ulcers in leprosy. International Journal of Dermatology1993;32(3):210‐3. [CENTRAL: CN‐00091437] ">Bansal 1993</a> used we could not pool the results<i>.</i> We judged the evidence for the results of these comparisons to be of very low certainty and consequently, we have very little confidence in the effect estimates. We downgraded due to study limitations (1 study was not adequately randomised and potentially had unit of analysis error (<a href="./references#CD012235-bbs2-0001" title="BansalN , Mukul . Comparison of topical phenytoin with normal saline in the treatment of chronic trophic ulcers in leprosy. International Journal of Dermatology1993;32(3):210‐3. [CENTRAL: CN‐00091437] ">Bansal 1993</a>), attrition bias (<a href="./references#CD012235-bbs2-0003" title="BhatiaA , NandaS , GuptaU , GuptaS , ReddyB . Topical phenytoin suspension and normal saline in the treatment of leprosy trophic ulcers: a randomised, double blind, comparative study. Journal of Dermatological Treatment2004;15(5):321‐7. [CENTRAL: CN‐00491464] ">Bhatia 2004</a>), and no information on allocation concealment) and imprecision (wide CIs (both studies)). The study authors did not report acceptability of treatment or costs. See <a href="./full#CD012235-tbl-0005">summary of findings Table 5</a>. </p> </section> <section id="CD012235-sec-0098"> <h5 class="title">Footwear ‐ canvas shoes compared to PVC boots</h5> <p>One study, with a total of 110 participants (farmers in Ethiopia), evaluated the effect of canvas shoes versus PVC boots on number of persons being ulcer‐free at one year (<a href="./references#CD012235-bbs2-0011" title="SebokaG , SaundersonP , CurrieH . Footwear for farmers affected by leprosy. Leprosy Review1998;69(2):182‐3. [CENTRAL: CN‐00339604] ">Seboka 1998</a>). Of the 110 participants, 38 had ulcers at baseline, thus the study evaluated both prevention of ulcers (primary outcome) and healing of ulcers (primary outcome). Seventy‐two participants had scars (not ulcers) at the start of the study (27 in the canvas group, 45 in the PVC group) and none of these developed new ulcers during the year. In the 38 participants who had ulcers at baseline, there was little or no difference between groups in the number of people with healed ulcers at one year (RR 1.16, 95% CI 0.77 to 1.74; <a href="./references#CD012235-fig-0013" title="">Analysis 8.1</a>). They also reported the number of persons having ulcers not healed after one year (RR 0.52, 95% CI 0.15 to 1.75; <a href="./references#CD012235-fig-0014" title="">Analysis 8.2</a>; Fisher's exact test P = 0.41; 4/25 versus 4/13 participants). The width of the CIs around the effect estimates for both outcomes makes the results inconclusive. Amongst the 110 participants, none developed new ulcers (only one was lost to follow‐up). They also reported on adverse events that PVC boots could become very hot in strong sunlight, with the possibility of burning feet. We judged the evidence to be of very low certainty and have very little confidence in the result. We downgraded due to study limitations (unclear randomisation, unclear blinding) and due to imprecision (1 study, wide CI). </p> <p>On acceptability of treatment (secondary outcome) the study authors reported that the canvas shoes were socially acceptable, but 85% of the farmers rated them as good for their work, rather than "excellent" (8%) at first follow‐up at three months. The study authors reported that PVC boots were well liked and not stigmatising. We are moderately confident in this result, and have downgraded due to imprecision (1 study). Costs were not reported, but the study authors state that canvas shoes and PVC boots cost the same and that PVC boots are more durable than canvas shoes. See <a href="./full#CD012235-tbl-0006">summary of findings Table 6</a>. </p> </section> <section id="CD012235-sec-0099"> <h5 class="title">Padded moulded double‐rocker plaster shoe compared to padded below‐knee plaster</h5> <p>One study with a total of 47 participants, with a total of 55 ulcers, evaluated the effect of padded moulded double‐rocker plaster shoe versus padded below‐knee plaster on ulcers healed (primary outcome) or nearly healed after six weeks (<a href="./references#CD012235-bbs2-0008" title="PringDJ , CasiebancaN . Simple plantar ulcers treated by below‐knee plaster and moulded double‐rocker plaster shoe ‐ a comparative study. Leprosy Review1982;53(4):261‐4. [CENTRAL: CN‐00249869] ">Pring 1982</a>). The authors reported an effect size of RR 0.96 (95% CI 0.77 to 1.19; <a href="./references#CD012235-fig-0015" title="">Analysis 9.1</a>). We judged the evidence to be of very low certainty and have very little confidence in the effect estimate. We downgraded due to study limitations (no information on baseline characteristics; unit of analysis is ulcers, not participants; unclear randomisation procedure; unclear if blinding of outcome assessor), and due to indirectness (padded moulded double‐rocker plaster shoe and padded below‐knee plasters might not be acceptable interventions today for people with leprosy), and due to imprecision (1 study, small number of participants). The authors reported acceptability and cost (secondary outcomes), but gave no information on how they were measured. They stated that the plaster shoes were more acceptable to persons with leprosy, and that the below‐knee plaster immobilises the foot more. The moulded double‐rocker plaster shoe is also cheaper. Adverse events were not reported. See <a href="./full#CD012235-tbl-0007">summary of findings Table 7</a>. </p> </section> <section id="CD012235-sec-0100"> <h5 class="title">Pulsed magnetic fields (in addition to self‐care and protective footwear) compared to self‐care and footwear </h5> <p>One study with a total of 40 (7 excluded during study) participants evaluated the effect of pulsed magnetic fields (in addition to self‐care and protective footwear) compared to self‐care and footwear on healing of ulcers (primary outcome) at four to five weeks (<a href="./references#CD012235-bbs2-0010" title="SarmaGR , SubrahmanyamS , DeenabandhuA , BabuCR , MadhivathananS , KesavarajN . Exposure to pulsed magnetic fields in the treatment of plantar ulcers in leprosy patients ‐ a pilot , randomized, double blind, controlled clinical trial. Indian Journal of Leprosy1997;69(3):241‐50. [CENTRAL: CN‐00145841] ">Sarma 1997</a>). 'Pulsed magnetic fields' are low‐frequency, low‐intensity pulsed magnetic fields inducing no significant heating of the tissue. The authors reported in the control group that the geometric mean volumes of the ulcers were 2843 cu mm³ and 1478 cu mm³ on the day of admission and at the end of treatment (P = 0.03); the corresponding values in the pulsed magnetic field group were 2428 cu mm³ and 337 cu mm³, respectively (P &lt; 0.001). A decrease in the volume of 40% or more was observed in 53% of control participants and 89% of pulsed magnetic field participants (P = 0.02): a decrease of 80% or more was observed in none of the controls and in 33% of pulsed magnetic field participants. The difference in ulcer volumes between the two treatment strategies did not reach statistical significance (MD ‐1.14 cm³, 95% CI ‐5.37 to 3.09; <a href="./references#CD012235-fig-0016" title="">Analysis 10.1</a>). We judged the evidence to be of very low certainty, and have very little confidence in the effect estimate. We downgraded due to study limitations (unclear randomisation procedure, 7 of 20 participants excluded) and due to imprecision (1 study with few participants). The authors reported the costs (secondary outcome) of the equipment used: "The cost of construction of an enclosure is around Rs. 5000/‐ (about 150 USD) and the function generator together with the centre‐zero milliammeter costs another Rs. 6000/‐ (about 180 USD). Where uninterrupted power supply is a problem, an inverter and a 12‐volt battery together costing about RS. 5000/‐ (about 150 USD) would be required". The study authors did not report adverse events, or acceptability of treatment. See <a href="./full#CD012235-tbl-0008">summary of findings Table 8</a>. </p> </section> <section id="CD012235-sec-0101"> <h5 class="title">Low‐level laser therapy compared to simple dressing</h5> <p>One study with 25 participants (<a href="./references#CD012235-bbs2-0002" title="BarretoJG , SalgadoCG . Clinic‐epidemiological evaluation of ulcers in patients with leprosy sequelae and the effect of low level laser therapy on wound healing: a randomized clinical trial. BMC Infectious Diseases2010;10:237. [CENTRAL: CN‐00760396; PUBMED: 20698989] ">Barreto 2010</a>), evaluated the effect of low‐level laser therapy compared to simple dressing on ulcer size after 12 weeks (primary outcome ‐ healing of ulcer). As with regards to the ulcer size, the results were inconclusive (MD ‐0.60 cm², 95% CI ‐6.47 to 5.27; <a href="./references#CD012235-fig-0017" title="">Analysis 11.1</a>). The study also reports the differences in ulcer depth (MD ‐1.30 mm, 95% CI ‐5.26 to 2.66; <a href="./references#CD012235-fig-0018" title="">Analysis 11.2</a>). </p> <p>We judged the evidence to be of very low certainty and have very little confidence in the effect estimates. We downgraded due to study limitations (unclear allocation concealment, no blinding of outcome assessor), and due to indirectness (we are unsure if the intervention ‐ laser therapy ‐ is available to people with ulcers caused by nerve damage in leprosy) and due to imprecision (1 study, small sample size, wide CI). The study authors reported costs (secondary outcome). Costs were not analysed between groups, but the trial authors state: "Patients have an average of 3.4 simple dressings per week at the dressing service of UREMC, resulting in an estimated expenditure of USD 100,000 per year on disposable dressing material alone." The study authors did not report adverse events or acceptability of treatment. See <a href="./full#CD012235-tbl-0009">summary of findings Table 9</a>. </p> </section> <section id="CD012235-sec-0102"> <h5 class="title">Intralesional pentoxifylline compared to daily simple dressing</h5> <p>One study with 40 participants evaluated the effect of intralesional pentoxifylline (injection) compared to daily simple dressing on healing of ulcer(s<b>)</b> (primary outcome) (<a href="./references#CD012235-bbs2-0005" title="MikhaelNM , El‐EsawyFM . Intralesional pentoxifylline in the treatment of lepromatous ulcers. Journal of the Egyptian Women's Dermatologic Society2015;12(2):102‐7. [CENTRAL: CN‐01299200] ">Mikhael 2015</a>). The authors found a risk ratio (RR) of 5.00 (95% CI 1.25 to 19.99) for healing of ulcers at eight weeks (<a href="./references#CD012235-fig-0019" title="">Analysis 12.1</a>). They also found a MD in ulcer depth of ‐0.22 cm (95% CI ‐0.40 to ‐0.04, <a href="./references#CD012235-fig-0020" title="">Analysis 12.2</a>). We judged the evidence to be of very low certainty and have very little confidence in the effect estimates presented. We downgraded due to study limitations (unclear allocation concealment and unclear if there was blinding of outcome assessor) and due to imprecision (1 small study, very wide CIs). The participants were asked about possible side effects. The only adverse events (secondary outcome) reported was tolerable pain during the injection (very low‐certainty evidence). We downgraded due to study limitations mentioned and in addition it was unclear how information of side effects was documented and if both intervention and control group were asked. The study authors did not report acceptability of treatment or costs. See <a href="./full#CD012235-tbl-0010">summary of findings Table 10</a>. </p> </section> <section id="CD012235-sec-0103"> <h5 class="title">Light‐emitting diode (LED) compared to conventional dressing therapy</h5> <p>One study with 60 participants evaluated the effect of light‐emitting diode (LED, infrared or long visible wavelength light) compared to conventional dressing therapy on mean change of wound size (primary outcome ‐ healing of ulcer) (<a href="./references#CD012235-bbs2-0004" title="LeeRH , LeeJM , KimJP . Research on effect of light emitting diode (LED) on treating skin ulcer of Hansen's disease. Korean Leprosy Bulletin2012;45(1):41‐52. [CENTRAL: CN‐01045879] ">Lee 2012</a>). The study authors reported that the average reduction in wound size was 26.55 mm3/day in the control group and 338.02 mm3/day in the LED group (MD 311.47, 95% CI 106.47 to 516.47; <a href="./references#CD012235-fig-0021" title="">Analysis 13.1</a>). The research period was eight months, but the exact length of follow‐up was not reported. We judged the evidence to be of very low certainty and have very little confidence in the effect estimates. We downgraded due to study limitations (concealment or sequence generation not reported, no blinding) and due to imprecision (only 1 study, few participants, wide CI). The study authors did not report on adverse events, or on acceptability of treatment or costs. See <a href="./full#CD012235-tbl-0011">summary of findings Table 11</a>. </p> </section> <section id="CD012235-sec-0104"> <h5 class="title">Topical human amniotic membrane‐mesenchymal stem cell‐conditioned medium gel alone, with vitamin C or with vitamin E </h5> <p>One study with 66 participants and three arms evaluated the effect of topical human amniotic membrane‐mesenchymal stem cell‐conditioned medium (hAMMSC‐CM) and a mixture of topical hAMMSC‐CM + vitamin C and hAMMSC‐CM + vitamin E on healing of ulcer (primary outcome) (<a href="./references#CD012235-bbs2-0007" title="PrakoeswaCR , NatallyaFR , HarnindyaD , ThohirohA , OktaviyantiRN , PratiwiKD , et al. The efficacy of topical human amniotic membrane‐mesenchymal stem cell‐conditions medium (hAMMSC‐CM) and a mixture of topical hAMMSC‐CM + vitamin C and hAMMSC‐CM + vitamin E on chronic plantar ulcers in leprosy: a randomised control trial. Journal of Dermatological Treatment2018;29(8):835‐40. [CENTRAL: CN‐01607409; DOI: 10.1080/09546634.2018.1467541] ">Prakoeswa 2018</a>). The three arms, with 22 participants each, evaluated hAMMSC‐CM + vitamin C versus hAMMSC‐CM , hAMMSC‐CM + vitamin E versus hAMMSC‐CM and hAMMSC‐CM + vitamin C versus a mixture of topical hAMMSC‐CM + vitamin E. When comparing hAMMSC‐CM + vitamin C versus hAMMSC‐CM the authors found a mean difference (MD) at eight weeks follow‐up in ulcer size of 0.31 cm² (95% CI ‐0.35 to 0.97, <a href="./references#CD012235-fig-0022" title="">Analysis 14.1</a>) and ulcer depth of ‐0.10 cm² (95% CI ‐0.17 to ‐0.03, <a href="./references#CD012235-fig-0023" title="">Analysis 14.2</a>). For hAMMSC‐CM + vitamin E versus hAMMSC‐CM the MD in ulcer size was 1.14 cm² (95% CI 0.32 to 1.96, <a href="./references#CD012235-fig-0024" title="">Analysis 15.1</a>) and ulcer depth was ‐0.08 cm² (95% CI ‐0.17 to 0.01, <a href="./references#CD012235-fig-0025" title="">Analysis 15.2</a>). Finally, when comparing hAMMSC‐CM + vitamin C versus a mixture of topical hAMMSC‐CM + vitamin E, the MD in ulcer size was 0.83 cm² (95% CI ‐0.03 to 1.69, <a href="./references#CD012235-fig-0026" title="">Analysis 16.1</a>) and ulcer depth was 0.02 cm² (95% CI ‐0.06 to 0.10, <a href="./references#CD012235-fig-0027" title="">Analysis 16.2</a>). Overall there was little or no difference between the treatment groups. </p> <p>We judged the evidence to be of very low certainty and have very little confidence in the effect estimates presented. We downgraded due to study limitations (unclear concealment of allocation, unclear if there was blinding of outcome assessor, clinician or patient) sparse data and imprecision (only 1 study, few participants). The study authors reported that no adverse events (such as allergy or infection) were encountered in any group. The study authors did not report acceptability of treatment or costs. See <a href="./full#CD012235-tbl-0013">summary of findings Table 13</a>; <a href="./full#CD012235-tbl-0014">summary of findings Table 14</a>; <a href="./full#CD012235-tbl-0015">summary of findings Table 15</a>. </p> </section> </section> <section id="CD012235-sec-0105"> <h4 class="title">Interventions for people with leprosy and no existing ulcer(s)</h4> <section id="CD012235-sec-0106"> <h5 class="title">Wax therapy compared to foot soaks</h5> <p>One study, with a total of 44 participants, evaluated the effect of wax therapy compared to foot soaks, and the authors reported that the participants who were in the group that were given wax therapy felt subjectively much better than those who had foot soaks (acceptability of treatment ‐ secondary outcome) (<a href="./references#CD012235-bbs2-0012" title="SharmaR , BargotraR , GuptaR , DarHA . Comparative study of the effects of wax therapy and foot soaks on dry plantar skin and ulcers in leprosy patients. JK Science2005;7(2):81‐3. [CENTRAL: CN‐01911700; EMBASE: 40846955] ">Sharma 2005</a>). The study also measured the skin being fissure and callous‐free (tertiary outcome) and results were in favour of wax therapy at six weeks (RR 2.22, 95% CI 1.07 to 4.60; <a href="./references#CD012235-fig-0028" title="">Analysis 17.1</a>). However, we judged this evidence to be of very low certainty and have very little confidence in this evidence. We downgraded the evidence for the results of these two outcomes due to study limitations (unclear allocation concealment, unclear if outcome assessor was blinded, and study authors are not clear in numbers of persons or feet reported), and due to imprecision (1 study with 44 participants, wide CI) and due to indirectness (wax therapy probably not available to most people with leprosy as treatment is given in hospital). Adverse events and cost of intervention were not reported. See <a href="./full#CD012235-tbl-0012">summary of findings Table 12</a>. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012235-sec-0107" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012235-sec-0107"></div> <section id="CD012235-sec-0108"> <h3 class="title" id="CD012235-sec-0108">Summary of main results</h3> <p>It is not possible to draw any firm conclusions based on the available evidence, which was of very low certainty. </p> <p>We have presented results for our primary outcomes, measured by the following key comparisons. </p> <p> <ul id="CD012235-list-0012"> <li> <p>Zinc tape compared to magnesium sulphate glycerine (<a href="./full#CD012235-tbl-0001">summary of findings Table for the main comparison</a>). </p> </li> <li> <p>Zinc tape compared to povidone iodine (10%) (<a href="./full#CD012235-tbl-0002">summary of findings Table 2</a>). </p> </li> <li> <p>Adhesive zinc tape compared to gauze soaked in Eusol (<a href="./full#CD012235-tbl-0003">summary of findings Table 3</a>). </p> </li> <li> <p>Topical phenytoin compared to saline dressing (<a href="./full#CD012235-tbl-0005">summary of findings Table 5</a>). </p> </li> <li> <p>Footwear ‐ canvas shoes compared to PVC boots (<a href="./full#CD012235-tbl-0006">summary of findings Table 6</a>). </p> </li> <li> <p>Exposure to pulsed magnetic fields (plus self‐care and protective footwear) compared to self‐care and footwear (<a href="./full#CD012235-tbl-0008">summary of findings Table 8</a>). </p> </li> </ul> </p> <p>Only one of the trials measured our primary outcome 'prevention of ulcers(s)': the study compared canvas shoes with PVC boots, and none of the participants developed new ulcers during the duration of the trial (1 year). Seventy‐two participants had scars (not ulcers) at the start of the study (27 in the canvas group and 45 in the PVC group). Although, it is worth noting that some treatments are not intended to prevent ulcers. </p> <p>Healing of existing ulcers was measured by all of the key comparisons, as follows.</p> <p> <ul id="CD012235-list-0013"> <li> <p>There were more healed ulcers and a greater reduction in mean ulcer area in the zinc tape group compared to the magnesium sulphate glycerine group. </p> </li> <li> <p>Although there was a bigger reduction in mean ulcer area with zinc tape, there was no clear difference between zinc tape and povidone iodine. </p> </li> <li> <p>The healing time for deep ulcers in the zinc tape group was 17 days compared to 30 days in a group whose ulcers were treated with gauze soaked in Eusol. </p> </li> <li> <p>Two studies suggested that topical phenytoin had a better effect on healing of ulcers compared to saline dressing: a greater mean percentage reduction of ulcer area/volume with phenytoin. </p> </li> <li> <p>There was no clear difference in achieving healed ulcers or becoming ulcer‐free in those wearing canvas shoes compared to PVC boots. </p> </li> <li> <p>There was no clear difference in volume of ulcers between people exposed to pulsed magnetic fields (plus self‐care and protective footwear) versus those who practiced self‐care and wore protective footwear. </p> </li> </ul> </p> <p>Half of the key comparisons measured and reported adverse events, either those sufficiently serious to stop the intervention, or minor ones reported by participants. </p> <p> <ul id="CD012235-list-0014"> <li> <p>There were no signs of skin sensitisation in either of the following groups: zinc tape or gauze soaked in Eusol. </p> </li> <li> <p>No adverse effects were observed in those treated with phenytoin or normal saline.</p> </li> <li> <p>Comparing canvas shoes with PVC boots, the only issue reported was that the PVC boots could become very hot in strong sunlight, leading to the possibility of burnt feet. </p> </li> </ul> </p> <p>Some key treatment categories, such as self‐care programmes, education, information, dry dressings, or skin care were not assessed by any included study, but in some studies, they may have been added to the intervention or used in the control groups. None of the 14 included studies measured quality of life. Only one study measured our tertiary outcome, 'prevention or treatment of other skin changes, such as cracking, thickening or pigmentary changes'. </p> </section> <section id="CD012235-sec-0109"> <h3 class="title" id="CD012235-sec-0109">Overall completeness and applicability of evidence</h3> <p>The findings of this review did not allow us to fully address our objectives; we are restrained by the limited types of interventions assessed, the included studies not reporting our outcomes of interest (apart from healing of ulcers), and the general low certainty of the evidence we could include. </p> <p>Many of the included studies assessed novel interventions in single small trials, which were not sufficiently powered to provide meaningful, reliable results. However, the studies were based in the Americas, Africa, and Asia, and thus involved the community of people affected by leprosy. In general, the follow‐up time for the outcome, 'healing of existing ulcers' was adequate. </p> <p>A number of important interventions were not assessed by the included studies. These included self‐care programmes, education, information, dry dressings, or skin care; however, in some studies, they may have been added to the intervention or used in the control groups. </p> <p>Only one study measured prevention of ulcer(s) and prevention or treatment of other skin changes; however, healing of existing ulcer(s) was very well measured. Adverse events were mentioned in some studies, but it was often unclear how this outcome was measured. None of the studies reported any quality of life measures. The acceptability of treatment was reported in a few studies, but we generally lack information on how this outcome was measured. A few studies reported the direct cost involved. </p> <section id="CD012235-sec-0110"> <h4 class="title">Certainty of the evidence</h4> <p>There are 15 different comparisons presented in our 'Summary of findings' table, and the body of evidence for each comparison is very limited for each intervention. In our GRADE outcomes, we downgraded each outcome by at least one level for study limitations, mainly in relation to potential selection, detection, performance, or attrition bias. We downgraded all outcomes but one (acceptability of treatment in <a href="./full#CD012235-tbl-0006">summary of findings Table 6</a>) for imprecision due to single study data with only a small number of participants analysed. This meant that the 95% CIs surrounding any estimated effect sizes were wide, showing great uncertainty with the evidence provided. Indirectness was also a reason for downgrading in six comparisons: topical ketanserin (2%) compared to clioquinol cream (3%) or zinc paste (<a href="./full#CD012235-tbl-0004">summary of findings Table 4</a>), footwear ‐ canvas shoes compared to PVC boots (<a href="./full#CD012235-tbl-0006">summary of findings Table 6</a>), padded moulded double‐rocker plaster shoe compared to padded below‐knee plaster (<a href="./full#CD012235-tbl-0007">summary of findings Table 7</a>), low‐level laser therapy compared to simple dressing (<a href="./full#CD012235-tbl-0009">summary of findings Table 9</a>), intralesional pentoxifylline compared to daily simple dressing (<a href="./full#CD012235-tbl-0010">summary of findings Table 10</a>), and wax therapy compared to foot soaks (<a href="./full#CD012235-tbl-0012">summary of findings Table 12</a>). Hence, we rated all outcomes as very low certainty, except for acceptability of treatment which we rated as moderate in the comparison of footwear ‐ canvas shoes compared to PVC boots for ulceration and other skin changes caused by nerve damage in leprosy (<a href="./full#CD012235-tbl-0006">summary of findings Table 6</a>). </p> </section> </section> <section id="CD012235-sec-0111"> <h3 class="title" id="CD012235-sec-0111">Potential biases in the review process</h3> <p>The search for literature in the various databases is finite, until our search dates, so newer studies might be missing. We identified two ongoing studies. Two review authors independently selected studies for inclusion, extracted data, and assessed risk of bias with a third review author acting as arbiter in order to minimise the risk of bias in the review process. In addition, we attempted to contact a few study authors for additional information. None of the review authors had a conflict of interest regarding any of the interventions in this review. </p> <p>A few studies included participants that had several treated ulcers, and thus an element of clustering. This should have been accounted for in the analysis. In the studies that explicitly included people with several ulcers without reporting how this was handled in the analysis, we made a note of this in the <a href="./references#CD012235-sec-0134" title="">Characteristics of included studies</a> tables. However, we judged that the clustering was not comprehensive enough to make any difference to the reported results. </p> <p>For this version of the review, we did not search for unpublished and ongoing trials by corresponding with authors; field experts; and experts on tropical medicine or leprosy or both. Thus, there might be a risk we may not have included all the evidence available. </p> <p>We judged that the clinical heterogeneity between trials was so big that we did not pool any results. </p> </section> <section id="CD012235-sec-0112"> <h3 class="title" id="CD012235-sec-0112">Agreements and disagreements with other studies or reviews</h3> <p>The evidence base is very limited for interventions for ulceration and other skin changes caused by nerve damage in leprosy. As stated in a comment in <a href="./references#CD012235-bbs2-0076" title="SrinivasanH . Do we need trials of agents alleged to improve healing of plantar ulcers?. Leprosy Review1989;60(4):278‐82. [PUBMED: 2691790] ">Srinivasan 1989</a>, lots of interventions have been tried for healing such ulcers and he warned against novel "healing agents". Our review identified many interventions that had been tried out in single trials, hardly any replicated by others. We have not identified other reviews that address interventions for prevention or healing of ulcers and other skin changes in leprosy. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012235-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Examples of ulcers in patients with leprosy: (A) Blister formed after walking long distances that later became an ulcer. (B) Fissure on the base of the second toe of the right foot. (C) Right medial malleolus ulcer from a patient with leprosy and HBP. (D) Plantar ulcer on the region of second metatarsal head. (E) Myiasis in a chronic leg ulcer. (F) Chronic ulcer on a lower limb stump.Pictures first appeared in Barreto 2010, with kind permission from Josafá Gonçalves Barreto." data-id="CD012235-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Examples of ulcers in patients with leprosy: (A) Blister formed after walking long distances that later became an ulcer. (B) Fissure on the base of the second toe of the right foot. (C) Right medial malleolus ulcer from a patient with leprosy and HBP. (D) Plantar ulcer on the region of second metatarsal head. (E) Myiasis in a chronic leg ulcer. (F) Chronic ulcer on a lower limb stump. </p> <p>Pictures first appeared in <a href="./references#CD012235-bbs2-0002" title="BarretoJG , SalgadoCG . Clinic‐epidemiological evaluation of ulcers in patients with leprosy sequelae and the effect of low level laser therapy on wound healing: a randomized clinical trial. BMC Infectious Diseases2010;10:237. [CENTRAL: CN‐00760396; PUBMED: 20698989] ">Barreto 2010</a>, with kind permission from Josafá Gonçalves Barreto. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012235-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012235-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012235-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Zinc tape versus magnesium sulphate/glycerin, Outcome 1 Number of ulcers healed after one month." data-id="CD012235-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Zinc tape versus magnesium sulphate/glycerin, Outcome 1 Number of ulcers healed after one month. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Zinc tape versus magnesium sulphate/glycerin, Outcome 2 Mean ulcer area (mm2) after one month." data-id="CD012235-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Zinc tape versus magnesium sulphate/glycerin, Outcome 2 Mean ulcer area (mm<sup>2</sup>) after one month. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Zinc tape versus povidone iodine (10%), Outcome 1 Mean reduction of ulcer area at six weeks (mm2)." data-id="CD012235-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Zinc tape versus povidone iodine (10%), Outcome 1 Mean reduction of ulcer area at six weeks (mm<sup>2</sup>). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Topical ketanserin (2%) versus clioquinol cream (3%) or zinc paste, Outcome 1 Healing of ulcer after three months." data-id="CD012235-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Topical ketanserin (2%) versus clioquinol cream (3%) or zinc paste, Outcome 1 Healing of ulcer after three months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Topical phenytoin (unknown solution) versus saline dressing, Outcome 1 Mean percentage of ulcer volume reduction at four weeks." data-id="CD012235-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Topical phenytoin (unknown solution) versus saline dressing, Outcome 1 Mean percentage of ulcer volume reduction at four weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Topical 2% phenytoin versus saline dressing, Outcome 1 Mean percentage reduction of ulcer size area at four weeks." data-id="CD012235-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Topical 2% phenytoin versus saline dressing, Outcome 1 Mean percentage reduction of ulcer size area at four weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Topical 4% phenytoin versus saline dressing, Outcome 1 Mean percentage reduction of ulcer area at four weeks." data-id="CD012235-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Topical 4% phenytoin versus saline dressing, Outcome 1 Mean percentage reduction of ulcer area at four weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Topical 4% phenytoin versus 2% phenytoin, Outcome 1 Mean percentage reduction of ulcer size at four weeks." data-id="CD012235-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Topical 4% phenytoin versus 2% phenytoin, Outcome 1 Mean percentage reduction of ulcer size at four weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Footwear ‐ canvas shoes versus PVC boots, Outcome 1 Number of persons with healed ulcers at one year." data-id="CD012235-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Footwear ‐ canvas shoes versus PVC boots, Outcome 1 Number of persons with healed ulcers at one year. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Footwear ‐ canvas shoes versus PVC boots, Outcome 2 Number of persons having ulcers not healed at one year." data-id="CD012235-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Footwear ‐ canvas shoes versus PVC boots, Outcome 2 Number of persons having ulcers not healed at one year. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Padded moulded double‐rocker plaster shoe versus padded below‐knee plaster, Outcome 1 Ulcers fully or nearly healed at six weeks." data-id="CD012235-fig-0015" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Padded moulded double‐rocker plaster shoe versus padded below‐knee plaster, Outcome 1 Ulcers fully or nearly healed at six weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Exposure to pulsed magnetic fields (in addition to self‐care and protective footwear) versus self‐care and footwear, Outcome 1 Mean volume (cm³) of ulcers at four to five weeks." data-id="CD012235-fig-0016" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Exposure to pulsed magnetic fields (in addition to self‐care and protective footwear) versus self‐care and footwear, Outcome 1 Mean volume (cm³) of ulcers at four to five weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-011-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-011-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Low‐level laser therapy versus simple dressing, Outcome 1 Size of ulcer (area, cm²) after 12 weeks." data-id="CD012235-fig-0017" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-011-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11 Low‐level laser therapy versus simple dressing, Outcome 1 Size of ulcer (area, cm²) after 12 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-011-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-011-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-011-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Low‐level laser therapy versus simple dressing, Outcome 2 Size of ulcer (depth, mm) after 12 weeks." data-id="CD012235-fig-0018" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-011-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11 Low‐level laser therapy versus simple dressing, Outcome 2 Size of ulcer (depth, mm) after 12 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-011-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-012-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-012-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Intralesional pentoxifylline versus daily simple dressing, Outcome 1 Complete healing of ulcer at 8 weeks." data-id="CD012235-fig-0019" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-012-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12 Intralesional pentoxifylline versus daily simple dressing, Outcome 1 Complete healing of ulcer at 8 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-012-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-012-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-012-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Intralesional pentoxifylline versus daily simple dressing, Outcome 2 Ulcer depth (cm) at 8 weeks." data-id="CD012235-fig-0020" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-012-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12 Intralesional pentoxifylline versus daily simple dressing, Outcome 2 Ulcer depth (cm) at 8 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-012-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-013-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-013-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Light‐emitting diode (LED) versus conventional dressing, Outcome 1 Mean reduction in wound size (mm³) at 8 months." data-id="CD012235-fig-0021" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-013-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13 Light‐emitting diode (LED) versus conventional dressing, Outcome 1 Mean reduction in wound size (mm³) at 8 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-013-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-014-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-014-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 hAMMSC‐CM + vitamin C versus hAMMSC‐CM, Outcome 1 Mean reduction (cm2) in ulcer size at eight weeks." data-id="CD012235-fig-0022" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-014-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14 hAMMSC‐CM + vitamin C versus hAMMSC‐CM, Outcome 1 Mean reduction (cm<sup>2</sup>) in ulcer size at eight weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-014-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-014-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-014-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 hAMMSC‐CM + vitamin C versus hAMMSC‐CM, Outcome 2 Mean reduction (cm2) in ulcer depth at eight weeks." data-id="CD012235-fig-0023" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-014-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.2</div> <div class="figure-caption"> <p>Comparison 14 hAMMSC‐CM + vitamin C versus hAMMSC‐CM, Outcome 2 Mean reduction (cm<sup>2</sup>) in ulcer depth at eight weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-014-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-015-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-015-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 hAMMSC‐CM + vitamin E versus hAMMSC‐CM, Outcome 1 Mean reduction (cm2) in ulcer size at eight weeks." data-id="CD012235-fig-0024" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-015-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.1</div> <div class="figure-caption"> <p>Comparison 15 hAMMSC‐CM + vitamin E versus hAMMSC‐CM, Outcome 1 Mean reduction (cm<sup>2</sup>) in ulcer size at eight weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-015-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-015-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-015-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 hAMMSC‐CM + vitamin E versus hAMMSC‐CM, Outcome 2 Mean reduction (cm2) in ulcer depth at eight weeks." data-id="CD012235-fig-0025" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-015-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.2</div> <div class="figure-caption"> <p>Comparison 15 hAMMSC‐CM + vitamin E versus hAMMSC‐CM, Outcome 2 Mean reduction (cm<sup>2</sup>) in ulcer depth at eight weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-015-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-016-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-016-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 hAMMSC‐CM + vitamin E versus hAMMSC‐CM + vitamin C, Outcome 1 Mean reduction (cm2) in ulcer size at eight weeks." data-id="CD012235-fig-0026" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-016-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.1</div> <div class="figure-caption"> <p>Comparison 16 hAMMSC‐CM + vitamin E versus hAMMSC‐CM + vitamin C, Outcome 1 Mean reduction (cm<sup>2</sup>) in ulcer size at eight weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-016-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-016-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-016-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 hAMMSC‐CM + vitamin E versus hAMMSC‐CM + vitamin C, Outcome 2 Mean reduction (cm2) in ulcer depth at eight weeks." data-id="CD012235-fig-0027" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-016-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.2</div> <div class="figure-caption"> <p>Comparison 16 hAMMSC‐CM + vitamin E versus hAMMSC‐CM + vitamin C, Outcome 2 Mean reduction (cm<sup>2</sup>) in ulcer depth at eight weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-016-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012235-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/urn:x-wiley:14651858:media:CD012235:CD012235-CMP-017-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_t/tCD012235-CMP-017-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Wax therapy versus foot soaks, Outcome 1 Number of feet being fissure‐ and callous‐free at six weeks." data-id="CD012235-fig-0028" src="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-017-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.1</div> <div class="figure-caption"> <p>Comparison 17 Wax therapy versus foot soaks, Outcome 1 Number of feet being fissure‐ and callous‐free at six weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/media/CDSR/CD012235/image_n/nCD012235-CMP-017-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012235-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Zinc tape compared to magnesium sulphate glycerin for ulceration caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Zinc tape compared to magnesium sulphate glycerin for ulceration caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic, India (<a href="./references#CD012235-bbs2-0014" title="WaltonR , FritschiE , UmapathyV . Treatment of plantar ulcers in leprosy patients in the community with adhesive zinc tape. Leprosy Review1986;57(1):53‐6. [CENTRAL: CN‐00181239] ">Walton 1986</a>)<br/> <b>Intervention:</b> zinc tape<br/> <b>Comparison:</b> magnesium sulphate/glycerin </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with magnesium sulphate/glycerin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Zinc tape</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcers</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Primary outcome: healing of ulcers (number of ulcers healed after 1 month)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.00<br/> (0.43 to 9.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>143 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>286 per 1000<br/> (61 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcers</p> <p>(mean ulcer area (mm<sup>3</sup>)<br/> Follow‐up: mean of one month </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean ulcer area was 56.7</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 14.3 lower<br/> (26.51 lower to 2.09 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Priimary outcome: adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: costs</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (such as 35% lost to follow‐up, consecutive cases were randomly allocated, no blinding of outcome assessor, and potential unit of analysis error). Also downgraded two levels for imprecision due to sparse data and wide confidence intervals. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Zinc tape compared to magnesium sulphate glycerin for ulceration caused by nerve damage in leprosy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012235-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Zinc tape compared to povidone iodine (10%) for ulceration and other skin changes caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Zinc tape compared to povidone iodine (10%) for ulceration and other skin changes caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration and other skin changes caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic, Indonesia (<a href="./references#CD012235-bbs2-0006" title="OverbeekST , ThamLM . Effect of zinc oxide tape on plantar ulcers in leprosy in Indonesia [Het effect van zinkoxide‐tape op plantaire ulcera bij leprapatiënten in Indonesië]. Nederlands Tidshrift foor Geneeskunde1991;135(30):1350‐3. [CENTRAL: CN‐00616028] ">Overbeek 1991</a>)<br/> <b>Intervention:</b> zinc tape<br/> <b>Comparison:</b> povidone iodine (10%) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with povidone iodine (10%)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with zinc tape</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcers</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcers</p> <p>(mean reduction of ulcer area at 6 weeks (mm<sup>2</sup>)) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction of ulcer area at six weeks was 260</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 128 higher<br/> (110.01 lower to 366.01 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: costs</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (quasi‐randomised trial, high loss to follow‐up, and no reporting of blinding of outcome assessor), and two levels due to imprecision (1 study, few participants, wide confidence interval). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Zinc tape compared to povidone iodine (10%) for ulceration and other skin changes caused by nerve damage in leprosy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012235-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Adhesive zinc tape compared to gauze soaked in eusol for ulceration caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Adhesive zinc tape compared to gauze soaked in eusol for ulceration caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration caused by nerve damage in leprosy<br/> <b>Setting:</b> hospital in India (<a href="./references#CD012235-bbs2-0013" title="SöderbergT , HallmansG , StenströmS , LoboD , PintoJ , MaroofS , et al. Treatment of leprosy wounds with adhesive zinc tape. Leprosy Review1982;53(4):271‐6. [CENTRAL: CN‐00181158] ">Söderberg 1982</a>)<br/> <b>Intervention:</b> adhesive zinc tape<br/> <b>Comparison:</b> gauze soaked in eusol </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign=""> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Risk with gauze soaked in eusol</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Risk with adhesive zinc tape</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Primary outcome: prevention of ulcers</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Total number of participants was 90 and they had a total of 128 plantar ulcers<sup>b</sup>. The average healing time was shorter for the group treated with zinc tape. The results varied between the two hospitals involved. In one hospital, it took about 20 days (CI 18 to 23) for superficial ulcers to heal in the zinc tape group versus about 30 (CI 27 to 33) in the gauze group. For deep ulcers the average healing time was two weeks more. In the other hospital, the average number of days to heal in the zinc tape group for superficial wounds was about 13 (CI 9 to 15) days and 23 (CI 16 to 28) days in the gauze group. For deep ulcers it took 17 days (CI 12 to 20) in the zinc tape group and 30 (CI 21 to 63) in the gauze group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events (skin sensitisation at 2 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The study authors reported: "No signs of skin sensitization were observed in either the tape‐treated or the gauze‐treated wounds". </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Secondary outcome: quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not clear how or if this was adequately measured. However, the study authors say: "The zinc tape has the following advantages: 1. shorter healing time, 2. low cost, 3. easy application, 4. more convenient for patients: (a) can be worn under shoes without causing pressure; (b) socially more acceptable, no bandages are needed". </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: costs</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (allocation random alternate basis, no blinding outcome assessor, and inadequate reporting of data), and two levels for imprecision (few participants)).<br/> <sup>b</sup> There was a lack information on how many participants and how many ulcers (deep or superficial ulcers) there were in intervention and control group. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Adhesive zinc tape compared to gauze soaked in eusol for ulceration caused by nerve damage in leprosy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012235-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Topical ketanserin (2%) compared to clioquinol cream (3%) or zinc paste for ulceration caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Topical ketanserin (2%) compared to clioquinol cream (3%) or zinc paste for ulceration caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic, Mexico (<a href="./references#CD012235-bbs2-0009" title="SalazarJ , SerranoG , Leon‐QuinteroG , Torres‐MendozaB . Use of topical ketanserin for the treatment of ulcers in leprosy patients. Indian Journal of Leprosy2001;73(2):103‐10. [CENTRAL: CN‐00374140] ">Salazar 2001</a>)<br/> <b>Intervention:</b> topical ketanserin (2%)<br/> <b>Comparison:</b> clioquinol cream (3%) or zinc paste </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with clioquinol cream (3%) or zinc paste</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with topical ketanserin (2%)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Primary outcome: prevention of ulcers</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Primary outcome: healing of ulcers (healing of ulcer at 3 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 6.00<br/> (1.45 to 24.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>66<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>61 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>364 per 1000<br/> (88 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events<br/> (assessed at 3 months as minimum, moderate or severe) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Treatment was not suspended in any of the patients because of side effects</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: cost of intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (randomisation procedure not reported, blinding not reported, and unclear if appropriate statistical analysis used) and two levels due to imprecision (1 study, very wide confidence interval).<br/> <sup>b</sup>Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (randomisation procedure not reported, blinding not reported), one level due to indirectness (not clear how side effects were measured and reported), and one level due to imprecision (1 study). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Topical ketanserin (2%) compared to clioquinol cream (3%) or zinc paste for ulceration caused by nerve damage in leprosy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012235-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Topical phenytoin compared to saline dressing for ulceration and other skin changes caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Topical phenytoin compared to saline dressing for ulceration and other skin changes caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration and other skin changes caused by nerve damage in leprosy<br/> <b>Setting:</b> hospital, India<br/> <b>Intervention:</b> topical phenytoin: 2% (<a href="https://archie.cochrane.org/sections/documents/view?version=z1901301230375818131380639122700%26format=REVMAN#STD-Bhatia-2004" target="_blank">Bhatia 2004</a>), unknown (<a href="https://archie.cochrane.org/sections/documents/view?version=z1901301230375818131380639122700%26format=REVMAN#STD-Bansal-1993" target="_blank">Bansal 1993</a>)<br/> <b>Comparison:</b> saline dressing </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with saline dressing</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with topical phenytoin (2%)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcers</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcers (mean percentage of ulcer volume reduction at 4 weeks (<a href="./references#CD012235-bbs2-0001" title="BansalN , Mukul . Comparison of topical phenytoin with normal saline in the treatment of chronic trophic ulcers in leprosy. International Journal of Dermatology1993;32(3):210‐3. [CENTRAL: CN‐00091437] ">Bansal 1993</a>)) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean percentage reduction of ulcer volume was 55.5%</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 16.60% higher<br/> (8.46 higher to 24.74 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcers</p> <p>(mean percentage reduction of ulcer size area at 4 weeks (<a href="./references#CD012235-bbs2-0003" title="BhatiaA , NandaS , GuptaU , GuptaS , ReddyB . Topical phenytoin suspension and normal saline in the treatment of leprosy trophic ulcers: a randomised, double blind, comparative study. Journal of Dermatological Treatment2004;15(5):321‐7. [CENTRAL: CN‐00491464] ">Bhatia 2004</a>)) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean percentage reduction of ulcer size area was 49.1%</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 39.30% higher<br/> (25.82 higher to 52.78 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events</p> <p>(up to 4 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No adverse effects were observed in any of the patients treated with phenytoin or normal saline. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>123</p> <p>(2 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: cost of intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (non‐adequate random sequence generation, unit of analysis error) and two levels due to imprecision (sparse data and consequently wide confidence interval).<br/> <sup>b</sup>Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (unclear whether allocation was concealed and high risk of attrition bias) and two levels due to imprecision (sparse data). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Topical phenytoin compared to saline dressing for ulceration and other skin changes caused by nerve damage in leprosy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012235-tbl-0006"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Footwear ‐ canvas shoes compared to PVC boots for ulceration and other skin changes caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Footwear ‐ canvas shoes compared to PVC boots for ulceration and other skin changes caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration and other skin changes caused by nerve damage in leprosy<br/> <b>Setting:</b> community practice, Ethiopia (<a href="./references#CD012235-bbs2-0011" title="SebokaG , SaundersonP , CurrieH . Footwear for farmers affected by leprosy. Leprosy Review1998;69(2):182‐3. [CENTRAL: CN‐00339604] ">Seboka 1998</a>)<br/> <b>Intervention:</b> footwear ‐ canvas shoes<br/> <b>Comparison:</b> footwear ‐ PVC boots </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with PVC boots</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with canvas shoes</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Primary outcome: prevention of ulcer (number of persons developing new ulcers at 1 year) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>None of the 45 participants with scars developed new ulcers</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>None of the 27 participants with scars developed new ulcers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 (1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Seventy‐two participants had scars (not ulcers) at the start of the study (27 in canvas group, 45 in PVC group) and none of these developed new ulcers during the year. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Primary outcome: healing of ulcer (number of persons being ulcer‐free at 1 year)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.16<br/> (0.77 to 1.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>38<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>692 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>803 per 1000<br/> (533 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Primary outcome: healing of ulcer (number of persons having ulcers not healed at 1 year) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.52<br/> (0.15 to 1.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>38<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>308 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>160 per 1000<br/> (46 to 538) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>One adverse comment was that PVC boots could become very hot in strong sunlight, with possibility of burning the feet </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The canvas shoes were socially acceptable, but 85% of farmers rated them as good for their work, rather than "excellent" (8%) at first follow‐up at three months. More than 80% rated the PVC boots as excellent for social acceptability and work suitability. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>110<sup>d</sup> </p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: costs</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>110<sup>d</sup> </p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Costs not reported. Study authors only reported that canvas shoes and PVC boots cost the same. PVC boots are more durable than canvas shoes. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (unclear randomisation, unclear blinding) and two levels due to imprecision (1 study, small number of participants, wide confidence interval).<br/> <sup>b</sup>Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (unclear randomisation, unclear blinding), one level due to indirectness (unclear how this outcome was measured), and one level for imprecision.<br/> <sup>c</sup>Downgraded by one level to moderate‐certainty evidence. One level due to study limitations (unclear randomisation, unclear blinding).<br/> <sup>d</sup>For these outcomes, the results are reported for all 110 participants in the study (i.e. those with existing ulcers and those with no existing ulcers). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Footwear ‐ canvas shoes compared to PVC boots for ulceration and other skin changes caused by nerve damage in leprosy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012235-tbl-0007"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Padded moulded double‐rocker plaster shoe compared to padded below‐knee plaster for ulceration and other skin changes caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Padded moulded double‐rocker plaster shoe compared to padded below‐knee plaster for ulceration and other skin changes caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration and other skin changes caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic, India (<a href="./references#CD012235-bbs2-0008" title="PringDJ , CasiebancaN . Simple plantar ulcers treated by below‐knee plaster and moulded double‐rocker plaster shoe ‐ a comparative study. Leprosy Review1982;53(4):261‐4. [CENTRAL: CN‐00249869] ">Pring 1982</a>)<br/> <b>Intervention:</b> padded moulded double‐rocker plaster shoe<br/> <b>Comparison:</b> padded below‐knee plaster </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with padded below‐knee plaster</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with padded moulded double‐rocker plaster shoe</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Primary outcome: healing of ulcer (ulcers fully or nearly healed at 6 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.96<br/> (0.77 to 1.19) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>55<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>875 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>840 per 1000<br/> (674 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study authors stated: "The MD shoe is more acceptable to the patient"</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: costs of intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study authors stated: "The MD shoe is ......cheaper to apply and, more important.."</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : moulded double‐rocker; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded by four levels to very low‐certainty evidence. Two levels due to study limitations (no information on baseline characteristics; unit of analysis is ulcers, not patients; unclear randomisation procedure; unclear if blinding of outcome assessor), one level due to indirectness (padded moulded double‐rocker plaster shoe and padded below‐knee plasters might not be acceptable interventions today for people with leprosy), and one level due to imprecision (1 study, small number of participants). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Padded moulded double‐rocker plaster shoe compared to padded below‐knee plaster for ulceration and other skin changes caused by nerve damage in leprosy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012235-tbl-0008"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Exposure to pulsed magnetic fields (in addition to self‐care and protective footwear) compared to self‐care and footwear for ulceration and other skin changes caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Exposure to pulsed magnetic fields (in addition to self‐care and protective footwear) compared to self‐care and footwear for ulceration and other skin changes caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration and other skin changes caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic, India (<a href="./references#CD012235-bbs2-0010" title="SarmaGR , SubrahmanyamS , DeenabandhuA , BabuCR , MadhivathananS , KesavarajN . Exposure to pulsed magnetic fields in the treatment of plantar ulcers in leprosy patients ‐ a pilot , randomized, double blind, controlled clinical trial. Indian Journal of Leprosy1997;69(3):241‐50. [CENTRAL: CN‐00145841] ">Sarma 1997</a>)<br/> <b>Intervention:</b> exposure to pulsed magnetic fields (in addition to self‐care and protective footwear)<br/> <b>Comparison:</b> self‐care and footwear </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign=""> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Risk with self‐care and footwear</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Risk with exposure to pulsed magnetic fields (in addition to self‐care and protective footwear)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (at 4 to 5 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>In the control group, the geometric mean volumes of the ulcers were 2843 cu mm and 1478 cu mm on the day of admission and at the end of treatment (P = 0.03); the corresponding values in the PMF group were 2428 cu mm and 337 cu mm, respectively (P &lt; 0.001). A decrease in the volume of 40% or more was observed in 53% of control patients and 89% of PMF participants (P = 0.02): a decrease of 80% or more was observed in none of the controls and in 33% of PMF participants. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome 2 (healing of ulcer):</p> <p>Mean volume of ulcers at four to five weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean volume (cm<sup>2</sup>) after four to five weeks was 1.48 </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD was 1.14 lower (5.37 lower to 3.09 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome 3 (adverse events)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome 1 (quality of life)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome 2 (acceptability of treatment)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome 3 (cost of intervention)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The authors state: "The cost of construction of an enclosure is around Rs. 5000/‐ (about 150 USD) and the function generator together with the centre‐zero milliammeter costs another Rs. 6000/‐ (about 180 USD). Where uninterrupted power supply is a problem, an inverter and a 12‐volt battery together costing about RS. 5000/‐ (about 150 USD) would be required." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>PMF</b> : pulsed magnetic field; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup> Downgraded by three levels. One level due to study limitations (unclear randomisation procedure, 7 of 20 patients lost to follow‐up) and two levels due to imprecision (1 study with few participants). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Exposure to pulsed magnetic fields (in addition to self‐care and protective footwear) compared to self‐care and footwear for ulceration and other skin changes caused by nerve damage in leprosy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012235-tbl-0009"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Low‐level laser therapy compared to simple dressing for ulceration and other skin changes caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Low‐level laser therapy compared to simple dressing for ulceration and other skin changes caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration and other skin changes caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic in Brasil (<a href="./references#CD012235-bbs2-0002" title="BarretoJG , SalgadoCG . Clinic‐epidemiological evaluation of ulcers in patients with leprosy sequelae and the effect of low level laser therapy on wound healing: a randomized clinical trial. BMC Infectious Diseases2010;10:237. [CENTRAL: CN‐00760396; PUBMED: 20698989] ">Barreto 2010</a>)<br/> <b>Intervention:</b> low‐level laser therapy<br/> <b>Comparison:</b> simple dressing </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with simple dressing</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with low‐level laser therapy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (size of ulcer (area) at 12 weeks (cm<sup>2</sup>)) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean size of ulcer (area) after 12 weeks was 4.4</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.60 lower<br/> (6.47 lower to 5.27 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (size of ulcer (depth) at 12 weeks (mm))</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean size of ulcer (depth) after 12 weeks was 5.4</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1.30 mm lower<br/> (5.26 lower to 2.66 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse effects</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: costs</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Costs not analysed between groups, but trial authors state: "Patients have an average of 3.4 simple dressings per week at the dressing service of UREMC, resulting in an estimated expenditure of USD 100,000 per year on disposable dressing material alone." </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by four levels. One level due to study limitations (unclear allocation concealment, no blinding of outcome assessor), one level due to indirectness (we are unsure if the intervention ‐ laser therapy ‐ is available to people with ulcers caused by nerve damage in leprosy) and two levels due to imprecision (1 study, small sample size, wide confidence interval).<br/> <sup>b</sup>Downgraded by four levels. One level due to study limitations (unclear allocation concealment, no blinding of outcome assessor), one level due to indirectness (we are unsure if the intervention ‐ laser therapy ‐ is available to people with ulcers caused by nerve damage in leprosy) and two levels due to imprecision (1 study, small sample size). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Low‐level laser therapy compared to simple dressing for ulceration and other skin changes caused by nerve damage in leprosy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012235-tbl-0010"> <div class="table-heading"><span class="table-label">Summary of findings 10.</span> <span class="table-title">Intralesional pentoxifylline compared to daily simple dressing for ulceration and other skin changes caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Intralesional pentoxifylline compared to daily simple dressing for ulceration and other skin changes caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration and other skin changes caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic, Egypt (<a href="./references#CD012235-bbs2-0005" title="MikhaelNM , El‐EsawyFM . Intralesional pentoxifylline in the treatment of lepromatous ulcers. Journal of the Egyptian Women's Dermatologic Society2015;12(2):102‐7. [CENTRAL: CN‐01299200] ">Mikhael 2015</a>)<br/> <b>Intervention:</b> intralesional pentoxifylline<br/> <b>Comparison:</b> daily simple dressing </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with daily simple dressing</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with intralesional pentoxifylline</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Primary outcome: healing of ulcer (complete healing of ulcer at 4 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 9.00<br/> (1.64 to 49.45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>500 per 1000<br/> (154 to 846) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (ulcer depth (cm) at 4 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean ulcer depth was 0.45</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.22 cm lower<br/> (0.40 lower to 0.04 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events (at 4 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The patients were asked about any possible side effects such as pain, skin rash, discolouration, or discomfort. There were no side effects, except tolerable pain during the injection in intervention group. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝<br/> Very low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: cost of intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>OR</b> : odds ratio; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by three levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment and unclear if there was blinding of outcome assessor) and two levels due to imprecision (1 small study, very wide confidence intervals).<br/> <sup>b</sup>Downgraded by three levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment and unclear if there was blinding of outcome assessor), one level due to imprecision (1 small study) and one level due to indirectness (unclear how information of side effects were documented and if both intervention and control group were asked). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 10.</span> <span class="table-title">Intralesional pentoxifylline compared to daily simple dressing for ulceration and other skin changes caused by nerve damage in leprosy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012235-tbl-0011"> <div class="table-heading"><span class="table-label">Summary of findings 11.</span> <span class="table-title">Light‐emitting diode (LED) irradiation compared to conventional dressing therapy for ulceration and other skin changes caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Light‐emitting diode (LED) irradiation compared to conventional dressing therapy for ulceration and other skin changes caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration and other skin changes caused by nerve damage in leprosy<br/> <b>Setting:</b> hospital/outpatient clinic, Korea (<a href="./references#CD012235-bbs2-0004" title="LeeRH , LeeJM , KimJP . Research on effect of light emitting diode (LED) on treating skin ulcer of Hansen's disease. Korean Leprosy Bulletin2012;45(1):41‐52. [CENTRAL: CN‐01045879] ">Lee 2012</a>)<br/> <b>Intervention:</b> light‐emitting diode (LED) irradiation<br/> <b>Comparison:</b> conventional dressing therapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with conventional dressing therapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with LED irradiation</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (mean change of wound size (mm<sup>3</sup>) after 8 months treatment) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change of wound size was 26.55</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 311.47 higher<br/> (106.47 higher to 516.47 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: cost of intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by three levels to very low‐certainty evidence. One level due to study limitations (concealment or sequence generation not reported, no blinding) and two levels due to imprecision (only 1 study, few participants, wide confidence interval). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 11.</span> <span class="table-title">Light‐emitting diode (LED) irradiation compared to conventional dressing therapy for ulceration and other skin changes caused by nerve damage in leprosy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012235-tbl-0012"> <div class="table-heading"><span class="table-label">Summary of findings 12.</span> <span class="table-title">Wax therapy compared to foot soaks for skin changes caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Wax therapy compared to foot soaks for skin changes caused by nerve damage in leprosy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> skin changes caused by nerve damage in leprosy<br/> <b>Setting:</b> hospital, India (<a href="./references#CD012235-bbs2-0012" title="SharmaR , BargotraR , GuptaR , DarHA . Comparative study of the effects of wax therapy and foot soaks on dry plantar skin and ulcers in leprosy patients. JK Science2005;7(2):81‐3. [CENTRAL: CN‐01911700; EMBASE: 40846955] ">Sharma 2005</a>)<br/> <b>Intervention:</b> wax therapy<br/> <b>Comparison:</b> foot soaks </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with foot soaks</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with wax therapy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not applicable</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Tertiary outcome: prevention and treatment of other skin changes (number of feet being fissure‐ and callous‐free at 6 weeks) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.22<br/> (1.07 to 4.60) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>44<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>300 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>666 per 1000<br/> (321 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse effects</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment (at 6 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>"Patients given wax therapy felt subjectively much better than those who had foot soaks" </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outome: cost of intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT</b> : randomised controlled trial; <b>RR</b>: risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by four levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment, unclear if outcome assessor was blinded, and study authors are not clear in numbers of persons or feet reported), two levels due to imprecision (1 study with 44 participants, wide confidence interval) and one level due to indirectness (wax therapy probably not available to most people with leprosy; treatment is given in hospital).<br/> <sup>b</sup>Downgraded by four levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment, unclear if outcome assessor was blinded, and study authors are not clear in numbers of persons or feet reported), two levels due to imprecision (1 study with 44 participants) and one level due to indirectness (wax therapy probably not available to most people with leprosy; treament is given in hospital). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 12.</span> <span class="table-title">Wax therapy compared to foot soaks for skin changes caused by nerve damage in leprosy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012235-tbl-0013"> <div class="table-heading"><span class="table-label">Summary of findings 13.</span> <span class="table-title">hAMMSC‐CM + vitamin C compared to hAMMSC‐CM for ulceration caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>hAMMSC‐CM + vitamin C compared to hAMMSC‐CM for ulceration caused by nerve damage in leprosy </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic in Indonesia (<a href="./references#CD012235-bbs2-0007" title="PrakoeswaCR , NatallyaFR , HarnindyaD , ThohirohA , OktaviyantiRN , PratiwiKD , et al. The efficacy of topical human amniotic membrane‐mesenchymal stem cell‐conditions medium (hAMMSC‐CM) and a mixture of topical hAMMSC‐CM + vitamin C and hAMMSC‐CM + vitamin E on chronic plantar ulcers in leprosy: a randomised control trial. Journal of Dermatological Treatment2018;29(8):835‐40. [CENTRAL: CN‐01607409; DOI: 10.1080/09546634.2018.1467541] ">Prakoeswa 2018</a>)<br/> <b>Intervention:</b> hAMMSC‐CM + vitamin C<br/> <b>Comparison:</b> hAMMSC‐CM </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with</b> </p> <p><b>hAMMSC‐CM</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with</b> </p> <p><b>hAMMSC‐CM + vitamin C</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not applicable</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (size, cm², at 8 weeks)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction was 1.70</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.31 cm<sup>2</sup> higher </p> <p>(0.35 lower to 0.97 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (depth, cm², at 8 weeks)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction was 0.35</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.10 cm<sup>2</sup> lower </p> <p>(0.17 lower to 0.03 lower)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>"No adverse events were encountered in any group"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outome: cost of intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by three levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment, unclear if outcome assessor was blinded), two levels due to imprecision (1 study with a total of 66 patients with three arms).<br/> <sup>b</sup>Downgraded by three levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment, unclear if outcome assessor was blinded, one level due to sparce data (1 study with a total of 66 patients with three arms) and one level due to other considerations (unclear how adverse events were measured). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 13.</span> <span class="table-title">hAMMSC‐CM + vitamin C compared to hAMMSC‐CM for ulceration caused by nerve damage in leprosy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012235-tbl-0014"> <div class="table-heading"><span class="table-label">Summary of findings 14.</span> <span class="table-title">hAMMSC‐CM + vitamin E compared to hAMMSC‐CM for ulceration caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>hAMMSC‐CM + vitamin E compared to hAMMSC‐CM for ulceration caused by nerve damage in leprosy </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic in Indonesia (<a href="./references#CD012235-bbs2-0007" title="PrakoeswaCR , NatallyaFR , HarnindyaD , ThohirohA , OktaviyantiRN , PratiwiKD , et al. The efficacy of topical human amniotic membrane‐mesenchymal stem cell‐conditions medium (hAMMSC‐CM) and a mixture of topical hAMMSC‐CM + vitamin C and hAMMSC‐CM + vitamin E on chronic plantar ulcers in leprosy: a randomised control trial. Journal of Dermatological Treatment2018;29(8):835‐40. [CENTRAL: CN‐01607409; DOI: 10.1080/09546634.2018.1467541] ">Prakoeswa 2018</a>)<br/> <b>Intervention:</b> hAMMSC‐CM + vitamin E<br/> <b>Comparison:</b> hAMMSC‐CM </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with</b> </p> <p><b>hAMMSC‐CM</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with</b> </p> <p><b>hAMMSC‐CM + vitamin E</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not applicable</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (size, cm<sup>2</sup> at 8 weeks) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction was 1.70</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1<b>.</b>14 cm<sup>2</sup> higher </p> <p>(0.35 higher to 0.97 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (depth, cm<sup>2</sup> at 8 weeks) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction was 0.35</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.08 cm<sup>2</sup> lower </p> <p>(0.17 lower to 0.01 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study authors reported: "No adverse events were encountered in any group"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outome: cost of intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by three levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment, unclear if outcome assessor was blinded), two levels due to imprecision (1 study with a total of 66 patients with 3 arms).<br/> <sup>b</sup>Downgraded by three levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment, unclear if outcome assessor was blinded), one level due to sparce data (1 study with a total of 66 patients with 3 arms) and one level due to other considerations (unclear how adverse events were measured). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 14.</span> <span class="table-title">hAMMSC‐CM + vitamin E compared to hAMMSC‐CM for ulceration caused by nerve damage in leprosy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012235-tbl-0015"> <div class="table-heading"><span class="table-label">Summary of findings 15.</span> <span class="table-title">hAMMSC‐CM + vitamin E compared to hAMMSC‐CM + vitamin C for ulceration caused by nerve damage in leprosy</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>hAMMSC‐ CM +vitamin E compared to hAMMSC‐CM + vitamin C for ulceration caused by nerve damage in leprosy </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> ulceration caused by nerve damage in leprosy<br/> <b>Setting:</b> outpatient clinic in Indonesia (<a href="./references#CD012235-bbs2-0007" title="PrakoeswaCR , NatallyaFR , HarnindyaD , ThohirohA , OktaviyantiRN , PratiwiKD , et al. The efficacy of topical human amniotic membrane‐mesenchymal stem cell‐conditions medium (hAMMSC‐CM) and a mixture of topical hAMMSC‐CM + vitamin C and hAMMSC‐CM + vitamin E on chronic plantar ulcers in leprosy: a randomised control trial. Journal of Dermatological Treatment2018;29(8):835‐40. [CENTRAL: CN‐01607409; DOI: 10.1080/09546634.2018.1467541] ">Prakoeswa 2018</a>)<br/> <b>Intervention:</b> hAMMSC‐CM + vitamin E<br/> <b>Comparison:</b> hAMMSC‐CM + vitamin C </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with</b> </p> <p><b>hAMMSC‐CM + vitamin C</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with</b> </p> <p><b>hAMMSC‐CM + vitamin E</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: prevention of ulcer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not applicable</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (size, cm<sup>2</sup>, at 8 weeks) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction was 2.01</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.83 cm<sup>2</sup> higher </p> <p>(0.03 lower to 1.69 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: healing of ulcer (depth, cm<sup>2</sup>, at 8 weeks) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction was 0.25</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.02 cm<sup>2</sup> higher </p> <p>(0.06 lower to 0.10 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcome: adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study authors reported: "No adverse events were encountered in any group"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p>Very low<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outcome: acceptability of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary outome: cost of intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by three levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment, unclear if outcome assessor was blinded), two levels due to imprecision (1 study with a total of 66 patients with three arms).<br/> <sup>b</sup>Downgraded by three levels to very low‐certainty evidence. One level due to study limitations (unclear allocation concealment, unclear if outcome assessor was blinded, one level due to sparce data (1 study with a total of 66 patients with 3 arms) and one level due to other considerations (unclear how adverse events were measured). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 15.</span> <span class="table-title">hAMMSC‐CM + vitamin E compared to hAMMSC‐CM + vitamin C for ulceration caused by nerve damage in leprosy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012235-tbl-0016"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Glossary of terms</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Definition</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Afferent nerves</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensory nerves that carry information from the outside world, such as sensations of heat, cold, and pain, to the brain and spinal cord. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Autonomic fibres</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nerve fibres that collectively make up the sympathetic (involuntary) and parasympathetic ('relaxation response') parts of the autonomic peripheral nervous system. Common symptoms of autonomic nerve damage include an inability to sweat normally and change in vasodilatation. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bacilli</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Plural of bacillus, bacteria.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Capillary haemodynamics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood flow in the capillaries, where oxygen transfer occurs in the body.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Efferent nerves</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Motor nerves that transmit impulses from the brain and spinal cord to the muscles.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Facial nerve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>It is composed of motor, sensory fibres and autonomic fibres. The important motor part innervates the facial muscles responsible for eye closure and mouth and facial movements. In leprosy, the eye is at risk of corneal ulceration for exposure and decreased lachrymal gland function. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fibroblast</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A large flat cell that secretes the proteins that form collagen and elastic fibres and the substance between the cells of connective tissue. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medial nerve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>It is composed of motor, sensory, and autonomic fibres. The autonomic fibres are responsible for sweating and oil gland secretion. Sensation is affected on the lateral side of the forearm and the palmar side of the hand, thumb, index, middle, and half of the ring finger. It innervates the muscles of the hand and in leprosy affects predominately the intrinsic muscles of the thumb, making opposition and prehension difficult. Weakness and paralysis causes the thumb to be flat within the hand. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor fibres</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor nerves (or efferent nerves)<i>,</i> transmit impulses from the brain and spinal cord to the muscles. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multibacillary</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Having numerous bacilli. "Multibacillary leprosy" classification by World Health Organization for the purpose of treatment is a person with more than five lesions. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Paucibacillary</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Having just a few bacilli. "Paucibacillary leprosy" classification by World Health Organization for the purpose of treatment is a person with five or fewer lesions. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Peripheral nerve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A vast transmission network of afferent and efferent nerves from the central nervous system (brain and spinal cord) distally to every other part of the body. The motor, sensory, and autonomic fibres have specific functions within the area innervated by the specific peripheral nerve. Nerves can be composed primarily of motor or sensory fibres or be mixed, having both motor and sensory fibres. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Peroneal nerve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The common peroneal divides into the superficial and deep peroneal branches. The deep branch innervates the muscles of the anterior compartment of the leg (anterior tibial muscle, the long extensor muscle of the big toe and the long extensor muscles of the toes). When weak or paralysed, it makes it difficult to lift the foot and toes as well as evert the foot when walking. In leprosy, it is frequently referred to as "foot drop". Its sensory fibres innervate the lateral dorsal surface of the lower leg and foot. The sensory fibres of the superficial branch provides sensation to the web space of the big toe and the medial surface of the second toe. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tibial nerve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One of the two major divisions of the sciatic nerve, it courses down the back of the leg to terminate as the medial and lateral plantar nerves in the foot; it supplies the hamstring muscles, the muscles of the back of the lower leg, and the intrinsic muscles of the foot. It causes clawing of the toes if muscles are paralysed. It provides sensation to the back of the leg and sole of the foot. The sensory loss to the sole of the foot puts the foot at high risk for injury and ulceration. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sensory fibres</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sensory nerves (or afferent nerves), carry information from the outside world, such as sensations of temperature (hot, cold), touch, texture and pain, to the brain and spinal cord. They alert the body to pleasant feelings as well as to danger. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sural nerve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A sensory nerve in the calf region (sura) of the leg. It is made up of collateral branches of the tibial nerve and common fibular nerve. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Trigeminal nerve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The three‐branch trigeminal (fifth cranial) nerve innervating the face, eyes, nose, mouth, and jaws. The corneal sensory loss in leprosy can cause the eye to be at risk for increased dryness and corneal abrasions. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ulceration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Formation or development of an ulcer. On the skin, it is a loss of epidermis, often part of the dermis and even subcutaneous fat layers of the skin. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ulnar nerve in the upper extremity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is composed of motor, sensory, and autonomic fibres. The autonomic fibres are responsible for sweating and oil gland secretion. Sensation is affected on the ulnar (medial) side of the forearm, hand, the palmar side of the 5th and half of the 4th fingers. It innervates the muscles of the hand and in leprosy affects predominately the distal intrinsic muscles used for fine motor tasks. Weakness and paralysis causes finger clawing. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vasodilation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A widening of the blood vessels caused by a relaxation of the smooth muscle cells in the vessel wall. The sympathetic nervous system has nerves that play an important role in vasodilatation and vasoconstriction. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Glossary of terms</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/full#CD012235-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012235-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Zinc tape versus magnesium sulphate/glycerin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of ulcers healed after one month <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mean ulcer area (mm<sup>2</sup>) after one month <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Zinc tape versus magnesium sulphate/glycerin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012235-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Zinc tape versus povidone iodine (10%)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean reduction of ulcer area at six weeks (mm<sup>2</sup>) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Zinc tape versus povidone iodine (10%)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012235-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Topical ketanserin (2%) versus clioquinol cream (3%) or zinc paste</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Healing of ulcer after three months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Topical ketanserin (2%) versus clioquinol cream (3%) or zinc paste</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012235-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Topical phenytoin (unknown solution) versus saline dressing</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean percentage of ulcer volume reduction at four weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.60 [8.46, 24.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Topical phenytoin (unknown solution) versus saline dressing</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012235-tbl-0021"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Topical 2% phenytoin versus saline dressing</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean percentage reduction of ulcer size area at four weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Topical 2% phenytoin versus saline dressing</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-tbl-0021">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012235-tbl-0022"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Topical 4% phenytoin versus saline dressing</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean percentage reduction of ulcer area at four weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Topical 4% phenytoin versus saline dressing</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-tbl-0022">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012235-tbl-0023"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Topical 4% phenytoin versus 2% phenytoin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean percentage reduction of ulcer size at four weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Topical 4% phenytoin versus 2% phenytoin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-tbl-0023">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012235-tbl-0024"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Footwear ‐ canvas shoes versus PVC boots</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of persons with healed ulcers at one year <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Number of persons having ulcers not healed at one year <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Footwear ‐ canvas shoes versus PVC boots</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-tbl-0024">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012235-tbl-0025"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Padded moulded double‐rocker plaster shoe versus padded below‐knee plaster</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Ulcers fully or nearly healed at six weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Padded moulded double‐rocker plaster shoe versus padded below‐knee plaster</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-tbl-0025">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012235-tbl-0026"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Exposure to pulsed magnetic fields (in addition to self‐care and protective footwear) versus self‐care and footwear</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean volume (cm³) of ulcers at four to five weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Exposure to pulsed magnetic fields (in addition to self‐care and protective footwear) versus self‐care and footwear</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-tbl-0026">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012235-tbl-0027"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Low‐level laser therapy versus simple dressing</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Size of ulcer (area, cm²) after 12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Size of ulcer (depth, mm) after 12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Low‐level laser therapy versus simple dressing</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-tbl-0027">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012235-tbl-0028"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Intralesional pentoxifylline versus daily simple dressing</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete healing of ulcer at 8 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Ulcer depth (cm) at 8 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Intralesional pentoxifylline versus daily simple dressing</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-tbl-0028">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012235-tbl-0029"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Light‐emitting diode (LED) versus conventional dressing</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean reduction in wound size (mm³) at 8 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Light‐emitting diode (LED) versus conventional dressing</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-tbl-0029">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012235-tbl-0030"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">hAMMSC‐CM + vitamin C versus hAMMSC‐CM</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean reduction (cm<sup>2</sup>) in ulcer size at eight weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [‐0.35, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mean reduction (cm<sup>2</sup>) in ulcer depth at eight weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.17, ‐0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">hAMMSC‐CM + vitamin C versus hAMMSC‐CM</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-tbl-0030">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012235-tbl-0031"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">hAMMSC‐CM + vitamin E versus hAMMSC‐CM</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean reduction (cm<sup>2</sup>) in ulcer size at eight weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.32, 1.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mean reduction (cm<sup>2</sup>) in ulcer depth at eight weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.17, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">hAMMSC‐CM + vitamin E versus hAMMSC‐CM</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-tbl-0031">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012235-tbl-0032"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">hAMMSC‐CM + vitamin E versus hAMMSC‐CM + vitamin C</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean reduction (cm<sup>2</sup>) in ulcer size at eight weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [‐0.03, 1.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mean reduction (cm<sup>2</sup>) in ulcer depth at eight weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.06, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">hAMMSC‐CM + vitamin E versus hAMMSC‐CM + vitamin C</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-tbl-0032">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012235-tbl-0033"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Wax therapy versus foot soaks</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of feet being fissure‐ and callous‐free at six weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Wax therapy versus foot soaks</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012235.pub2/references#CD012235-tbl-0033">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012235.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD012235-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012235-note-0021">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012235-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD012235-note-0001">Bahasa Malaysia</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012235\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012235\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012235\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012235\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012235\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012235\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012235\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012235\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012235\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012235\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012235\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012235\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012235\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012235\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012235\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012235\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012235\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012235\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=PrHmaMrX&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012235.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012235.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012235.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012235.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012235.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725669135"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012235.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725669139"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012235.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e80e0baacf466',t:'MTc0MDcyNTY2OS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 